AU2005214349B2 - Substituted azole derivatives, compositions, and methods of use - Google Patents
Substituted azole derivatives, compositions, and methods of use Download PDFInfo
- Publication number
- AU2005214349B2 AU2005214349B2 AU2005214349A AU2005214349A AU2005214349B2 AU 2005214349 B2 AU2005214349 B2 AU 2005214349B2 AU 2005214349 A AU2005214349 A AU 2005214349A AU 2005214349 A AU2005214349 A AU 2005214349A AU 2005214349 B2 AU2005214349 B2 AU 2005214349B2
- Authority
- AU
- Australia
- Prior art keywords
- phenyl
- dichloro
- imidazol
- biphenyl
- ylmethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title claims abstract description 582
- 150000007980 azole derivatives Chemical class 0.000 title abstract description 7
- 239000000203 mixture Chemical class 0.000 title description 63
- 150000001875 compounds Chemical class 0.000 claims abstract description 162
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 62
- 102000002727 Protein Tyrosine Phosphatase Human genes 0.000 claims abstract description 46
- 108020000494 protein-tyrosine phosphatase Proteins 0.000 claims abstract description 46
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 38
- 201000010099 disease Diseases 0.000 claims abstract description 32
- 239000003112 inhibitor Substances 0.000 claims abstract description 14
- 230000001404 mediated effect Effects 0.000 claims abstract description 13
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims abstract description 8
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims abstract description 6
- 229920002554 vinyl polymer Polymers 0.000 claims description 423
- -1 isoxazol-3-ol-5-yl Chemical group 0.000 claims description 391
- 239000005711 Benzoic acid Substances 0.000 claims description 312
- 125000000217 alkyl group Chemical group 0.000 claims description 164
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 87
- 239000002253 acid Substances 0.000 claims description 85
- QPJVMBTYPHYUOC-UHFFFAOYSA-N Methyl benzoate Natural products COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 claims description 84
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 54
- 150000003839 salts Chemical class 0.000 claims description 52
- 125000001424 substituent group Chemical group 0.000 claims description 52
- 239000003937 drug carrier Substances 0.000 claims description 45
- 239000001257 hydrogen Substances 0.000 claims description 36
- 229910052739 hydrogen Inorganic materials 0.000 claims description 36
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 25
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 22
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 19
- 125000002947 alkylene group Chemical group 0.000 claims description 18
- 239000003814 drug Substances 0.000 claims description 18
- 230000015572 biosynthetic process Effects 0.000 claims description 17
- 238000003786 synthesis reaction Methods 0.000 claims description 15
- 229940124597 therapeutic agent Drugs 0.000 claims description 13
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 claims description 12
- 108010051696 Growth Hormone Proteins 0.000 claims description 12
- 239000000122 growth hormone Substances 0.000 claims description 12
- 102000004877 Insulin Human genes 0.000 claims description 11
- 108090001061 Insulin Proteins 0.000 claims description 11
- 230000002401 inhibitory effect Effects 0.000 claims description 11
- 229940125396 insulin Drugs 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 claims description 8
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 claims description 8
- 208000002705 Glucose Intolerance Diseases 0.000 claims description 7
- 206010018429 Glucose tolerance impaired Diseases 0.000 claims description 7
- 206010028980 Neoplasm Diseases 0.000 claims description 7
- 239000003102 growth factor Substances 0.000 claims description 7
- 208000030507 AIDS Diseases 0.000 claims description 6
- 208000024827 Alzheimer disease Diseases 0.000 claims description 6
- 208000035473 Communicable disease Diseases 0.000 claims description 6
- 102000004127 Cytokines Human genes 0.000 claims description 6
- 108090000695 Cytokines Proteins 0.000 claims description 6
- 208000008589 Obesity Diseases 0.000 claims description 6
- 201000004681 Psoriasis Diseases 0.000 claims description 6
- 230000008512 biological response Effects 0.000 claims description 6
- 201000011510 cancer Diseases 0.000 claims description 6
- 229940088597 hormone Drugs 0.000 claims description 6
- 239000005556 hormone Substances 0.000 claims description 6
- 208000026278 immune system disease Diseases 0.000 claims description 6
- 239000003607 modifier Substances 0.000 claims description 6
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims description 6
- 235000020824 obesity Nutrition 0.000 claims description 6
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 claims description 5
- 229940123208 Biguanide Drugs 0.000 claims description 5
- 229920001268 Cholestyramine Polymers 0.000 claims description 5
- 108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 claims description 5
- 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 claims description 5
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 claims description 5
- 229940122199 Insulin secretagogue Drugs 0.000 claims description 5
- 229940122355 Insulin sensitizer Drugs 0.000 claims description 5
- 229940100389 Sulfonylurea Drugs 0.000 claims description 5
- 229960002632 acarbose Drugs 0.000 claims description 5
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 claims description 5
- 239000012190 activator Substances 0.000 claims description 5
- 229930013930 alkaloid Natural products 0.000 claims description 5
- 239000002168 alkylating agent Substances 0.000 claims description 5
- 229940100198 alkylating agent Drugs 0.000 claims description 5
- 230000000340 anti-metabolite Effects 0.000 claims description 5
- 239000001961 anticonvulsive agent Substances 0.000 claims description 5
- 239000000935 antidepressant agent Substances 0.000 claims description 5
- 229940005513 antidepressants Drugs 0.000 claims description 5
- 229940100197 antimetabolite Drugs 0.000 claims description 5
- 239000002256 antimetabolite Substances 0.000 claims description 5
- 230000037396 body weight Effects 0.000 claims description 5
- 229940125753 fibrate Drugs 0.000 claims description 5
- 239000003862 glucocorticoid Substances 0.000 claims description 5
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 claims description 5
- 208000027866 inflammatory disease Diseases 0.000 claims description 5
- 208000023275 Autoimmune disease Diseases 0.000 claims description 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 4
- 208000015181 infectious disease Diseases 0.000 claims description 4
- HSROEKDCBORKAF-OVCLIPMQSA-N 4-[[4-(2,4-difluorophenyl)-2-[(e)-2-[4-[3-(trifluoromethyl)phenyl]phenyl]ethenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC(F)=CC=2)F)=C1 HSROEKDCBORKAF-OVCLIPMQSA-N 0.000 claims description 3
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 claims description 3
- 229940126033 PPAR agonist Drugs 0.000 claims description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 claims description 3
- 230000000202 analgesic effect Effects 0.000 claims description 3
- 230000001773 anti-convulsant effect Effects 0.000 claims description 3
- 230000001430 anti-depressive effect Effects 0.000 claims description 3
- 230000000561 anti-psychotic effect Effects 0.000 claims description 3
- 229960003965 antiepileptics Drugs 0.000 claims description 3
- 230000003115 biocidal effect Effects 0.000 claims description 3
- 239000000544 cholinesterase inhibitor Substances 0.000 claims description 3
- RIXQNBZYAOTNAH-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[[4-[3-(trifluoromethyl)phenyl]phenyl]methyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(CC=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 RIXQNBZYAOTNAH-UHFFFAOYSA-N 0.000 claims description 3
- BNJUVNAHELIDJJ-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[[4-[4-(trifluoromethyl)phenyl]phenyl]methyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(CC=2C=CC(=CC=2)C=2C=CC(=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 BNJUVNAHELIDJJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims description 3
- 239000002307 peroxisome proliferator activated receptor agonist Substances 0.000 claims description 3
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 claims description 3
- KOEQTENTJFSOHT-CXUHLZMHSA-N 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-(3-methylsulfonylphenyl)phenyl]ethenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound CS(=O)(=O)C1=CC=CC(C=2C=CC(\C=C\C=3N(C=C(N=3)C=3C(=CC(Cl)=CC=3)Cl)CC=3C=CC(=CC=3)C(O)=O)=CC=2)=C1 KOEQTENTJFSOHT-CXUHLZMHSA-N 0.000 claims description 2
- VQCXCIIBIOEJFX-OVCLIPMQSA-N 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-[3-(trifluoromethyl)phenyl]phenyl]ethenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 VQCXCIIBIOEJFX-OVCLIPMQSA-N 0.000 claims description 2
- UUWVTNCNELQWLK-FZSIALSZSA-N 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-[4-(trifluoromethyl)phenyl]phenyl]ethenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=CC(=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 UUWVTNCNELQWLK-FZSIALSZSA-N 0.000 claims description 2
- GGOIDUCNVZOMHK-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[2-[4-[4-(trifluoromethyl)phenyl]phenyl]ethyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(CCC=2C=CC(=CC=2)C=2C=CC(=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 GGOIDUCNVZOMHK-UHFFFAOYSA-N 0.000 claims description 2
- 229940122041 Cholinesterase inhibitor Drugs 0.000 claims description 2
- 102000003914 Cholinesterases Human genes 0.000 claims description 2
- 108090000322 Cholinesterases Proteins 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- 229940048961 cholinesterase Drugs 0.000 claims description 2
- 102100025101 GATA-type zinc finger protein 1 Human genes 0.000 claims 2
- 102000018997 Growth Hormone Human genes 0.000 claims 2
- 101001032756 Rattus norvegicus Granzyme-like protein 1 Proteins 0.000 claims 2
- XNLWJFYYOIRPIO-UHFFFAOYSA-N 3-phenylbenzoic acid Chemical compound OC(=O)C1=CC=CC(C=2C=CC=CC=2)=C1 XNLWJFYYOIRPIO-UHFFFAOYSA-N 0.000 claims 1
- PAGBHTZDVXZRCN-OVCLIPMQSA-N 4-[[2-[(e)-2-[4-(3-cyanophenyl)phenyl]ethenyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=C(C=CC=2)C#N)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 PAGBHTZDVXZRCN-OVCLIPMQSA-N 0.000 claims 1
- ASXCPWOLCBTNNI-UFWORHAWSA-N 4-[[2-[(e)-2-[4-(4-butoxyphenyl)phenyl]ethenyl]-4-(2,4-difluorophenyl)imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(OCCCC)=CC=C1C(C=C1)=CC=C1\C=C\C1=NC(C=2C(=CC(F)=CC=2)F)=CN1CC1=CC=C(C(O)=O)C=C1 ASXCPWOLCBTNNI-UFWORHAWSA-N 0.000 claims 1
- UQBKDKHIBOFDGF-CXUHLZMHSA-N 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-(2-fluoro-6-methoxyphenyl)phenyl]ethenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound COC1=CC=CC(F)=C1C(C=C1)=CC=C1\C=C\C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CC1=CC=C(C(O)=O)C=C1 UQBKDKHIBOFDGF-CXUHLZMHSA-N 0.000 claims 1
- DTMSWCICBXBSAP-UBKPWBPPSA-N 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-(4-methylsulfonylphenyl)phenyl]ethenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C(C=C1)=CC=C1\C=C\C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CC1=CC=C(C(O)=O)C=C1 DTMSWCICBXBSAP-UBKPWBPPSA-N 0.000 claims 1
- IMHWADHAWYAYOF-CXUHLZMHSA-N 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-[3-(methanesulfonamido)phenyl]phenyl]ethenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound CS(=O)(=O)NC1=CC=CC(C=2C=CC(\C=C\C=3N(C=C(N=3)C=3C(=CC(Cl)=CC=3)Cl)CC=3C=CC(=CC=3)C(O)=O)=CC=2)=C1 IMHWADHAWYAYOF-CXUHLZMHSA-N 0.000 claims 1
- KRSFENHPGWHVTP-OVCLIPMQSA-N 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-[3-(trifluoromethylsulfonylamino)phenyl]phenyl]ethenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=C(NS(=O)(=O)C(F)(F)F)C=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 KRSFENHPGWHVTP-OVCLIPMQSA-N 0.000 claims 1
- SXCDIMQFEGHCBV-UBKPWBPPSA-N 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-[4-(4,4,4-trifluorobutoxy)phenyl]phenyl]ethenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=CC(OCCCC(F)(F)F)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 SXCDIMQFEGHCBV-UBKPWBPPSA-N 0.000 claims 1
- UANLRKGBZGLHHY-UBKPWBPPSA-N 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-[4-(methanesulfonamido)phenyl]phenyl]ethenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(NS(=O)(=O)C)=CC=C1C(C=C1)=CC=C1\C=C\C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CC1=CC=C(C(O)=O)C=C1 UANLRKGBZGLHHY-UBKPWBPPSA-N 0.000 claims 1
- HMUKGHJJVPAMQT-LICLKQGHSA-N methyl 3-[4-[(e)-2-[4-(2,4-dichlorophenyl)-1-[(4-methoxycarbonylphenyl)methyl]imidazol-2-yl]ethenyl]phenyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(=O)OC)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 HMUKGHJJVPAMQT-LICLKQGHSA-N 0.000 claims 1
- VQAWPDCWVWTFIX-LICLKQGHSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-(3-methylsulfonylphenyl)phenyl]ethenyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=C(C=CC=2)S(C)(=O)=O)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 VQAWPDCWVWTFIX-LICLKQGHSA-N 0.000 claims 1
- XPOFBHIORQFYGE-CNHKJKLMSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-(4-methylsulfonylphenyl)phenyl]ethenyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=CC(=CC=2)S(C)(=O)=O)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 XPOFBHIORQFYGE-CNHKJKLMSA-N 0.000 claims 1
- ZFTXBNKZVLNXEK-CNHKJKLMSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-[4-(4,4,4-trifluorobutoxy)phenyl]phenyl]ethenyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=CC(OCCCC(F)(F)F)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 ZFTXBNKZVLNXEK-CNHKJKLMSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 13
- 238000002360 preparation method Methods 0.000 abstract description 13
- 208000035475 disorder Diseases 0.000 abstract description 6
- 241001465754 Metazoa Species 0.000 abstract description 2
- 229960004365 benzoic acid Drugs 0.000 description 300
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 286
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 225
- 238000005481 NMR spectroscopy Methods 0.000 description 159
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 131
- 235000010233 benzoic acid Nutrition 0.000 description 116
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 93
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 90
- 125000003118 aryl group Chemical group 0.000 description 71
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 70
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 68
- 235000019439 ethyl acetate Nutrition 0.000 description 62
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 61
- 239000000460 chlorine Substances 0.000 description 57
- 239000010410 layer Substances 0.000 description 50
- 150000002148 esters Chemical class 0.000 description 48
- DASJDMQCPIDJIF-UHFFFAOYSA-N 2-bromo-1-(2,4-dichlorophenyl)ethanone Chemical compound ClC1=CC=C(C(=O)CBr)C(Cl)=C1 DASJDMQCPIDJIF-UHFFFAOYSA-N 0.000 description 47
- 125000003545 alkoxy group Chemical group 0.000 description 46
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 41
- 229910052757 nitrogen Inorganic materials 0.000 description 39
- 239000011541 reaction mixture Substances 0.000 description 39
- 150000004702 methyl esters Chemical class 0.000 description 37
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 36
- 239000011734 sodium Substances 0.000 description 36
- 229960000583 acetic acid Drugs 0.000 description 35
- 238000006467 substitution reaction Methods 0.000 description 35
- NLWBJPPMPLPZIE-UHFFFAOYSA-N methyl 4-(bromomethyl)benzoate Chemical compound COC(=O)C1=CC=C(CBr)C=C1 NLWBJPPMPLPZIE-UHFFFAOYSA-N 0.000 description 33
- 238000010898 silica gel chromatography Methods 0.000 description 33
- 239000000243 solution Substances 0.000 description 33
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 31
- 239000012044 organic layer Substances 0.000 description 31
- CPDDDTNAMBSPRN-ZZXKWVIFSA-N (e)-3-(4-bromophenyl)prop-2-enoic acid Chemical compound OC(=O)\C=C\C1=CC=C(Br)C=C1 CPDDDTNAMBSPRN-ZZXKWVIFSA-N 0.000 description 29
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 29
- 239000012267 brine Substances 0.000 description 29
- 125000000623 heterocyclic group Chemical group 0.000 description 29
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 29
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 28
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- 125000001072 heteroaryl group Chemical group 0.000 description 27
- 239000002904 solvent Substances 0.000 description 27
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 26
- 239000004305 biphenyl Substances 0.000 description 24
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 21
- 229910052736 halogen Inorganic materials 0.000 description 21
- 239000000725 suspension Substances 0.000 description 21
- 125000004647 alkyl sulfenyl group Chemical group 0.000 description 20
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 20
- 125000004414 alkyl thio group Chemical group 0.000 description 20
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 20
- 125000000753 cycloalkyl group Chemical group 0.000 description 20
- 150000002367 halogens Chemical group 0.000 description 20
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 20
- 125000005010 perfluoroalkyl group Chemical group 0.000 description 19
- YDCHPLOFQATIDS-UHFFFAOYSA-N methyl 2-bromoacetate Chemical compound COC(=O)CBr YDCHPLOFQATIDS-UHFFFAOYSA-N 0.000 description 18
- 125000004043 oxo group Chemical group O=* 0.000 description 18
- 239000000543 intermediate Substances 0.000 description 16
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 16
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 15
- WOAORAPRPVIATR-UHFFFAOYSA-N [3-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=CC(C(F)(F)F)=C1 WOAORAPRPVIATR-UHFFFAOYSA-N 0.000 description 15
- 125000004188 dichlorophenyl group Chemical group 0.000 description 15
- 239000000706 filtrate Substances 0.000 description 15
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 15
- 125000004429 atom Chemical group 0.000 description 14
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 14
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 13
- 125000006239 protecting group Chemical group 0.000 description 13
- 230000002829 reductive effect Effects 0.000 description 13
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 description 13
- 125000006296 sulfonyl amino group Chemical group [H]N(*)S(*)(=O)=O 0.000 description 13
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 125000003342 alkenyl group Chemical group 0.000 description 12
- 125000000304 alkynyl group Chemical group 0.000 description 12
- 239000002585 base Substances 0.000 description 12
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 12
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 11
- COIQUVGFTILYGA-UHFFFAOYSA-N (4-hydroxyphenyl)boronic acid Chemical compound OB(O)C1=CC=C(O)C=C1 COIQUVGFTILYGA-UHFFFAOYSA-N 0.000 description 10
- LRYZJEXQHWCLJY-UHFFFAOYSA-N 1-phenyl-2-(trifluoromethyl)benzene Chemical group FC(F)(F)C1=CC=CC=C1C1=CC=CC=C1 LRYZJEXQHWCLJY-UHFFFAOYSA-N 0.000 description 10
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 10
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
- 102100038803 Somatotropin Human genes 0.000 description 10
- 125000004432 carbon atom Chemical group C* 0.000 description 10
- 238000010931 ester hydrolysis Methods 0.000 description 10
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 10
- 229910052717 sulfur Inorganic materials 0.000 description 10
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 10
- ZEEPSBBAWJEOQY-UHFFFAOYSA-N 2-[(4-bromophenyl)methyl]-5-(2,4-dichlorophenyl)-1h-imidazole Chemical compound ClC1=CC(Cl)=CC=C1C1=CNC(CC=2C=CC(Br)=CC=2)=N1 ZEEPSBBAWJEOQY-UHFFFAOYSA-N 0.000 description 9
- 239000004215 Carbon black (E152) Substances 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 9
- 229930195733 hydrocarbon Natural products 0.000 description 9
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 description 9
- RJLCEKIRWRVWNQ-UHFFFAOYSA-N methyl 4-[[2-[(4-bromophenyl)methyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(CC=2C=CC(Br)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 RJLCEKIRWRVWNQ-UHFFFAOYSA-N 0.000 description 9
- KXKVLQRXCPHEJC-UHFFFAOYSA-N methyl acetate Chemical compound COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 9
- VOLRSQPSJGXRNJ-UHFFFAOYSA-N 4-nitrobenzyl bromide Chemical compound [O-][N+](=O)C1=CC=C(CBr)C=C1 VOLRSQPSJGXRNJ-UHFFFAOYSA-N 0.000 description 8
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 8
- 150000001412 amines Chemical class 0.000 description 8
- 125000000732 arylene group Chemical group 0.000 description 8
- 150000001735 carboxylic acids Chemical class 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 125000005843 halogen group Chemical group 0.000 description 8
- 239000012074 organic phase Substances 0.000 description 8
- 230000036961 partial effect Effects 0.000 description 8
- 239000000546 pharmaceutical excipient Substances 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 239000012453 solvate Substances 0.000 description 8
- 229940124530 sulfonamide Drugs 0.000 description 8
- HZFFUMBZBGETES-UHFFFAOYSA-N (3-methylsulfonylphenyl)boronic acid Chemical compound CS(=O)(=O)C1=CC=CC(B(O)O)=C1 HZFFUMBZBGETES-UHFFFAOYSA-N 0.000 description 7
- 125000002252 acyl group Chemical group 0.000 description 7
- 125000004423 acyloxy group Chemical group 0.000 description 7
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 7
- 150000001408 amides Chemical class 0.000 description 7
- 125000003435 aroyl group Chemical group 0.000 description 7
- 125000005333 aroyloxy group Chemical group 0.000 description 7
- 150000001502 aryl halides Chemical class 0.000 description 7
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 7
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 7
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 7
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 7
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N ethyl benzoate Chemical compound CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 7
- 125000000524 functional group Chemical group 0.000 description 7
- 125000003037 imidazol-2-yl group Chemical group [H]N1C([*])=NC([H])=C1[H] 0.000 description 7
- 229910052740 iodine Inorganic materials 0.000 description 7
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 7
- 229940002612 prodrug Drugs 0.000 description 7
- 239000000651 prodrug Substances 0.000 description 7
- XTQHKBHJIVJGKJ-UHFFFAOYSA-N sulfur monoxide Chemical compound S=O XTQHKBHJIVJGKJ-UHFFFAOYSA-N 0.000 description 7
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 6
- FBRJYBGLCHWYOE-UHFFFAOYSA-N 2-(trifluoromethyl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1C(F)(F)F FBRJYBGLCHWYOE-UHFFFAOYSA-N 0.000 description 6
- 102400000322 Glucagon-like peptide 1 Human genes 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- 102100033001 Tyrosine-protein phosphatase non-receptor type 1 Human genes 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 6
- 125000004442 acylamino group Chemical group 0.000 description 6
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 description 6
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 description 6
- 125000005275 alkylenearyl group Chemical group 0.000 description 6
- 125000004419 alkynylene group Chemical group 0.000 description 6
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 6
- 238000005859 coupling reaction Methods 0.000 description 6
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 125000005842 heteroatom Chemical group 0.000 description 6
- 150000002431 hydrogen Chemical class 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- FBNUVJGXPPSQKT-UHFFFAOYSA-N methyl 4-[[2-(4-bromophenyl)-4-(2,4-dichlorophenyl)imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(C=2C=CC(Br)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 FBNUVJGXPPSQKT-UHFFFAOYSA-N 0.000 description 6
- 230000036515 potency Effects 0.000 description 6
- 229910000104 sodium hydride Inorganic materials 0.000 description 6
- 239000003765 sweetening agent Substances 0.000 description 6
- QOWSWEBLNVACCL-UHFFFAOYSA-N 4-Bromophenyl acetate Chemical compound OC(=O)CC1=CC=C(Br)C=C1 QOWSWEBLNVACCL-UHFFFAOYSA-N 0.000 description 5
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 5
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 5
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 5
- GELXFVQAWNTGPQ-UHFFFAOYSA-N [N].C1=CNC=N1 Chemical compound [N].C1=CNC=N1 GELXFVQAWNTGPQ-UHFFFAOYSA-N 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 229940050390 benzoate Drugs 0.000 description 5
- 235000010290 biphenyl Nutrition 0.000 description 5
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 5
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000007859 condensation product Substances 0.000 description 5
- 230000008878 coupling Effects 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 5
- 125000004367 cycloalkylaryl group Chemical group 0.000 description 5
- 125000005215 cycloalkylheteroaryl group Chemical group 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 150000001987 diarylethers Chemical class 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- SNRNTDKTXDJNBA-UHFFFAOYSA-N ethyl 4-[2-[(4-bromophenyl)methyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1N1C(CC=2C=CC(Br)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 SNRNTDKTXDJNBA-UHFFFAOYSA-N 0.000 description 5
- GWOAQFMQVYNVLB-UHFFFAOYSA-N ethyl 4-[4-(2,4-dichlorophenyl)-2-[[4-(4-hydroxyphenyl)phenyl]methyl]imidazol-1-yl]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1N1C(CC=2C=CC(=CC=2)C=2C=CC(O)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 GWOAQFMQVYNVLB-UHFFFAOYSA-N 0.000 description 5
- UMPRJGKLMUDRHL-UHFFFAOYSA-N ethyl 4-fluorobenzoate Chemical compound CCOC(=O)C1=CC=C(F)C=C1 UMPRJGKLMUDRHL-UHFFFAOYSA-N 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 235000003599 food sweetener Nutrition 0.000 description 5
- 125000005549 heteroarylene group Chemical group 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- OVPLZYJGTGDFNB-UHFFFAOYSA-N propan-2-yl carbamate Chemical compound CC(C)OC(N)=O OVPLZYJGTGDFNB-UHFFFAOYSA-N 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- 239000012312 sodium hydride Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 5
- XMCRWEBERCXJCH-UHFFFAOYSA-N 1-(2,4-dichlorophenyl)ethanone Chemical compound CC(=O)C1=CC=C(Cl)C=C1Cl XMCRWEBERCXJCH-UHFFFAOYSA-N 0.000 description 4
- CSGDTHXBRAAOHV-UHFFFAOYSA-N 2-bromo-1-(2,4-difluorophenyl)ethanone Chemical compound FC1=CC=C(C(=O)CBr)C(F)=C1 CSGDTHXBRAAOHV-UHFFFAOYSA-N 0.000 description 4
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 4
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 4
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 4
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 4
- HUOFUOCSQCYFPW-UHFFFAOYSA-N [4-(trifluoromethoxy)phenyl]boronic acid Chemical compound OB(O)C1=CC=C(OC(F)(F)F)C=C1 HUOFUOCSQCYFPW-UHFFFAOYSA-N 0.000 description 4
- 125000003158 alcohol group Chemical group 0.000 description 4
- 230000029936 alkylation Effects 0.000 description 4
- 238000005804 alkylation reaction Methods 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 239000003435 antirheumatic agent Substances 0.000 description 4
- 239000007900 aqueous suspension Substances 0.000 description 4
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 4
- 125000001246 bromo group Chemical group Br* 0.000 description 4
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 239000002988 disease modifying antirheumatic drug Substances 0.000 description 4
- 239000002270 dispersing agent Substances 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 4
- JMZFEHDNIAQMNB-UHFFFAOYSA-N m-aminophenylboronic acid Chemical compound NC1=CC=CC(B(O)O)=C1 JMZFEHDNIAQMNB-UHFFFAOYSA-N 0.000 description 4
- SOGFJZKOBONTPT-AWNIVKPZSA-N methyl 4-[[2-[(e)-2-(4-bromophenyl)ethenyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(\C=C\C=2C=CC(Br)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 SOGFJZKOBONTPT-AWNIVKPZSA-N 0.000 description 4
- VOIRJTGXKQVRAJ-UHFFFAOYSA-N methyl 4-[[2-[[4-(3-aminophenyl)phenyl]methyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(CC=2C=CC(=CC=2)C=2C=C(N)C=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 VOIRJTGXKQVRAJ-UHFFFAOYSA-N 0.000 description 4
- KGDQMNVZZNCLBF-UHFFFAOYSA-N methyl 5-fluoro-2-(trifluoromethyl)benzoate Chemical compound COC(=O)C1=CC(F)=CC=C1C(F)(F)F KGDQMNVZZNCLBF-UHFFFAOYSA-N 0.000 description 4
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 4
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 239000000375 suspending agent Substances 0.000 description 4
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 4
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 4
- 239000000080 wetting agent Substances 0.000 description 4
- WRQNDLDUNQMTCL-UHFFFAOYSA-N (4-ethoxyphenyl)boronic acid Chemical compound CCOC1=CC=C(B(O)O)C=C1 WRQNDLDUNQMTCL-UHFFFAOYSA-N 0.000 description 3
- VOAAEKKFGLPLLU-UHFFFAOYSA-N (4-methoxyphenyl)boronic acid Chemical compound COC1=CC=C(B(O)O)C=C1 VOAAEKKFGLPLLU-UHFFFAOYSA-N 0.000 description 3
- MNJYZNVROSZZQC-UHFFFAOYSA-N (4-tert-butylphenyl)boronic acid Chemical compound CC(C)(C)C1=CC=C(B(O)O)C=C1 MNJYZNVROSZZQC-UHFFFAOYSA-N 0.000 description 3
- QABZTGNRWBRJBO-GORDUTHDSA-N (e)-3-(5-bromo-2-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(Br)C=C1\C=C\C(O)=O QABZTGNRWBRJBO-GORDUTHDSA-N 0.000 description 3
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 3
- WFQDTOYDVUWQMS-UHFFFAOYSA-N 1-fluoro-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C=C1 WFQDTOYDVUWQMS-UHFFFAOYSA-N 0.000 description 3
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 3
- IBAHURGLDDFWHM-UHFFFAOYSA-N 2-(4-bromophenyl)-5-(2,4-dichlorophenyl)-1h-imidazole Chemical compound ClC1=CC(Cl)=CC=C1C1=CNC(C=2C=CC(Br)=CC=2)=N1 IBAHURGLDDFWHM-UHFFFAOYSA-N 0.000 description 3
- PHVIBSLNGTZEGJ-UHFFFAOYSA-N 2-[(4-bromophenoxy)methyl]-5-(2,4-dichlorophenyl)-1h-imidazole Chemical compound ClC1=CC(Cl)=CC=C1C1=CNC(COC=2C=CC(Br)=CC=2)=N1 PHVIBSLNGTZEGJ-UHFFFAOYSA-N 0.000 description 3
- LGMWGXGEUNTNKY-UHFFFAOYSA-N 4-[4-[[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]methyl]phenyl]phenol Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1CC(C=C1)=CC=C1C1=CC=C(O)C=C1 LGMWGXGEUNTNKY-UHFFFAOYSA-N 0.000 description 3
- DFDLFGGAFPNDEG-OVCLIPMQSA-N 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-[3-(trifluoromethyl)phenyl]phenyl]ethenyl]imidazol-1-yl]methyl]aniline Chemical compound C1=CC(N)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 DFDLFGGAFPNDEG-OVCLIPMQSA-N 0.000 description 3
- ZCQRTQRBPDVSID-UHFFFAOYSA-N 5-(2,4-dichlorophenyl)-2-(4-methoxyphenyl)-1h-imidazole Chemical compound C1=CC(OC)=CC=C1C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1 ZCQRTQRBPDVSID-UHFFFAOYSA-N 0.000 description 3
- NTUHXZBTKLKQHF-YIXHJXPBSA-N 5-(2,4-dichlorophenyl)-2-[(e)-2-[4-(4-methoxyphenyl)phenyl]ethenyl]-1h-imidazole Chemical compound C1=CC(OC)=CC=C1C(C=C1)=CC=C1\C=C\C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1 NTUHXZBTKLKQHF-YIXHJXPBSA-N 0.000 description 3
- CMFNPQVFMAPHRV-UHFFFAOYSA-N 5-[4-[4-[[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]methyl]phenyl]phenoxy]-2-(trifluoromethyl)benzoic acid Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1CC(C=C1)=CC=C1C(C=C1)=CC=C1OC1=CC=C(C(F)(F)F)C(C(O)=O)=C1 CMFNPQVFMAPHRV-UHFFFAOYSA-N 0.000 description 3
- KBTUEDXGIYWFQT-UHFFFAOYSA-N 6-(4-tert-butylphenoxy)isoquinoline-3-carboxylic acid Chemical compound C1=CC(C(C)(C)C)=CC=C1OC1=CC=C(C=NC(=C2)C(O)=O)C2=C1 KBTUEDXGIYWFQT-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 229910004373 HOAc Inorganic materials 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 101001087394 Homo sapiens Tyrosine-protein phosphatase non-receptor type 1 Proteins 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 101001134300 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Multidomain regulatory protein Rv1364c Proteins 0.000 description 3
- 101000615835 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Phosphoserine phosphatase SerB2 Proteins 0.000 description 3
- 101001082202 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Triple specificity protein phosphatase PtpB Proteins 0.000 description 3
- 101001134301 Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) Multidomain regulatory protein MT1410 Proteins 0.000 description 3
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 102100028516 Receptor-type tyrosine-protein phosphatase U Human genes 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical class O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 3
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 3
- 101710128896 Tyrosine-protein phosphatase non-receptor type 1 Proteins 0.000 description 3
- 125000006241 alcohol protecting group Chemical group 0.000 description 3
- 125000004450 alkenylene group Chemical group 0.000 description 3
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- 125000004350 aryl cycloalkyl group Chemical group 0.000 description 3
- 125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 229910000024 caesium carbonate Inorganic materials 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 125000006627 ethoxycarbonylamino group Chemical group 0.000 description 3
- YNCKJZLWICAACG-UHFFFAOYSA-N ethyl 4-[2-[[4-(4-aminophenyl)phenyl]methyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1N1C(CC=2C=CC(=CC=2)C=2C=CC(N)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 YNCKJZLWICAACG-UHFFFAOYSA-N 0.000 description 3
- 238000003818 flash chromatography Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 125000005349 heteroarylcycloalkyl group Chemical group 0.000 description 3
- 125000006629 isopropoxycarbonylamino group Chemical group 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 238000007726 management method Methods 0.000 description 3
- 125000006626 methoxycarbonylamino group Chemical group 0.000 description 3
- AEVVPCLMVOUGEX-AWNIVKPZSA-N methyl 4-[[2-[(e)-2-(4-aminophenyl)ethenyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(\C=C\C=2C=CC(N)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 AEVVPCLMVOUGEX-AWNIVKPZSA-N 0.000 description 3
- YVSPBHMYSFRMMT-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-(4-hydroxyphenyl)imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(C=2C=CC(O)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 YVSPBHMYSFRMMT-UHFFFAOYSA-N 0.000 description 3
- MOKBNNULLFUDGE-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[4-(4-hydroxyphenyl)phenyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(C=2C=CC(=CC=2)C=2C=CC(O)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 MOKBNNULLFUDGE-UHFFFAOYSA-N 0.000 description 3
- BJDQLBHBRPQKIE-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[4-[(4-methylsulfonylphenyl)methoxy]phenyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(C=2C=CC(OCC=3C=CC(=CC=3)S(C)(=O)=O)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 BJDQLBHBRPQKIE-UHFFFAOYSA-N 0.000 description 3
- WHGLCUIWOLTJKG-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[[4-(4-hydroxyphenyl)phenyl]methyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(CC=2C=CC(=CC=2)C=2C=CC(O)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 WHGLCUIWOLTJKG-UHFFFAOYSA-N 0.000 description 3
- QAWFLJGZSZIZHO-UHFFFAOYSA-N methyl 4-bromobutanoate Chemical compound COC(=O)CCCBr QAWFLJGZSZIZHO-UHFFFAOYSA-N 0.000 description 3
- LCAUVFVOLNRVKG-UHFFFAOYSA-N methyl 5-fluoro-2-nitrobenzoate Chemical compound COC(=O)C1=CC(F)=CC=C1[N+]([O-])=O LCAUVFVOLNRVKG-UHFFFAOYSA-N 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 125000003367 polycyclic group Chemical group 0.000 description 3
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 3
- VXGABWCSZZWXPC-UHFFFAOYSA-N sarcosine methyl ester hydrochloride Natural products CNCC(=O)OC VXGABWCSZZWXPC-UHFFFAOYSA-N 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000010269 sulphur dioxide Nutrition 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 3
- 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 description 3
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- QUPFQMXWFNJUNJ-UHFFFAOYSA-N (4-butoxyphenyl)boronic acid Chemical compound CCCCOC1=CC=C(B(O)O)C=C1 QUPFQMXWFNJUNJ-UHFFFAOYSA-N 0.000 description 2
- VDUKDQTYMWUSAC-UHFFFAOYSA-N (4-methylsulfonylphenyl)boronic acid Chemical compound CS(=O)(=O)C1=CC=C(B(O)O)C=C1 VDUKDQTYMWUSAC-UHFFFAOYSA-N 0.000 description 2
- YEMUSDCFQUBPAL-SNAWJCMRSA-N (e)-3-(3-bromophenyl)prop-2-enoic acid Chemical compound OC(=O)\C=C\C1=CC=CC(Br)=C1 YEMUSDCFQUBPAL-SNAWJCMRSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 2
- WCPFQQHADRJANG-UHFFFAOYSA-N 1-(4-methoxyphenyl)cyclopropane-1-carboxylic acid Chemical compound C1=CC(OC)=CC=C1C1(C(O)=O)CC1 WCPFQQHADRJANG-UHFFFAOYSA-N 0.000 description 2
- ZZBKSEMEGZSSRR-UHFFFAOYSA-N 1-[(4-bromophenyl)methyl]-4-(2,4-dichlorophenyl)-2-(4-methoxyphenyl)imidazole Chemical compound C1=CC(OC)=CC=C1C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CC1=CC=C(Br)C=C1 ZZBKSEMEGZSSRR-UHFFFAOYSA-N 0.000 description 2
- VQQMFKBSWXTTPO-VOTSOKGWSA-N 1-[(E)-2-(3-bromophenyl)ethenyl]-4-(2,4-dichlorophenyl)imidazole Chemical compound BrC=1C=C(C=CC1)/C=C/N1C=NC(=C1)C1=C(C=C(C=C1)Cl)Cl VQQMFKBSWXTTPO-VOTSOKGWSA-N 0.000 description 2
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 2
- YIBLNPVJFPNRCQ-UHFFFAOYSA-N 1-hydroxy-4-phenylcyclohexa-2,4-diene-1-carboxylic acid Chemical compound C1=CC(C(=O)O)(O)CC=C1C1=CC=CC=C1 YIBLNPVJFPNRCQ-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 2
- SZEBGAQWWSUOHT-UHFFFAOYSA-N 2-(4-bromophenoxy)acetic acid Chemical compound OC(=O)COC1=CC=C(Br)C=C1 SZEBGAQWWSUOHT-UHFFFAOYSA-N 0.000 description 2
- ZHSXRUUAVWAKHM-UHFFFAOYSA-N 2-[(4-bromophenyl)methyl]-4-(2,4-dichlorophenyl)-1-ethylimidazole Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1CC1=CC=C(Br)C=C1 ZHSXRUUAVWAKHM-UHFFFAOYSA-N 0.000 description 2
- YURDOBSCDWLBBM-FPYGCLRLSA-N 2-[(e)-2-(4-bromophenyl)ethenyl]-5-(2,4-dichlorophenyl)-1h-imidazole Chemical compound ClC1=CC(Cl)=CC=C1C1=CNC(\C=C\C=2C=CC(Br)=CC=2)=N1 YURDOBSCDWLBBM-FPYGCLRLSA-N 0.000 description 2
- BRVYWEUSLHVZAV-FPYGCLRLSA-N 2-[(e)-2-(4-bromophenyl)ethenyl]-5-(2,4-difluorophenyl)-1h-imidazole Chemical compound FC1=CC(F)=CC=C1C1=CNC(\C=C\C=2C=CC(Br)=CC=2)=N1 BRVYWEUSLHVZAV-FPYGCLRLSA-N 0.000 description 2
- ZGEUNYOPCNCPCE-FARCUNLSSA-N 2-[(e)-2-(5-bromo-2-methoxyphenyl)ethenyl]-5-(2,4-dichlorophenyl)-1h-imidazole Chemical compound COC1=CC=C(Br)C=C1\C=C\C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1 ZGEUNYOPCNCPCE-FARCUNLSSA-N 0.000 description 2
- OYIFNHCXNCRBQI-UHFFFAOYSA-N 2-aminoadipic acid Chemical compound OC(=O)C(N)CCCC(O)=O OYIFNHCXNCRBQI-UHFFFAOYSA-N 0.000 description 2
- IZHVBANLECCAGF-UHFFFAOYSA-N 2-hydroxy-3-(octadecanoyloxy)propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC IZHVBANLECCAGF-UHFFFAOYSA-N 0.000 description 2
- KCZLRXZFRLFOGP-CXUHLZMHSA-N 3-[4-[(e)-2-[4-(2,4-dichlorophenyl)-1-[(4-methoxycarbonylphenyl)methyl]imidazol-2-yl]ethenyl]phenyl]benzoic acid Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(O)=O)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 KCZLRXZFRLFOGP-CXUHLZMHSA-N 0.000 description 2
- OZZZHXFJLJHIJW-UHFFFAOYSA-N 3-[4-[[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]methoxy]phenyl]phenol Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1COC(C=C1)=CC=C1C1=CC=CC(O)=C1 OZZZHXFJLJHIJW-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- ZQBWNLKMDBGHST-UHFFFAOYSA-N 4-[2-[[4-[4-(4-tert-butylphenoxy)phenyl]phenyl]methyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]benzoic acid Chemical compound C1=CC(C(C)(C)C)=CC=C1OC1=CC=C(C=2C=CC(CC=3N(C=C(N=3)C=3C(=CC(Cl)=CC=3)Cl)C=3C=CC(=CC=3)C(O)=O)=CC=2)C=C1 ZQBWNLKMDBGHST-UHFFFAOYSA-N 0.000 description 2
- YKQHJOCVYLPEQC-UHFFFAOYSA-N 4-[4-(2,4-dichlorophenyl)-2-[[4-(3-methylsulfonylphenyl)phenyl]methyl]imidazol-1-yl]benzoic acid Chemical compound CS(=O)(=O)C1=CC=CC(C=2C=CC(CC=3N(C=C(N=3)C=3C(=CC(Cl)=CC=3)Cl)C=3C=CC(=CC=3)C(O)=O)=CC=2)=C1 YKQHJOCVYLPEQC-UHFFFAOYSA-N 0.000 description 2
- LENUMONZJPGOHT-LHHJGKSTSA-N 4-[4-[(E)-2-[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]ethenyl]phenyl]phenol Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1\C=C\C(C=C1)=CC=C1C1=CC=C(O)C=C1 LENUMONZJPGOHT-LHHJGKSTSA-N 0.000 description 2
- OYVYUHTWFLBLHS-LHHJGKSTSA-N 4-[4-[(E)-2-[4-(2,4-difluorophenyl)-1-ethylimidazol-2-yl]ethenyl]phenyl]phenol Chemical compound CCN1C=C(C=2C(=CC(F)=CC=2)F)N=C1\C=C\C(C=C1)=CC=C1C1=CC=C(O)C=C1 OYVYUHTWFLBLHS-LHHJGKSTSA-N 0.000 description 2
- NCNMYIKQFNGFAW-UHFFFAOYSA-N 4-[4-[5-(2,4-dichlorophenyl)-1H-imidazol-2-yl]phenyl]phenol Chemical compound C1=CC(O)=CC=C1C1=CC=C(C=2NC=C(N=2)C=2C(=CC(Cl)=CC=2)Cl)C=C1 NCNMYIKQFNGFAW-UHFFFAOYSA-N 0.000 description 2
- IICZHWMRRGIMLX-RGVLZGJSSA-N 4-[[2-[(e)-2-[4-[(4-butylphenyl)sulfonylamino]phenyl]ethenyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(CCCC)=CC=C1S(=O)(=O)NC(C=C1)=CC=C1\C=C\C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CC1=CC=C(C(O)=O)C=C1 IICZHWMRRGIMLX-RGVLZGJSSA-N 0.000 description 2
- BNCYSNHOQQCGCM-UHFFFAOYSA-N 4-[[2-[4-(4-amino-3-methoxyphenyl)phenyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]methyl]benzoic acid Chemical compound C1=C(N)C(OC)=CC(C=2C=CC(=CC=2)C=2N(C=C(N=2)C=2C(=CC(Cl)=CC=2)Cl)CC=2C=CC(=CC=2)C(O)=O)=C1 BNCYSNHOQQCGCM-UHFFFAOYSA-N 0.000 description 2
- IAZFWCDWOMYCQE-UHFFFAOYSA-N 4-[[2-[[4-[4-(4-tert-butylphenoxy)phenyl]phenyl]methyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(C)(C)C)=CC=C1OC1=CC=C(C=2C=CC(CC=3N(C=C(N=3)C=3C(=CC(Cl)=CC=3)Cl)CC=3C=CC(=CC=3)C(O)=O)=CC=2)C=C1 IAZFWCDWOMYCQE-UHFFFAOYSA-N 0.000 description 2
- HGVNMIAHGZQMEZ-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[4-[3-(trifluoromethyl)phenyl]phenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 HGVNMIAHGZQMEZ-UHFFFAOYSA-N 0.000 description 2
- BOAKHACUJKLDFJ-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[4-[4-(methanesulfonamido)-3-methoxyphenyl]phenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=C(NS(C)(=O)=O)C(OC)=CC(C=2C=CC(=CC=2)C=2N(C=C(N=2)C=2C(=CC(Cl)=CC=2)Cl)CC=2C=CC(=CC=2)C(O)=O)=C1 BOAKHACUJKLDFJ-UHFFFAOYSA-N 0.000 description 2
- NUFGQWGADGDEAT-FZSIALSZSA-N 4-[[4-(2,4-difluorophenyl)-2-[(E)-2-[4-(4-hydroxyphenyl)phenyl]ethenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=CC(O)=CC=2)=NC(C=2C(=CC(F)=CC=2)F)=C1 NUFGQWGADGDEAT-FZSIALSZSA-N 0.000 description 2
- WCBZEKVPZXEDTK-CNHKJKLMSA-N 4-[[4-(2,4-difluorophenyl)-2-[(e)-2-[4-(4-ethoxyphenyl)phenyl]ethenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(OCC)=CC=C1C(C=C1)=CC=C1\C=C\C1=NC(C=2C(=CC(F)=CC=2)F)=CN1CC1=CC=C(C(O)=O)C=C1 WCBZEKVPZXEDTK-CNHKJKLMSA-N 0.000 description 2
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 2
- TUXYZHVUPGXXQG-UHFFFAOYSA-N 4-bromobenzoic acid Chemical compound OC(=O)C1=CC=C(Br)C=C1 TUXYZHVUPGXXQG-UHFFFAOYSA-N 0.000 description 2
- ZEYHEAKUIGZSGI-UHFFFAOYSA-N 4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-N 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- PGLWOKDSIWCTBZ-UHFFFAOYSA-N 5-(2,4-dichlorophenyl)-2-(fluoren-9-ylidenemethyl)-1h-imidazole Chemical compound ClC1=CC(Cl)=CC=C1C1=CNC(C=C2C3=CC=CC=C3C3=CC=CC=C32)=N1 PGLWOKDSIWCTBZ-UHFFFAOYSA-N 0.000 description 2
- ACBLSVSMPDXEAL-RIYZIHGNSA-N 5-(2,4-dichlorophenyl)-2-[(e)-2-[2-methoxy-5-[2-(4-methoxyphenyl)ethynyl]phenyl]ethenyl]-1h-imidazole Chemical compound C1=CC(OC)=CC=C1C#CC1=CC=C(OC)C(\C=C\C=2NC=C(N=2)C=2C(=CC(Cl)=CC=2)Cl)=C1 ACBLSVSMPDXEAL-RIYZIHGNSA-N 0.000 description 2
- WKZRONRIYFBVQJ-UHFFFAOYSA-N 5-(2,4-dichlorophenyl)-2-[1-(4-methoxyphenyl)cyclopropyl]-1h-imidazole Chemical compound C1=CC(OC)=CC=C1C1(C=2NC=C(N=2)C=2C(=CC(Cl)=CC=2)Cl)CC1 WKZRONRIYFBVQJ-UHFFFAOYSA-N 0.000 description 2
- GYKVPPJLGWBKRZ-UHFFFAOYSA-N 5-(2,4-dichlorophenyl)-2-[2-[4-(trifluoromethyl)phenyl]ethyl]-1h-imidazole Chemical compound C1=CC(C(F)(F)F)=CC=C1CCC1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1 GYKVPPJLGWBKRZ-UHFFFAOYSA-N 0.000 description 2
- BITONMRBHOAYIT-UHFFFAOYSA-N 5-(2,4-dichlorophenyl)-2-[3-(4-iodophenyl)propyl]-1h-imidazole Chemical compound ClC1=CC(Cl)=CC=C1C1=CNC(CCCC=2C=CC(I)=CC=2)=N1 BITONMRBHOAYIT-UHFFFAOYSA-N 0.000 description 2
- MLAIJMKATYVBGY-UHFFFAOYSA-N 5-(2,4-dichlorophenyl)-2-[[3-(trifluoromethyl)phenyl]methyl]-1h-imidazole Chemical compound FC(F)(F)C1=CC=CC(CC=2NC=C(N=2)C=2C(=CC(Cl)=CC=2)Cl)=C1 MLAIJMKATYVBGY-UHFFFAOYSA-N 0.000 description 2
- TYYLNXLLSCNEDM-UHFFFAOYSA-N 6-(4-tert-butylphenoxy)-n-[5-(2,4-dichlorophenyl)-1h-imidazol-2-yl]isoquinoline-3-carboxamide Chemical compound C1=CC(C(C)(C)C)=CC=C1OC1=CC=C(C=NC(=C2)C(=O)NC=3NC=C(N=3)C=3C(=CC(Cl)=CC=3)Cl)C2=C1 TYYLNXLLSCNEDM-UHFFFAOYSA-N 0.000 description 2
- PVFOHMXILQEIHX-UHFFFAOYSA-N 8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]-9-[2-(2-bromophenyl)ethyl]purin-6-amine Chemical compound C=1C=2OCOC=2C=C(Br)C=1SC1=NC=2C(N)=NC=NC=2N1CCC1=CC=CC=C1Br PVFOHMXILQEIHX-UHFFFAOYSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- ZRPZPNYZFSJUPA-UHFFFAOYSA-N ARS-1620 Chemical compound Oc1cccc(F)c1-c1c(Cl)cc2c(ncnc2c1F)N1CCN(CC1)C(=O)C=C ZRPZPNYZFSJUPA-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- 235000006491 Acacia senegal Nutrition 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- 235000003911 Arachis Nutrition 0.000 description 2
- 244000105624 Arachis hypogaea Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 101150041968 CDC13 gene Proteins 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- 108010000518 Dual-Specificity Phosphatases Proteins 0.000 description 2
- 102000002266 Dual-Specificity Phosphatases Human genes 0.000 description 2
- 101710130332 ETS domain-containing protein Elk-4 Proteins 0.000 description 2
- XPDWGBQVDMORPB-UHFFFAOYSA-N Fluoroform Chemical compound FC(F)F XPDWGBQVDMORPB-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- UUIQMZJEGPQKFD-UHFFFAOYSA-N Methyl butyrate Chemical compound CCCC(=O)OC UUIQMZJEGPQKFD-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 101100466198 Mus musculus Ptpra gene Proteins 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 description 2
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 101710159587 Protein-tyrosine-phosphatase PTP1 Proteins 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 2
- 102100039664 Receptor-type tyrosine-protein phosphatase H Human genes 0.000 description 2
- 101710138742 Receptor-type tyrosine-protein phosphatase H Proteins 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- XUIQQIRLFMCWLN-UHFFFAOYSA-N [3-(methanesulfonamido)phenyl]boronic acid Chemical compound CS(=O)(=O)NC1=CC=CC(B(O)O)=C1 XUIQQIRLFMCWLN-UHFFFAOYSA-N 0.000 description 2
- ALMFIOZYDASRRC-UHFFFAOYSA-N [4-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=C(C(F)(F)F)C=C1 ALMFIOZYDASRRC-UHFFFAOYSA-N 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000556 agonist Substances 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- 235000019257 ammonium acetate Nutrition 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 150000001448 anilines Chemical class 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 229940125681 anticonvulsant agent Drugs 0.000 description 2
- 239000000164 antipsychotic agent Substances 0.000 description 2
- 229940005529 antipsychotics Drugs 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 150000001543 aryl boronic acids Chemical class 0.000 description 2
- 150000001499 aryl bromides Chemical class 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 230000005784 autoimmunity Effects 0.000 description 2
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- LUFPJJNWMYZRQE-UHFFFAOYSA-N benzylsulfanylmethylbenzene Chemical compound C=1C=CC=CC=1CSCC1=CC=CC=C1 LUFPJJNWMYZRQE-UHFFFAOYSA-N 0.000 description 2
- 150000004283 biguanides Chemical class 0.000 description 2
- 125000006268 biphenyl-3-yl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C1=C([H])C(*)=C([H])C([H])=C1[H] 0.000 description 2
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- MDQDBTCGQGXTBP-UHFFFAOYSA-N bromomethyl benzoate Chemical compound BrCOC(=O)C1=CC=CC=C1 MDQDBTCGQGXTBP-UHFFFAOYSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 239000012876 carrier material Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 125000004965 chloroalkyl group Chemical group 0.000 description 2
- WRJWRGBVPUUDLA-UHFFFAOYSA-N chlorosulfonyl isocyanate Chemical compound ClS(=O)(=O)N=C=O WRJWRGBVPUUDLA-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 125000000392 cycloalkenyl group Chemical group 0.000 description 2
- 125000002993 cycloalkylene group Chemical group 0.000 description 2
- 238000007872 degassing Methods 0.000 description 2
- 230000030609 dephosphorylation Effects 0.000 description 2
- 238000006209 dephosphorylation reaction Methods 0.000 description 2
- 238000010511 deprotection reaction Methods 0.000 description 2
- 125000001891 dimethoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- RMCFTCZSMDALIE-LICLKQGHSA-N ethyl 3-[4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-[3-(trifluoromethyl)phenyl]phenyl]ethenyl]imidazol-1-yl]methyl]phenyl]-3-oxopropanoate Chemical compound C1=CC(C(=O)CC(=O)OCC)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 RMCFTCZSMDALIE-LICLKQGHSA-N 0.000 description 2
- TVKROAKREMAHFW-UHFFFAOYSA-N ethyl 4-[2-[[4-[4-(4-tert-butylphenoxy)phenyl]phenyl]methyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1N1C(CC=2C=CC(=CC=2)C=2C=CC(OC=3C=CC(=CC=3)C(C)(C)C)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 TVKROAKREMAHFW-UHFFFAOYSA-N 0.000 description 2
- WMGXEKSOWBMPMA-UHFFFAOYSA-N ethyl 4-[4-(2,4-dichlorophenyl)-2-[[4-[3-(trifluoromethyl)phenyl]phenyl]methyl]imidazol-1-yl]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1N1C(CC=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 WMGXEKSOWBMPMA-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 125000001188 haloalkyl group Chemical group 0.000 description 2
- 125000001475 halogen functional group Chemical group 0.000 description 2
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 2
- LIAWOTKNAVAKCX-UHFFFAOYSA-N hydrazine;dihydrochloride Chemical compound Cl.Cl.NN LIAWOTKNAVAKCX-UHFFFAOYSA-N 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 150000002460 imidazoles Chemical class 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 2
- 125000000468 ketone group Chemical group 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229960000485 methotrexate Drugs 0.000 description 2
- APXOMRFLJBRHNX-UHFFFAOYSA-N methyl 2-[4-(bromomethyl)phenyl]acetate Chemical compound COC(=O)CC1=CC=C(CBr)C=C1 APXOMRFLJBRHNX-UHFFFAOYSA-N 0.000 description 2
- FBOGUMANEFNEEK-MDWZMJQESA-N methyl 2-[4-[[2-[(e)-2-(4-bromophenyl)ethenyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]methyl]phenyl]acetate Chemical compound C1=CC(CC(=O)OC)=CC=C1CN1C(\C=C\C=2C=CC(Br)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 FBOGUMANEFNEEK-MDWZMJQESA-N 0.000 description 2
- PERDKFBHSOQYMK-UHFFFAOYSA-N methyl 2-[4-[[4-(2,4-dichlorophenyl)-2-[2-[4-(trifluoromethyl)phenyl]ethyl]imidazol-1-yl]methyl]anilino]acetate Chemical compound C1=CC(NCC(=O)OC)=CC=C1CN1C(CCC=2C=CC(=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 PERDKFBHSOQYMK-UHFFFAOYSA-N 0.000 description 2
- ZYCPSZGMMFTLHZ-UHFFFAOYSA-N methyl 2-[4-[[4-(2,4-dichlorophenyl)-2-[[3-(trifluoromethyl)phenyl]methyl]imidazol-1-yl]methyl]anilino]acetate Chemical compound C1=CC(NCC(=O)OC)=CC=C1CN1C(CC=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 ZYCPSZGMMFTLHZ-UHFFFAOYSA-N 0.000 description 2
- BWJAYAJQJMIDEJ-UHFFFAOYSA-N methyl 2-amino-4-[4-[4-[[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]methyl]phenyl]phenoxy]benzoate Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1CC(C=C1)=CC=C1C(C=C1)=CC=C1OC1=CC=C(C(=O)OC)C(N)=C1 BWJAYAJQJMIDEJ-UHFFFAOYSA-N 0.000 description 2
- NNOMOPNBYWJNKH-UHFFFAOYSA-N methyl 2-amino-5-[4-[4-[[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]methyl]phenyl]phenoxy]benzoate Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1CC(C=C1)=CC=C1C(C=C1)=CC=C1OC1=CC=C(N)C(C(=O)OC)=C1 NNOMOPNBYWJNKH-UHFFFAOYSA-N 0.000 description 2
- QVNYNHCNNGKULA-UHFFFAOYSA-N methyl 2-amino-5-bromobenzoate Chemical compound COC(=O)C1=CC(Br)=CC=C1N QVNYNHCNNGKULA-UHFFFAOYSA-N 0.000 description 2
- CWVHAMGUQQAOJZ-UHFFFAOYSA-N methyl 4-[2-[(4-bromophenyl)methyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]-2-nitrobenzoate Chemical compound C1=C([N+]([O-])=O)C(C(=O)OC)=CC=C1N1C(CC=2C=CC(Br)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 CWVHAMGUQQAOJZ-UHFFFAOYSA-N 0.000 description 2
- QETCIIHNNGRKPI-UHFFFAOYSA-N methyl 4-[2-[[4-[4-(4-tert-butylphenoxy)phenyl]phenyl]methyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]-2-(methanesulfonamido)benzoate Chemical compound C1=C(NS(C)(=O)=O)C(C(=O)OC)=CC=C1N1C(CC=2C=CC(=CC=2)C=2C=CC(OC=3C=CC(=CC=3)C(C)(C)C)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 QETCIIHNNGRKPI-UHFFFAOYSA-N 0.000 description 2
- JBCIJAWTRPGKRR-UHFFFAOYSA-N methyl 4-[4-(2,4-dichlorophenyl)-2-[[4-(4-hydroxyphenyl)phenyl]methyl]imidazol-1-yl]-2-(methanesulfonamido)benzoate Chemical compound C1=C(NS(C)(=O)=O)C(C(=O)OC)=CC=C1N1C(CC=2C=CC(=CC=2)C=2C=CC(O)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 JBCIJAWTRPGKRR-UHFFFAOYSA-N 0.000 description 2
- RQTCBMPWHHKCLK-UHFFFAOYSA-N methyl 4-[4-(2,4-dichlorophenyl)-2-[[4-[4-[[3-(trifluoromethyl)phenyl]sulfonylamino]phenyl]phenyl]methyl]imidazol-1-yl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1N1C(CC=2C=CC(=CC=2)C=2C=CC(NS(=O)(=O)C=3C=C(C=CC=3)C(F)(F)F)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 RQTCBMPWHHKCLK-UHFFFAOYSA-N 0.000 description 2
- CEXRSWQZYOSPBE-UHFFFAOYSA-N methyl 4-[[2-[(4-bromophenoxy)methyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(COC=2C=CC(Br)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 CEXRSWQZYOSPBE-UHFFFAOYSA-N 0.000 description 2
- GHIPTZSEJVZIOH-AWNIVKPZSA-N methyl 4-[[2-[(e)-2-(4-bromophenyl)ethenyl]-4-(2,4-difluorophenyl)imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(\C=C\C=2C=CC(Br)=CC=2)=NC(C=2C(=CC(F)=CC=2)F)=C1 GHIPTZSEJVZIOH-AWNIVKPZSA-N 0.000 description 2
- NCJMBJLSGCNUFW-KPKJPENVSA-N methyl 4-[[2-[(e)-2-(5-bromo-2-methoxyphenyl)ethenyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(\C=C\C=2C(=CC=C(Br)C=2)OC)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 NCJMBJLSGCNUFW-KPKJPENVSA-N 0.000 description 2
- COSYXXJRENETQM-CIAFOILYSA-N methyl 4-[[2-[(e)-2-[4-[(4-butylphenyl)sulfonylamino]phenyl]ethenyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(CCCC)=CC=C1S(=O)(=O)NC(C=C1)=CC=C1\C=C\C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CC1=CC=C(C(=O)OC)C=C1 COSYXXJRENETQM-CIAFOILYSA-N 0.000 description 2
- IYFIHMSVLMVLPX-UHFFFAOYSA-N methyl 4-[[2-[4-(3-aminophenyl)phenyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(C=2C=CC(=CC=2)C=2C=C(N)C=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 IYFIHMSVLMVLPX-UHFFFAOYSA-N 0.000 description 2
- FODXHUOUFHFGLZ-UHFFFAOYSA-N methyl 4-[[2-[[4-[4-(4-tert-butylphenoxy)phenyl]phenyl]methyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(CC=2C=CC(=CC=2)C=2C=CC(OC=3C=CC(=CC=3)C(C)(C)C)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 FODXHUOUFHFGLZ-UHFFFAOYSA-N 0.000 description 2
- LQOYHZLVZICDFZ-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-(4-methoxyphenyl)imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 LQOYHZLVZICDFZ-UHFFFAOYSA-N 0.000 description 2
- YSECQFCRYDNOQJ-VIZOYTHASA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-(6-methoxypyridin-3-yl)phenyl]ethenyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=NC(OC)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 YSECQFCRYDNOQJ-VIZOYTHASA-N 0.000 description 2
- CGJWAZHYLVJAKL-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[1-(4-hydroxyphenyl)cyclopropyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(C2(CC2)C=2C=CC(O)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 CGJWAZHYLVJAKL-UHFFFAOYSA-N 0.000 description 2
- SDCKMMUDPCNNMJ-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[3-(4-iodophenyl)propyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(CCCC=2C=CC(I)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 SDCKMMUDPCNNMJ-UHFFFAOYSA-N 0.000 description 2
- HCEQSWDHNQCDCJ-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[3-[4-[3-(trifluoromethyl)phenyl]phenyl]propyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(CCCC=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 HCEQSWDHNQCDCJ-UHFFFAOYSA-N 0.000 description 2
- UUOYUBDTKHUYBO-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[[4-(2-methoxyphenyl)phenyl]methyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(CC=2C=CC(=CC=2)C=2C(=CC=CC=2)OC)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 UUOYUBDTKHUYBO-UHFFFAOYSA-N 0.000 description 2
- AJJZKZNYSQPFQK-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[[4-[3-(propylsulfonylamino)phenyl]phenyl]methyl]imidazol-1-yl]methyl]benzoate Chemical compound CCCS(=O)(=O)NC1=CC=CC(C=2C=CC(CC=3N(C=C(N=3)C=3C(=CC(Cl)=CC=3)Cl)CC=3C=CC(=CC=3)C(=O)OC)=CC=2)=C1 AJJZKZNYSQPFQK-UHFFFAOYSA-N 0.000 description 2
- CCQVLKRSNSURLU-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[[4-[3-(trifluoromethoxy)phenyl]phenyl]methyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(CC=2C=CC(=CC=2)C=2C=C(OC(F)(F)F)C=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 CCQVLKRSNSURLU-UHFFFAOYSA-N 0.000 description 2
- OOIDFCGDYKXQRT-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[[4-[4-(trifluoromethoxy)phenyl]phenoxy]methyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(COC=2C=CC(=CC=2)C=2C=CC(OC(F)(F)F)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 OOIDFCGDYKXQRT-UHFFFAOYSA-N 0.000 description 2
- PMWLHXJTGFJLLL-UHFFFAOYSA-N methyl 5-[2-[(4-bromophenyl)methyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]-2-(trifluoromethyl)benzoate Chemical compound C1=C(C(F)(F)F)C(C(=O)OC)=CC(N2C(=NC(=C2)C=2C(=CC(Cl)=CC=2)Cl)CC=2C=CC(Br)=CC=2)=C1 PMWLHXJTGFJLLL-UHFFFAOYSA-N 0.000 description 2
- OCYHWDSMRNTEFU-UHFFFAOYSA-N methyl 5-[2-[[4-[4-(4-tert-butylphenoxy)phenyl]phenyl]methyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]-2-(trifluoromethyl)benzoate Chemical compound C1=C(C(F)(F)F)C(C(=O)OC)=CC(N2C(=NC(=C2)C=2C(=CC(Cl)=CC=2)Cl)CC=2C=CC(=CC=2)C=2C=CC(OC=3C=CC(=CC=3)C(C)(C)C)=CC=2)=C1 OCYHWDSMRNTEFU-UHFFFAOYSA-N 0.000 description 2
- KSEVAVIZZSHYFG-UHFFFAOYSA-N methyl 5-[3-[4-[[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]methoxy]phenyl]phenoxy]-2-(trifluoromethyl)benzoate Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1COC(C=C1)=CC=C1C(C=1)=CC=CC=1OC1=CC=C(C(F)(F)F)C(C(=O)OC)=C1 KSEVAVIZZSHYFG-UHFFFAOYSA-N 0.000 description 2
- YLBYAQYAYGADMW-UHFFFAOYSA-N methyl 5-[4-(2,4-dichlorophenyl)-2-[[4-(4-hydroxyphenyl)phenyl]methyl]imidazol-1-yl]-2-(trifluoromethyl)benzoate Chemical compound C1=C(C(F)(F)F)C(C(=O)OC)=CC(N2C(=NC(=C2)C=2C(=CC(Cl)=CC=2)Cl)CC=2C=CC(=CC=2)C=2C=CC(O)=CC=2)=C1 YLBYAQYAYGADMW-UHFFFAOYSA-N 0.000 description 2
- NXPJDRCRMJDZQX-UHFFFAOYSA-N methyl 5-[4-[4-[[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]methyl]phenyl]phenoxy]-2-nitrobenzoate Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1CC(C=C1)=CC=C1C(C=C1)=CC=C1OC1=CC=C([N+]([O-])=O)C(C(=O)OC)=C1 NXPJDRCRMJDZQX-UHFFFAOYSA-N 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 239000000346 nonvolatile oil Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229940096701 plain lipid modifying drug hmg coa reductase inhibitors Drugs 0.000 description 2
- 229920001469 poly(aryloxy)thionylphosphazene Polymers 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000009822 protein phosphorylation Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- 108700027361 sarcosine methyl ester Proteins 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000003456 sulfonamides Chemical class 0.000 description 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 2
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 229940037128 systemic glucocorticoids Drugs 0.000 description 2
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- 150000003536 tetrazoles Chemical class 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- 229930192474 thiophene Natural products 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 229940086542 triethylamine Drugs 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000002691 unilamellar liposome Substances 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 description 1
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- DGFCTCGCMKEILT-UHFFFAOYSA-N (2-ethoxyphenyl)boronic acid Chemical compound CCOC1=CC=CC=C1B(O)O DGFCTCGCMKEILT-UHFFFAOYSA-N 0.000 description 1
- XOVMDVZAWWQSDC-UHFFFAOYSA-N (2-fluoro-6-methoxyphenyl)boronic acid Chemical compound COC1=CC=CC(F)=C1B(O)O XOVMDVZAWWQSDC-UHFFFAOYSA-N 0.000 description 1
- YDMRDHQUQIVWBE-UHFFFAOYSA-N (2-hydroxyphenyl)boronic acid Chemical compound OB(O)C1=CC=CC=C1O YDMRDHQUQIVWBE-UHFFFAOYSA-N 0.000 description 1
- ROEQGIFOWRQYHD-UHFFFAOYSA-N (2-methoxyphenyl)boronic acid Chemical compound COC1=CC=CC=C1B(O)O ROEQGIFOWRQYHD-UHFFFAOYSA-N 0.000 description 1
- MSQFFCRGQPVQRS-UHFFFAOYSA-N (2-methylsulfonylphenyl)boronic acid Chemical compound CS(=O)(=O)C1=CC=CC=C1B(O)O MSQFFCRGQPVQRS-UHFFFAOYSA-N 0.000 description 1
- DOMQFIFVDIAOOT-ROUUACIJSA-N (2S,3R)-N-[4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-1,2,4-triazol-3-yl]-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide Chemical compound COC1=C(C(=CC=C1)OC)N1C(=NN=C1C=1C=NC=C(C=1)C)NS(=O)(=O)[C@@H](C)[C@H](C)C1=NC=C(C=N1)C DOMQFIFVDIAOOT-ROUUACIJSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- ZTRKYYYDXARQRD-UHFFFAOYSA-N (3-butoxyphenyl)boronic acid Chemical compound CCCCOC1=CC=CC(B(O)O)=C1 ZTRKYYYDXARQRD-UHFFFAOYSA-N 0.000 description 1
- XDBHWPLGGBLUHH-UHFFFAOYSA-N (3-cyanophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(C#N)=C1 XDBHWPLGGBLUHH-UHFFFAOYSA-N 0.000 description 1
- WFWQWTPAPNEOFE-UHFFFAOYSA-N (3-hydroxyphenyl)boronic acid Chemical compound OB(O)C1=CC=CC(O)=C1 WFWQWTPAPNEOFE-UHFFFAOYSA-N 0.000 description 1
- ALTLCJHSJMGSLT-UHFFFAOYSA-N (3-methoxycarbonylphenyl)boronic acid Chemical compound COC(=O)C1=CC=CC(B(O)O)=C1 ALTLCJHSJMGSLT-UHFFFAOYSA-N 0.000 description 1
- NLLGFYPSWCMUIV-UHFFFAOYSA-N (3-methoxyphenyl)boronic acid Chemical compound COC1=CC=CC(B(O)O)=C1 NLLGFYPSWCMUIV-UHFFFAOYSA-N 0.000 description 1
- OQANPHBRHBJGNZ-FYJGNVAPSA-N (3e)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid Chemical compound C1=CC(=O)C(C(=O)O)=C\C1=N\NC1=CC=C(S(=O)(=O)NC=2N=CC=CC=2)C=C1 OQANPHBRHBJGNZ-FYJGNVAPSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- CJUHQADBFQRIMC-UHFFFAOYSA-N (4-propan-2-yloxyphenyl)boronic acid Chemical compound CC(C)OC1=CC=C(B(O)O)C=C1 CJUHQADBFQRIMC-UHFFFAOYSA-N 0.000 description 1
- DEQANNDTNATYII-OULOTJBUSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-19-[[(2r)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-n-[(2r,3r)-1,3-dihydroxybutan-2-yl]-7-[(1r)-1-hydroxyethyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxa Chemical compound C([C@@H](N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC1=O)C(=O)N[C@H](CO)[C@H](O)C)C1=CC=CC=C1 DEQANNDTNATYII-OULOTJBUSA-N 0.000 description 1
- DHADXDMPEUWEAS-UHFFFAOYSA-N (6-methoxypyridin-3-yl)boronic acid Chemical compound COC1=CC=C(B(O)O)C=N1 DHADXDMPEUWEAS-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 description 1
- XWGUEUJOVZAMMF-XVNBXDOJSA-N (e)-3-(6-methoxynaphthalen-2-yl)prop-2-enoic acid Chemical compound C1=C(\C=C\C(O)=O)C=CC2=CC(OC)=CC=C21 XWGUEUJOVZAMMF-XVNBXDOJSA-N 0.000 description 1
- UKGJZDSUJSPAJL-YPUOHESYSA-N (e)-n-[(1r)-1-[3,5-difluoro-4-(methanesulfonamido)phenyl]ethyl]-3-[2-propyl-6-(trifluoromethyl)pyridin-3-yl]prop-2-enamide Chemical compound CCCC1=NC(C(F)(F)F)=CC=C1\C=C\C(=O)N[C@H](C)C1=CC(F)=C(NS(C)(=O)=O)C(F)=C1 UKGJZDSUJSPAJL-YPUOHESYSA-N 0.000 description 1
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 1
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
- ZXMGHDIOOHOAAE-UHFFFAOYSA-N 1,1,1-trifluoro-n-(trifluoromethylsulfonyl)methanesulfonamide Chemical compound FC(F)(F)S(=O)(=O)NS(=O)(=O)C(F)(F)F ZXMGHDIOOHOAAE-UHFFFAOYSA-N 0.000 description 1
- IJOCNCZJDBTBIP-UHFFFAOYSA-N 1,1,1-trifluoro-n-methylmethanesulfonamide Chemical compound CNS(=O)(=O)C(F)(F)F IJOCNCZJDBTBIP-UHFFFAOYSA-N 0.000 description 1
- LDRPULCXZDDSGE-UHFFFAOYSA-N 1,1,1-trifluorobutane Chemical compound CCCC(F)(F)F LDRPULCXZDDSGE-UHFFFAOYSA-N 0.000 description 1
- UJPMYEOUBPIPHQ-UHFFFAOYSA-N 1,1,1-trifluoroethane Chemical compound CC(F)(F)F UJPMYEOUBPIPHQ-UHFFFAOYSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- VDFVNEFVBPFDSB-UHFFFAOYSA-N 1,3-dioxane Chemical compound C1COCOC1 VDFVNEFVBPFDSB-UHFFFAOYSA-N 0.000 description 1
- FTQOIXBLZHRTFH-UHFFFAOYSA-N 1,3-dioxane-2,4-diyl Chemical group C1C[O+]=CO[CH-]1 FTQOIXBLZHRTFH-UHFFFAOYSA-N 0.000 description 1
- VLXSIHLNPYRFFN-UHFFFAOYSA-N 1,4-dioxane;methanol Chemical compound OC.C1COCCO1 VLXSIHLNPYRFFN-UHFFFAOYSA-N 0.000 description 1
- UQKJSFHSLIWIPU-QGOAFFKASA-N 1-[(4-nitrophenyl)methyl]-4-phenyl-2-[(e)-2-[4-[3-(trifluoromethyl)phenyl]phenyl]ethenyl]imidazole Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C=CC=CC=2)=C1 UQKJSFHSLIWIPU-QGOAFFKASA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- YLRBJYMANQKEAW-UHFFFAOYSA-N 1-bromo-4-(bromomethyl)benzene Chemical compound BrCC1=CC=C(Br)C=C1 YLRBJYMANQKEAW-UHFFFAOYSA-N 0.000 description 1
- MPPPKRYCTPRNTB-UHFFFAOYSA-N 1-bromobutane Chemical compound CCCCBr MPPPKRYCTPRNTB-UHFFFAOYSA-N 0.000 description 1
- KBIAVTUACPKPFJ-UHFFFAOYSA-N 1-ethynyl-4-methoxybenzene Chemical compound COC1=CC=C(C#C)C=C1 KBIAVTUACPKPFJ-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
- WXRWCAWGXBJYOV-UHFFFAOYSA-N 1-phenoxybiphenylene Chemical group C=1C=CC=2C3=CC=CC=C3C=2C=1OC1=CC=CC=C1 WXRWCAWGXBJYOV-UHFFFAOYSA-N 0.000 description 1
- INMMVHOKQLWAQU-UHFFFAOYSA-N 1-phenyl-2-(trifluoromethoxy)benzene Chemical group FC(F)(F)OC1=CC=CC=C1C1=CC=CC=C1 INMMVHOKQLWAQU-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
- RBZRMBCLZMEYEH-UHFFFAOYSA-N 1h-pyrazol-1-ium-1-carboximidamide;chloride Chemical compound Cl.NC(=N)N1C=CC=N1 RBZRMBCLZMEYEH-UHFFFAOYSA-N 0.000 description 1
- 125000000453 2,2,2-trichloroethyl group Chemical group [H]C([H])(*)C(Cl)(Cl)Cl 0.000 description 1
- CXCHEKCRJQRVNG-UHFFFAOYSA-N 2,2,2-trifluoroethanesulfonyl chloride Chemical compound FC(F)(F)CS(Cl)(=O)=O CXCHEKCRJQRVNG-UHFFFAOYSA-N 0.000 description 1
- YRAJNWYBUCUFBD-UHFFFAOYSA-N 2,2,6,6-tetramethylheptane-3,5-dione Chemical compound CC(C)(C)C(=O)CC(=O)C(C)(C)C YRAJNWYBUCUFBD-UHFFFAOYSA-N 0.000 description 1
- HFFXLYHRNRKAPM-UHFFFAOYSA-N 2,4,5-trichloro-n-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C(=CC(Cl)=C(Cl)C=2)Cl)=N1 HFFXLYHRNRKAPM-UHFFFAOYSA-N 0.000 description 1
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 description 1
- FUJSJWRORKKPAI-UHFFFAOYSA-N 2-(2,4-dichlorophenoxy)acetyl chloride Chemical compound ClC(=O)COC1=CC=C(Cl)C=C1Cl FUJSJWRORKKPAI-UHFFFAOYSA-N 0.000 description 1
- RNEXKKNNOIRYGI-UHFFFAOYSA-N 2-(4-bromophenyl)guanidine Chemical compound NC(=N)NC1=CC=C(Br)C=C1 RNEXKKNNOIRYGI-UHFFFAOYSA-N 0.000 description 1
- HGGWOSYNRVOQJH-UHFFFAOYSA-N 2-(4-methylsulfonylphenyl)acetic acid Chemical compound CS(=O)(=O)C1=CC=C(CC(O)=O)C=C1 HGGWOSYNRVOQJH-UHFFFAOYSA-N 0.000 description 1
- NKDMRRRDULBVSB-UHFFFAOYSA-N 2-(hexanoylamino)benzoic acid Chemical compound CCCCCC(=O)NC1=CC=CC=C1C(O)=O NKDMRRRDULBVSB-UHFFFAOYSA-N 0.000 description 1
- VESLFCBOKMWCRG-UHFFFAOYSA-N 2-(methanesulfonamido)benzoic acid Chemical compound CS(=O)(=O)NC1=CC=CC=C1C(O)=O VESLFCBOKMWCRG-UHFFFAOYSA-N 0.000 description 1
- ZIZGWNOAHUCACM-UHFFFAOYSA-N 2-(trifluoromethyl)benzenesulfonyl chloride Chemical compound FC(F)(F)C1=CC=CC=C1S(Cl)(=O)=O ZIZGWNOAHUCACM-UHFFFAOYSA-N 0.000 description 1
- QWCKQJZIFLGMSD-UHFFFAOYSA-N 2-Aminobutanoic acid Natural products CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 description 1
- YIELZOLPPKTUAE-UHFFFAOYSA-N 2-[(4-bromophenoxy)methyl]-4-(2,4-dichlorophenyl)-1-ethylimidazole Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1COC1=CC=C(Br)C=C1 YIELZOLPPKTUAE-UHFFFAOYSA-N 0.000 description 1
- CMHXNOYGTKJIEI-BJMVGYQFSA-N 2-[(e)-2-(4-bromophenyl)ethenyl]-4-(2,4-dichlorophenyl)-1-ethylimidazole Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1\C=C\C1=CC=C(Br)C=C1 CMHXNOYGTKJIEI-BJMVGYQFSA-N 0.000 description 1
- OOVLRXCGBMYYGH-JXMROGBWSA-N 2-[(e)-2-(4-bromophenyl)ethenyl]-5-(2-chlorophenyl)-1h-imidazole Chemical compound ClC1=CC=CC=C1C1=CNC(\C=C\C=2C=CC(Br)=CC=2)=N1 OOVLRXCGBMYYGH-JXMROGBWSA-N 0.000 description 1
- GROOJJLSBPFRCF-DHZHZOJOSA-N 2-[(e)-2-(4-bromophenyl)ethenyl]-5-phenyl-1h-imidazole Chemical compound C1=CC(Br)=CC=C1\C=C\C1=NC(C=2C=CC=CC=2)=CN1 GROOJJLSBPFRCF-DHZHZOJOSA-N 0.000 description 1
- YQNRVGJCPCNMKT-LFVJCYFKSA-N 2-[(e)-[[2-(4-benzylpiperazin-1-ium-1-yl)acetyl]hydrazinylidene]methyl]-6-prop-2-enylphenolate Chemical compound [O-]C1=C(CC=C)C=CC=C1\C=N\NC(=O)C[NH+]1CCN(CC=2C=CC=CC=2)CC1 YQNRVGJCPCNMKT-LFVJCYFKSA-N 0.000 description 1
- UOSUOAJPKOHNFV-CXUHLZMHSA-N 2-[2-[(e)-2-(4-methoxyphenyl)ethenyl]-4-(4-phenylphenyl)imidazol-1-yl]acetic acid Chemical compound C1=CC(OC)=CC=C1\C=C\C1=NC(C=2C=CC(=CC=2)C=2C=CC=CC=2)=CN1CC(O)=O UOSUOAJPKOHNFV-CXUHLZMHSA-N 0.000 description 1
- BLXXCCIBGGBDHI-UHFFFAOYSA-N 2-[3-(trifluoromethyl)phenyl]acetic acid Chemical compound OC(=O)CC1=CC=CC(C(F)(F)F)=C1 BLXXCCIBGGBDHI-UHFFFAOYSA-N 0.000 description 1
- LWJFVXJMROIMEB-RUDMXATFSA-N 2-[4-(2,4-dichlorophenyl)-2-[(e)-2-(4-methoxyphenyl)ethenyl]imidazol-1-yl]acetic acid Chemical compound C1=CC(OC)=CC=C1\C=C\C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CC(O)=O LWJFVXJMROIMEB-RUDMXATFSA-N 0.000 description 1
- UKXRYFVFZWACFU-YIXHJXPBSA-N 2-[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-(4-methoxyphenyl)phenyl]ethenyl]imidazol-1-yl]acetic acid Chemical compound C1=CC(OC)=CC=C1C(C=C1)=CC=C1\C=C\C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CC(O)=O UKXRYFVFZWACFU-YIXHJXPBSA-N 0.000 description 1
- WFCRHMUPKHNFNS-UHFFFAOYSA-N 2-[4-[4-(2,4-dichlorophenyl)-1-[[4-[3-(trifluoromethyl)phenyl]phenyl]methyl]imidazol-2-yl]phenoxy]acetic acid Chemical compound C1=CC(OCC(=O)O)=CC=C1C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CC1=CC=C(C=2C=C(C=CC=2)C(F)(F)F)C=C1 WFCRHMUPKHNFNS-UHFFFAOYSA-N 0.000 description 1
- JVFLMNMIVJWZPG-LFIBNONCSA-N 2-[4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-(3-methylsulfonylphenyl)phenyl]ethenyl]imidazol-1-yl]methyl]phenyl]acetic acid Chemical compound CS(=O)(=O)C1=CC=CC(C=2C=CC(\C=C\C=3N(C=C(N=3)C=3C(=CC(Cl)=CC=3)Cl)CC=3C=CC(CC(O)=O)=CC=3)=CC=2)=C1 JVFLMNMIVJWZPG-LFIBNONCSA-N 0.000 description 1
- VDSCAQZTEPSRNO-LFIBNONCSA-N 2-[4-[[4-(2,6-dichlorophenyl)-2-[(e)-2-[4-[3-(trifluoromethyl)phenyl]phenyl]ethenyl]imidazol-1-yl]methyl]anilino]acetic acid Chemical compound C1=CC(NCC(=O)O)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC=CC=2Cl)Cl)=C1 VDSCAQZTEPSRNO-LFIBNONCSA-N 0.000 description 1
- SMJLRXWRRKKIDF-OVCLIPMQSA-N 2-[[4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-[3-(trifluoromethyl)phenyl]phenyl]ethenyl]imidazol-1-yl]methyl]phenyl]carbamoylamino]acetic acid Chemical compound C1=CC(NC(=O)NCC(=O)O)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 SMJLRXWRRKKIDF-OVCLIPMQSA-N 0.000 description 1
- OXAJWSLXTCIFFP-UHFFFAOYSA-N 2-[methyl(methylsulfonyl)amino]benzoic acid Chemical compound CS(=O)(=O)N(C)C1=CC=CC=C1C(O)=O OXAJWSLXTCIFFP-UHFFFAOYSA-N 0.000 description 1
- NYKAABWCZIZACT-UHFFFAOYSA-N 2-amino-5-[4-[3-[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]propyl]phenoxy]benzoic acid Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1CCCC(C=C1)=CC=C1OC1=CC=C(N)C(C(O)=O)=C1 NYKAABWCZIZACT-UHFFFAOYSA-N 0.000 description 1
- VGLRDMJXBWVAEY-FZSIALSZSA-N 2-amino-5-[4-[4-[(e)-2-[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]ethenyl]phenyl]phenoxy]benzoic acid Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1\C=C\C(C=C1)=CC=C1C(C=C1)=CC=C1OC1=CC=C(N)C(C(O)=O)=C1 VGLRDMJXBWVAEY-FZSIALSZSA-N 0.000 description 1
- KAJPSYJPHOMWGR-UHFFFAOYSA-N 2-amino-5-[4-[4-[[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]methyl]phenyl]phenoxy]benzoic acid Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1CC(C=C1)=CC=C1C(C=C1)=CC=C1OC1=CC=C(N)C(C(O)=O)=C1 KAJPSYJPHOMWGR-UHFFFAOYSA-N 0.000 description 1
- HTFXWAOSQODIBI-UHFFFAOYSA-N 2-benzyl-1,3-dihydropyrrolo[3,4-c]pyridine Chemical compound C1C2=CC=NC=C2CN1CC1=CC=CC=C1 HTFXWAOSQODIBI-UHFFFAOYSA-N 0.000 description 1
- IQHSSYROJYPFDV-UHFFFAOYSA-N 2-bromo-1,3-dichloro-5-(trifluoromethyl)benzene Chemical group FC(F)(F)C1=CC(Cl)=C(Br)C(Cl)=C1 IQHSSYROJYPFDV-UHFFFAOYSA-N 0.000 description 1
- WZWWEVCLPKAQTA-UHFFFAOYSA-N 2-bromo-1-(2-chlorophenyl)ethanone Chemical compound ClC1=CC=CC=C1C(=O)CBr WZWWEVCLPKAQTA-UHFFFAOYSA-N 0.000 description 1
- FLAYZKKEOIAALB-UHFFFAOYSA-N 2-bromo-1-(4-chlorophenyl)ethanone Chemical compound ClC1=CC=C(C(=O)CBr)C=C1 FLAYZKKEOIAALB-UHFFFAOYSA-N 0.000 description 1
- NSTREUWFTAOOKS-UHFFFAOYSA-N 2-fluorobenzoic acid Chemical compound OC(=O)C1=CC=CC=C1F NSTREUWFTAOOKS-UHFFFAOYSA-N 0.000 description 1
- HUHKPTZVUABHJN-UHFFFAOYSA-N 2-methylpropan-2-ol;n-(oxomethylidene)sulfamoyl chloride Chemical compound CC(C)(C)O.ClS(=O)(=O)N=C=O HUHKPTZVUABHJN-UHFFFAOYSA-N 0.000 description 1
- NQLNHTOCFWUYQE-UHFFFAOYSA-N 2-methylpropane-1-sulfonyl chloride Chemical compound CC(C)CS(Cl)(=O)=O NQLNHTOCFWUYQE-UHFFFAOYSA-N 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- SLAMLWHELXOEJZ-UHFFFAOYSA-M 2-nitrobenzoate Chemical compound [O-]C(=O)C1=CC=CC=C1[N+]([O-])=O SLAMLWHELXOEJZ-UHFFFAOYSA-M 0.000 description 1
- KFYCXHSDUYNICI-UHFFFAOYSA-N 2-o-tert-butyl 3-o-methyl 6-(4-tert-butylphenoxy)-3,4-dihydro-1h-isoquinoline-2,3-dicarboxylate Chemical compound C=1C=C2CN(C(=O)OC(C)(C)C)C(C(=O)OC)CC2=CC=1OC1=CC=C(C(C)(C)C)C=C1 KFYCXHSDUYNICI-UHFFFAOYSA-N 0.000 description 1
- PTICLGKPNSWENQ-UHFFFAOYSA-N 2-o-tert-butyl 3-o-methyl 6-hydroxy-3,4-dihydro-1h-isoquinoline-2,3-dicarboxylate Chemical compound OC1=CC=C2CN(C(=O)OC(C)(C)C)C(C(=O)OC)CC2=C1 PTICLGKPNSWENQ-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- LNMBCRKRCIMQLW-UHFFFAOYSA-N 2-tert-butylsulfanyl-2-methylpropane Chemical compound CC(C)(C)SC(C)(C)C LNMBCRKRCIMQLW-UHFFFAOYSA-N 0.000 description 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ONCAZCNPWWQQMW-UHFFFAOYSA-N 3-(trifluoromethyl)benzenesulfonyl chloride Chemical compound FC(F)(F)C1=CC=CC(S(Cl)(=O)=O)=C1 ONCAZCNPWWQQMW-UHFFFAOYSA-N 0.000 description 1
- YGYGASJNJTYNOL-CQSZACIVSA-N 3-[(4r)-2,2-dimethyl-1,1-dioxothian-4-yl]-5-(4-fluorophenyl)-1h-indole-7-carboxamide Chemical compound C1CS(=O)(=O)C(C)(C)C[C@@H]1C1=CNC2=C(C(N)=O)C=C(C=3C=CC(F)=CC=3)C=C12 YGYGASJNJTYNOL-CQSZACIVSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 1
- OEIUMLSCWINLBB-UHFFFAOYSA-N 3-[4-(trifluoromethyl)phenyl]propanoic acid Chemical compound OC(=O)CCC1=CC=C(C(F)(F)F)C=C1 OEIUMLSCWINLBB-UHFFFAOYSA-N 0.000 description 1
- PLSKAMYKHAOPJS-GIJQJNRQSA-N 3-[[2-[(e)-2-[4-(4-butoxyphenyl)phenyl]ethenyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(OCCCC)=CC=C1C(C=C1)=CC=C1\C=C\C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CC1=CC=CC(C(O)=O)=C1 PLSKAMYKHAOPJS-GIJQJNRQSA-N 0.000 description 1
- YDZQPLKVYPOKNI-UHFFFAOYSA-N 3-amino-4-[4-[4-[[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]methyl]phenyl]phenoxy]benzoic acid Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1CC(C=C1)=CC=C1C(C=C1)=CC=C1OC1=CC=C(C(O)=O)C=C1N YDZQPLKVYPOKNI-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-M 3-carboxy-2,3-dihydroxypropanoate Chemical compound OC(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-M 0.000 description 1
- ALKYHXVLJMQRLQ-UHFFFAOYSA-M 3-carboxynaphthalen-2-olate Chemical compound C1=CC=C2C=C(C([O-])=O)C(O)=CC2=C1 ALKYHXVLJMQRLQ-UHFFFAOYSA-M 0.000 description 1
- XOAKQCOPHMCADA-UHFFFAOYSA-N 4,8-dioxatricyclo[5.1.0.03,5]octane Chemical compound C1C2OC2CC2OC12 XOAKQCOPHMCADA-UHFFFAOYSA-N 0.000 description 1
- STHFDQDHPCGNGR-OVCLIPMQSA-N 4-(2,4-dichlorophenyl)-1-[(4-nitrophenyl)methyl]-2-[(e)-2-[4-[3-(trifluoromethyl)phenyl]phenyl]ethenyl]imidazole Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 STHFDQDHPCGNGR-OVCLIPMQSA-N 0.000 description 1
- NYCNYZQVSUFVPN-LICLKQGHSA-N 4-(2,4-dichlorophenyl)-1-[[4-(3-ethoxy-1h-pyrazol-5-yl)phenyl]methyl]-2-[(e)-2-[4-[3-(trifluoromethyl)phenyl]phenyl]ethenyl]imidazole Chemical compound N1N=C(OCC)C=C1C(C=C1)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 NYCNYZQVSUFVPN-LICLKQGHSA-N 0.000 description 1
- VZTNTPXQQHPWIE-XNTDXEJSSA-N 4-(2,4-dichlorophenyl)-1-ethyl-2-[(E)-2-(4-phenylphenyl)ethenyl]imidazole Chemical group ClC1=C(C=CC(=C1)Cl)C=1N=C(N(C=1)CC)/C=C/C1=CC=C(C=C1)C1=CC=CC=C1 VZTNTPXQQHPWIE-XNTDXEJSSA-N 0.000 description 1
- RFQVVIWTRKSRRJ-GIDUJCDVSA-N 4-(2,4-dichlorophenyl)-1-ethyl-2-[(e)-2-[4-(4-methoxyphenyl)phenyl]ethenyl]imidazole Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1\C=C\C(C=C1)=CC=C1C1=CC=C(OC)C=C1 RFQVVIWTRKSRRJ-GIDUJCDVSA-N 0.000 description 1
- NQTDVTTXWRQFTA-UHFFFAOYSA-N 4-(2,4-dichlorophenyl)-1-ethyl-2-[3-(4-methoxyphenyl)propyl]imidazole Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1CCCC1=CC=C(OC)C=C1 NQTDVTTXWRQFTA-UHFFFAOYSA-N 0.000 description 1
- REYJTYZQMLYPQV-UHFFFAOYSA-N 4-(2,4-dichlorophenyl)-2-(4-methoxyphenyl)-1-[[4-[3-(trifluoromethyl)phenyl]phenyl]methyl]imidazole Chemical compound C1=CC(OC)=CC=C1C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CC1=CC=C(C=2C=C(C=CC=2)C(F)(F)F)C=C1 REYJTYZQMLYPQV-UHFFFAOYSA-N 0.000 description 1
- MQFBEPUFKPQLCG-OVCLIPMQSA-N 4-(2,4-difluorophenyl)-1-[(4-nitrophenyl)methyl]-2-[(e)-2-[4-[3-(trifluoromethyl)phenyl]phenyl]ethenyl]imidazole Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC(F)=CC=2)F)=C1 MQFBEPUFKPQLCG-OVCLIPMQSA-N 0.000 description 1
- AMWCZBZTQLTBIU-LFIBNONCSA-N 4-(2,6-dichlorophenyl)-1-[(4-nitrophenyl)methyl]-2-[(e)-2-[4-[3-(trifluoromethyl)phenyl]phenyl]ethenyl]imidazole Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC=CC=2Cl)Cl)=C1 AMWCZBZTQLTBIU-LFIBNONCSA-N 0.000 description 1
- YQWVRZOQHCCIRK-SFQUDFHCSA-N 4-(2-chlorophenyl)-1-[(4-nitrophenyl)methyl]-2-[(e)-2-[4-[3-(trifluoromethyl)phenyl]phenyl]ethenyl]imidazole Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC=CC=2)Cl)=C1 YQWVRZOQHCCIRK-SFQUDFHCSA-N 0.000 description 1
- LZHMNCJMXQKSBY-UHFFFAOYSA-N 4-(4-methoxyphenyl)butanoic acid Chemical compound COC1=CC=C(CCCC(O)=O)C=C1 LZHMNCJMXQKSBY-UHFFFAOYSA-N 0.000 description 1
- OZDCZHDOIBUGAJ-UHFFFAOYSA-N 4-(trifluoromethyl)benzenesulfonyl chloride Chemical compound FC(F)(F)C1=CC=C(S(Cl)(=O)=O)C=C1 OZDCZHDOIBUGAJ-UHFFFAOYSA-N 0.000 description 1
- VJPPLCNBDLZIFG-ZDUSSCGKSA-N 4-[(3S)-3-(but-2-ynoylamino)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide Chemical compound C(C#CC)(=O)N[C@@H]1CN(CCC1)C1=C2C(=C(NC2=C(C=C1F)C(=O)N)C)C VJPPLCNBDLZIFG-ZDUSSCGKSA-N 0.000 description 1
- DANLZOIRUUHIIX-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]indazol-3-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(C1=CC=CC=C11)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F DANLZOIRUUHIIX-UHFFFAOYSA-N 0.000 description 1
- ZKMZVDNALLWQGS-FRKPEAEDSA-N 4-[2-[(e)-2-[4-[4-(3-carboxypropoxy)phenyl]phenyl]ethenyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]butanoic acid Chemical compound C1=CC(OCCCC(=O)O)=CC=C1C(C=C1)=CC=C1\C=C\C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CCCC(O)=O ZKMZVDNALLWQGS-FRKPEAEDSA-N 0.000 description 1
- IPBUABMKFMAYCV-UHFFFAOYSA-N 4-[2-[[6-(4-tert-butylphenoxy)isoquinoline-3-carbonyl]amino]-4-(2,4-dichlorophenyl)imidazol-1-yl]benzoic acid Chemical compound C1=CC(C(C)(C)C)=CC=C1OC1=CC=C(C=NC(=C2)C(=O)NC=3N(C=C(N=3)C=3C(=CC(Cl)=CC=3)Cl)C=3C=CC(=CC=3)C(O)=O)C2=C1 IPBUABMKFMAYCV-UHFFFAOYSA-N 0.000 description 1
- NJVOPVABDFKPAA-NYYWCZLTSA-N 4-[3-[(e)-2-[5-(2,4-dichlorophenyl)-1h-imidazol-2-yl]ethenyl]phenyl]phenol Chemical compound C1=CC(O)=CC=C1C1=CC=CC(\C=C\C=2NC=C(N=2)C=2C(=CC(Cl)=CC=2)Cl)=C1 NJVOPVABDFKPAA-NYYWCZLTSA-N 0.000 description 1
- YYHPIQYKCLQUEE-UHFFFAOYSA-N 4-[3-[4-[[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]methoxy]phenyl]phenoxy]butanoic acid Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1COC(C=C1)=CC=C1C1=CC=CC(OCCCC(O)=O)=C1 YYHPIQYKCLQUEE-UHFFFAOYSA-N 0.000 description 1
- SKXPFQWEZYNTGD-UHFFFAOYSA-N 4-[4-(2,4-dichlorophenyl)-1-[[4-[3-(trifluoromethyl)phenyl]phenyl]methyl]imidazol-2-yl]phenol Chemical compound C1=CC(O)=CC=C1C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CC1=CC=C(C=2C=C(C=CC=2)C(F)(F)F)C=C1 SKXPFQWEZYNTGD-UHFFFAOYSA-N 0.000 description 1
- WVICJZJKKNNLJY-UHFFFAOYSA-N 4-[4-(2,4-dichlorophenyl)-2-(fluoren-9-ylidenemethyl)imidazol-1-yl]butanoic acid Chemical compound N1=C(C=C2C3=CC=CC=C3C3=CC=CC=C32)N(CCCC(=O)O)C=C1C1=CC=C(Cl)C=C1Cl WVICJZJKKNNLJY-UHFFFAOYSA-N 0.000 description 1
- QCJBNDZELIVRGW-GIDUJCDVSA-N 4-[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-(4-methoxyphenyl)phenyl]ethenyl]imidazol-1-yl]butanoic acid Chemical compound C1=CC(OC)=CC=C1C(C=C1)=CC=C1\C=C\C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CCCC(O)=O QCJBNDZELIVRGW-GIDUJCDVSA-N 0.000 description 1
- MBTRKMIJTLZGIB-UHFFFAOYSA-N 4-[4-(2,4-dichlorophenyl)-2-[1-[4-[3-(trifluoromethyl)phenoxy]phenyl]cyclopropyl]imidazol-1-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1N1C(C2(CC2)C=2C=CC(OC=3C=C(C=CC=3)C(F)(F)F)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 MBTRKMIJTLZGIB-UHFFFAOYSA-N 0.000 description 1
- KUUYBBWMEJZZEV-UHFFFAOYSA-N 4-[4-(2,4-dichlorophenyl)-2-[3-[4-[3-(trifluoromethyl)phenyl]phenyl]propyl]imidazol-1-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1N1C(CCCC=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 KUUYBBWMEJZZEV-UHFFFAOYSA-N 0.000 description 1
- RWTCBKFCSFSIHL-UHFFFAOYSA-N 4-[4-(2,4-dichlorophenyl)-2-[[4-(4-ethoxyphenyl)phenyl]methyl]imidazol-1-yl]benzoic acid Chemical compound C1=CC(OCC)=CC=C1C(C=C1)=CC=C1CC1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1C1=CC=C(C(O)=O)C=C1 RWTCBKFCSFSIHL-UHFFFAOYSA-N 0.000 description 1
- OFFGENNAHJGXEY-UHFFFAOYSA-N 4-[4-(2,4-dichlorophenyl)-2-[[4-(4-hydroxyphenyl)phenyl]methyl]imidazol-1-yl]-2-(methanesulfonamido)benzoic acid Chemical compound C1=C(C(O)=O)C(NS(=O)(=O)C)=CC(N2C(=NC(=C2)C=2C(=CC(Cl)=CC=2)Cl)CC=2C=CC(=CC=2)C=2C=CC(O)=CC=2)=C1 OFFGENNAHJGXEY-UHFFFAOYSA-N 0.000 description 1
- QGWAXVJUTRYASA-UHFFFAOYSA-N 4-[4-(2,4-dichlorophenyl)-2-[[4-[3-(trifluoromethyl)phenyl]phenyl]methyl]imidazol-1-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1N1C(CC=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 QGWAXVJUTRYASA-UHFFFAOYSA-N 0.000 description 1
- CRPAROCLXRUUMQ-UHFFFAOYSA-N 4-[4-(2,4-dichlorophenyl)-2-[[4-[4-(4,4,4-trifluorobutoxy)phenyl]phenyl]methyl]imidazol-1-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1N1C(CC=2C=CC(=CC=2)C=2C=CC(OCCCC(F)(F)F)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 CRPAROCLXRUUMQ-UHFFFAOYSA-N 0.000 description 1
- WRZSUUUJUDTVTE-UHFFFAOYSA-N 4-[4-(2,4-dichlorophenyl)-2-[[4-[4-(4-methylsulfonylphenoxy)phenyl]phenyl]methyl]imidazol-1-yl]benzoic acid Chemical compound C1=CC(S(=O)(=O)C)=CC=C1OC1=CC=C(C=2C=CC(CC=3N(C=C(N=3)C=3C(=CC(Cl)=CC=3)Cl)C=3C=CC(=CC=3)C(O)=O)=CC=2)C=C1 WRZSUUUJUDTVTE-UHFFFAOYSA-N 0.000 description 1
- BNECQHHJLWYKGZ-UHFFFAOYSA-N 4-[4-(2,4-dichlorophenyl)-2-[[4-[4-[3-(trifluoromethyl)phenoxy]phenyl]phenyl]methyl]imidazol-1-yl]-n-methylbenzamide Chemical compound C1=CC(C(=O)NC)=CC=C1N1C(CC=2C=CC(=CC=2)C=2C=CC(OC=3C=C(C=CC=3)C(F)(F)F)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 BNECQHHJLWYKGZ-UHFFFAOYSA-N 0.000 description 1
- KVIPOXIKRMDBAP-FRKPEAEDSA-N 4-[4-(2,4-difluorophenyl)-2-[(e)-2-[4-(3-methylsulfonylphenyl)phenyl]ethenyl]imidazol-1-yl]benzoic acid Chemical compound CS(=O)(=O)C1=CC=CC(C=2C=CC(\C=C\C=3N(C=C(N=3)C=3C(=CC(F)=CC=3)F)C=3C=CC(=CC=3)C(O)=O)=CC=2)=C1 KVIPOXIKRMDBAP-FRKPEAEDSA-N 0.000 description 1
- BCXQCGVPZWITOI-VGOFMYFVSA-N 4-[4-[3-[(e)-2-[4-(2,4-dichlorophenyl)-1-(2-methoxy-2-oxoethyl)imidazol-2-yl]ethenyl]phenyl]phenoxy]butanoic acid Chemical compound COC(=O)CN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1\C=C\C(C=1)=CC=CC=1C1=CC=C(OCCCC(O)=O)C=C1 BCXQCGVPZWITOI-VGOFMYFVSA-N 0.000 description 1
- HMGKZZASYYGARW-UHFFFAOYSA-N 4-[4-[4-(2,4-dichlorophenyl)-1-[[4-[3-(trifluoromethyl)phenyl]phenyl]methyl]imidazol-2-yl]phenoxy]butanoic acid Chemical compound C1=CC(OCCCC(=O)O)=CC=C1C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CC1=CC=C(C=2C=C(C=CC=2)C(F)(F)F)C=C1 HMGKZZASYYGARW-UHFFFAOYSA-N 0.000 description 1
- HQIYIJMUJXSFPN-BLLMUTORSA-N 4-[4-[4-[(e)-2-[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]ethenyl]phenyl]phenoxy]aniline Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1\C=C\C(C=C1)=CC=C1C(C=C1)=CC=C1OC1=CC=C(N)C=C1 HQIYIJMUJXSFPN-BLLMUTORSA-N 0.000 description 1
- BFFVUNKIOAATDZ-UHFFFAOYSA-N 4-[4-[4-[[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]methyl]phenyl]phenoxy]-n-methylsulfonyl-2-(trifluoromethyl)benzamide Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1CC(C=C1)=CC=C1C(C=C1)=CC=C1OC1=CC=C(C(=O)NS(C)(=O)=O)C(C(F)(F)F)=C1 BFFVUNKIOAATDZ-UHFFFAOYSA-N 0.000 description 1
- LNKHBRDWRIIROP-UHFFFAOYSA-N 4-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]benzoic acid Chemical compound CC(C)(C)OC(=O)NCC1=CC=C(C(O)=O)C=C1 LNKHBRDWRIIROP-UHFFFAOYSA-N 0.000 description 1
- XYWIPYBIIRTJMM-IBGZPJMESA-N 4-[[(2S)-2-[4-[5-chloro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]-5-methoxy-2-oxopyridin-1-yl]butanoyl]amino]-2-fluorobenzamide Chemical compound CC[C@H](N1C=C(OC)C(=CC1=O)C1=C(C=CC(Cl)=C1)N1C=C(N=N1)C(F)(F)F)C(=O)NC1=CC(F)=C(C=C1)C(N)=O XYWIPYBIIRTJMM-IBGZPJMESA-N 0.000 description 1
- YYBSHYCSPRSNPH-LFYBBSHMSA-N 4-[[2-[(e)-2-(4-aminophenyl)ethenyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(N)=CC=C1\C=C\C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CC1=CC=C(C(O)=O)C=C1 YYBSHYCSPRSNPH-LFYBBSHMSA-N 0.000 description 1
- CFLKUEUGCHQRNX-UFWORHAWSA-N 4-[[2-[(e)-2-[4-(4-butoxyphenyl)phenyl]ethenyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(OCCCC)=CC=C1C(C=C1)=CC=C1\C=C\C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CC1=CC=C(C(O)=O)C=C1 CFLKUEUGCHQRNX-UFWORHAWSA-N 0.000 description 1
- BLKOGGCDJZOXAS-OVCLIPMQSA-N 4-[[2-[(e)-2-[4-(butylsulfonylamino)phenyl]ethenyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(NS(=O)(=O)CCCC)=CC=C1\C=C\C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CC1=CC=C(C(O)=O)C=C1 BLKOGGCDJZOXAS-OVCLIPMQSA-N 0.000 description 1
- LUQDWMQAMPPWOP-UHFFFAOYSA-N 4-[[2-[[4-[4-(4-tert-butylphenoxy)phenyl]phenyl]methyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]methyl]-n-methylsulfonylbenzamide Chemical compound C1=CC(C(C)(C)C)=CC=C1OC1=CC=C(C=2C=CC(CC=3N(C=C(N=3)C=3C(=CC(Cl)=CC=3)Cl)CC=3C=CC(=CC=3)C(=O)NS(C)(=O)=O)=CC=2)C=C1 LUQDWMQAMPPWOP-UHFFFAOYSA-N 0.000 description 1
- TZWGOGZKZHGGKQ-LDADJPATSA-N 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[2-methoxy-5-[2-(4-methoxyphenyl)ethynyl]phenyl]ethenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(OC)=CC=C1C#CC1=CC=C(OC)C(\C=C\C=2N(C=C(N=2)C=2C(=CC(Cl)=CC=2)Cl)CC=2C=CC(=CC=2)C(O)=O)=C1 TZWGOGZKZHGGKQ-LDADJPATSA-N 0.000 description 1
- OJHWXJHFTSENHC-CNHKJKLMSA-N 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-(4-propan-2-yloxyphenyl)phenyl]ethenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(OC(C)C)=CC=C1C(C=C1)=CC=C1\C=C\C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CC1=CC=C(C(O)=O)C=C1 OJHWXJHFTSENHC-CNHKJKLMSA-N 0.000 description 1
- FHEOGLYYFOZWNO-CAOOACKPSA-N 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-[(4-methylphenyl)sulfonylamino]phenyl]ethenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(C=C1)=CC=C1\C=C\C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CC1=CC=C(C(O)=O)C=C1 FHEOGLYYFOZWNO-CAOOACKPSA-N 0.000 description 1
- RBGYIXAHMOEOFC-LICLKQGHSA-N 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-[1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrol-2-yl]phenyl]ethenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound CC(C)(C)OC(=O)N1C=CC=C1C(C=C1)=CC=C1\C=C\C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CC1=CC=C(C(O)=O)C=C1 RBGYIXAHMOEOFC-LICLKQGHSA-N 0.000 description 1
- DFHMDHVXGABSBZ-LHHJGKSTSA-N 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-[2-fluoro-5-(trifluoromethyl)phenyl]phenyl]ethenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C(=CC=C(C=2)C(F)(F)F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 DFHMDHVXGABSBZ-LHHJGKSTSA-N 0.000 description 1
- XQMDWBQAMOGZMT-DENHBWNVSA-N 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-[4-(4-nitrophenoxy)phenyl]phenyl]ethenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=CC(OC=3C=CC(=CC=3)[N+]([O-])=O)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 XQMDWBQAMOGZMT-DENHBWNVSA-N 0.000 description 1
- NADNOSHTMBFGDZ-FZSIALSZSA-N 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-[[4-(trifluoromethyl)phenyl]sulfonylamino]phenyl]ethenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(\C=C\C=2C=CC(NS(=O)(=O)C=3C=CC(=CC=3)C(F)(F)F)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 NADNOSHTMBFGDZ-FZSIALSZSA-N 0.000 description 1
- RKLYCJPQBLIASR-OQLLNIDSSA-N 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[5-(4-hydroxyphenyl)-2-methoxyphenyl]ethenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound COC1=CC=C(C=2C=CC(O)=CC=2)C=C1\C=C\C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CC1=CC=C(C(O)=O)C=C1 RKLYCJPQBLIASR-OQLLNIDSSA-N 0.000 description 1
- QDILQYXINSVEOH-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[1-[4-[3-(trifluoromethyl)phenoxy]phenyl]cyclopropyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(C2(CC2)C=2C=CC(OC=3C=C(C=CC=3)C(F)(F)F)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 QDILQYXINSVEOH-UHFFFAOYSA-N 0.000 description 1
- WNLJNBMPXXGQOD-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[2-[4-(3-methylsulfonylphenyl)phenyl]ethyl]imidazol-1-yl]methyl]benzoic acid Chemical compound CS(=O)(=O)C1=CC=CC(C=2C=CC(CCC=3N(C=C(N=3)C=3C(=CC(Cl)=CC=3)Cl)CC=3C=CC(=CC=3)C(O)=O)=CC=2)=C1 WNLJNBMPXXGQOD-UHFFFAOYSA-N 0.000 description 1
- PBRIJBWQILUHLL-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[2-[4-[3-(trifluoromethyl)phenyl]phenyl]ethyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(CCC=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 PBRIJBWQILUHLL-UHFFFAOYSA-N 0.000 description 1
- VVSYHLCWNWLKMY-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[4-(3-methylsulfonylphenyl)benzoyl]imidazol-1-yl]methyl]benzoic acid Chemical compound CS(=O)(=O)C1=CC=CC(C=2C=CC(=CC=2)C(=O)C=2N(C=C(N=2)C=2C(=CC(Cl)=CC=2)Cl)CC=2C=CC(=CC=2)C(O)=O)=C1 VVSYHLCWNWLKMY-UHFFFAOYSA-N 0.000 description 1
- XGMXNNNGQZIGFC-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[4-[3-(trifluoromethoxy)phenyl]benzoyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(C(=O)C=2C=CC(=CC=2)C=2C=C(OC(F)(F)F)C=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 XGMXNNNGQZIGFC-UHFFFAOYSA-N 0.000 description 1
- QWVVLEFGIXLWPV-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[4-[3-(trifluoromethyl)phenyl]anilino]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(NC=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 QWVVLEFGIXLWPV-UHFFFAOYSA-N 0.000 description 1
- CLMVVBBJWXRTSJ-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[4-[3-(trifluoromethyl)phenyl]benzoyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(C(=O)C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 CLMVVBBJWXRTSJ-UHFFFAOYSA-N 0.000 description 1
- ZFELGNNAKCFBBS-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[4-[3-methoxy-4-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]phenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=C(NC(=O)OC(C)(C)C)C(OC)=CC(C=2C=CC(=CC=2)C=2N(C=C(N=2)C=2C(=CC(Cl)=CC=2)Cl)CC=2C=CC(=CC=2)C(O)=O)=C1 ZFELGNNAKCFBBS-UHFFFAOYSA-N 0.000 description 1
- JTDOAHFZJKJWSE-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[4-[4-(4,4,4-trifluorobutoxy)phenyl]phenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(C=2C=CC(=CC=2)C=2C=CC(OCCCC(F)(F)F)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 JTDOAHFZJKJWSE-UHFFFAOYSA-N 0.000 description 1
- XMARMSROMMZWOY-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[4-[[[2-(4-methylsulfonylphenyl)acetyl]amino]methyl]phenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(S(=O)(=O)C)=CC=C1CC(=O)NCC1=CC=C(C=2N(C=C(N=2)C=2C(=CC(Cl)=CC=2)Cl)CC=2C=CC(=CC=2)C(O)=O)C=C1 XMARMSROMMZWOY-UHFFFAOYSA-N 0.000 description 1
- YQILNXCUBPPBNJ-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[[4-[3-(2,2,2-trifluoroethylsulfonylamino)phenyl]phenyl]methyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(CC=2C=CC(=CC=2)C=2C=C(NS(=O)(=O)CC(F)(F)F)C=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 YQILNXCUBPPBNJ-UHFFFAOYSA-N 0.000 description 1
- AIRHTJWHWXLTBM-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[[4-[3-(methanesulfonamido)phenyl]phenyl]methyl]imidazol-1-yl]methyl]benzoic acid Chemical compound CS(=O)(=O)NC1=CC=CC(C=2C=CC(CC=3N(C=C(N=3)C=3C(=CC(Cl)=CC=3)Cl)CC=3C=CC(=CC=3)C(O)=O)=CC=2)=C1 AIRHTJWHWXLTBM-UHFFFAOYSA-N 0.000 description 1
- JGRGPTZQAHHFJT-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[[4-[3-(methoxycarbonylamino)phenyl]phenyl]methyl]imidazol-1-yl]methyl]benzoic acid Chemical compound COC(=O)NC1=CC=CC(C=2C=CC(CC=3N(C=C(N=3)C=3C(=CC(Cl)=CC=3)Cl)CC=3C=CC(=CC=3)C(O)=O)=CC=2)=C1 JGRGPTZQAHHFJT-UHFFFAOYSA-N 0.000 description 1
- WJSIXSYFTIZHSP-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[[4-[3-(propan-2-yloxycarbonylamino)phenyl]phenyl]methyl]imidazol-1-yl]methyl]benzoic acid Chemical compound CC(C)OC(=O)NC1=CC=CC(C=2C=CC(CC=3N(C=C(N=3)C=3C(=CC(Cl)=CC=3)Cl)CC=3C=CC(=CC=3)C(O)=O)=CC=2)=C1 WJSIXSYFTIZHSP-UHFFFAOYSA-N 0.000 description 1
- RXRTZKZMAYNSED-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[[4-[3-(trifluoromethoxy)phenyl]phenyl]methyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(CC=2C=CC(=CC=2)C=2C=C(OC(F)(F)F)C=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 RXRTZKZMAYNSED-UHFFFAOYSA-N 0.000 description 1
- NDOGSYCSVOLCHU-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[[4-[3-(trifluoromethylsulfonylamino)phenyl]phenyl]methyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(CC=2C=CC(=CC=2)C=2C=C(NS(=O)(=O)C(F)(F)F)C=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 NDOGSYCSVOLCHU-UHFFFAOYSA-N 0.000 description 1
- HNBAICNXVLKEIE-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[[4-[3-methoxy-4-(propan-2-yloxycarbonylamino)phenyl]phenyl]methyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=C(NC(=O)OC(C)C)C(OC)=CC(C=2C=CC(CC=3N(C=C(N=3)C=3C(=CC(Cl)=CC=3)Cl)CC=3C=CC(=CC=3)C(O)=O)=CC=2)=C1 HNBAICNXVLKEIE-UHFFFAOYSA-N 0.000 description 1
- YUMSDOHFKASMLQ-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[[4-[3-methoxy-4-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]phenyl]methyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=C(NC(=O)OC(C)(C)C)C(OC)=CC(C=2C=CC(CC=3N(C=C(N=3)C=3C(=CC(Cl)=CC=3)Cl)CC=3C=CC(=CC=3)C(O)=O)=CC=2)=C1 YUMSDOHFKASMLQ-UHFFFAOYSA-N 0.000 description 1
- QAQUDVIMBQXSBD-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[[4-[4-(4,4,4-trifluorobutoxy)phenyl]phenyl]methyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(CC=2C=CC(=CC=2)C=2C=CC(OCCCC(F)(F)F)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 QAQUDVIMBQXSBD-UHFFFAOYSA-N 0.000 description 1
- BXXYTDBMBOLOJM-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[[4-[4-(methanesulfonamido)phenyl]phenyl]methyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(NS(=O)(=O)C)=CC=C1C(C=C1)=CC=C1CC1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CC1=CC=C(C(O)=O)C=C1 BXXYTDBMBOLOJM-UHFFFAOYSA-N 0.000 description 1
- BXJXJXDUZCXDAJ-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[[4-[4-(trifluoromethoxy)phenyl]phenoxy]methyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(COC=2C=CC(=CC=2)C=2C=CC(OC(F)(F)F)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 BXJXJXDUZCXDAJ-UHFFFAOYSA-N 0.000 description 1
- XEGSSKRYFZIREP-UHFFFAOYSA-N 4-[[4-(2,4-dichlorophenyl)-2-[[4-[4-(trifluoromethoxy)phenyl]phenyl]methyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(CC=2C=CC(=CC=2)C=2C=CC(OC(F)(F)F)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 XEGSSKRYFZIREP-UHFFFAOYSA-N 0.000 description 1
- NYCMSIWGIPOVRZ-CAOOACKPSA-N 4-[[4-(4-chlorophenyl)-2-[(e)-2-[4-[3-(trifluoromethyl)phenyl]phenyl]ethenyl]imidazol-1-yl]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C=CC(Cl)=CC=2)=C1 NYCMSIWGIPOVRZ-CAOOACKPSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- WDFQBORIUYODSI-UHFFFAOYSA-N 4-bromoaniline Chemical compound NC1=CC=C(Br)C=C1 WDFQBORIUYODSI-UHFFFAOYSA-N 0.000 description 1
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 1
- ARIREUPIXAKDAY-UHFFFAOYSA-N 4-butylbenzaldehyde Chemical compound CCCCC1=CC=C(C=O)C=C1 ARIREUPIXAKDAY-UHFFFAOYSA-N 0.000 description 1
- OVFZELSNOHIDEF-UHFFFAOYSA-N 4-butylbenzenesulfonyl chloride Chemical compound CCCCC1=CC=C(S(Cl)(=O)=O)C=C1 OVFZELSNOHIDEF-UHFFFAOYSA-N 0.000 description 1
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 description 1
- KEBIIDPAYVEPES-UHFFFAOYSA-N 5-(2,4-dichlorophenyl)-1h-imidazol-2-amine Chemical compound N1C(N)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 KEBIIDPAYVEPES-UHFFFAOYSA-N 0.000 description 1
- FURYCJMATMMNLJ-RUDMXATFSA-N 5-(2,4-dichlorophenyl)-2-[(e)-2-(4-methoxyphenyl)ethenyl]-1h-imidazole Chemical compound C1=CC(OC)=CC=C1\C=C\C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1 FURYCJMATMMNLJ-RUDMXATFSA-N 0.000 description 1
- VIJXCGPMJCWBOP-FPYGCLRLSA-N 5-(2,4-dichlorophenyl)-2-[(e)-2-(4-nitrophenyl)ethenyl]-1h-imidazole Chemical compound C1=CC([N+](=O)[O-])=CC=C1\C=C\C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1 VIJXCGPMJCWBOP-FPYGCLRLSA-N 0.000 description 1
- ILWULYZGMWJBDN-UHFFFAOYSA-N 5-(2,4-dichlorophenyl)-2-[3-(4-methoxyphenyl)propyl]-1h-imidazole Chemical compound C1=CC(OC)=CC=C1CCCC1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1 ILWULYZGMWJBDN-UHFFFAOYSA-N 0.000 description 1
- BHPHBMRWJBXCHG-IZZDOVSWSA-N 5-(2,4-difluorophenyl)-2-[(e)-2-[4-[3-(trifluoromethyl)phenyl]phenyl]ethenyl]-1h-imidazole Chemical compound FC1=CC(F)=CC=C1C1=CNC(\C=C\C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=N1 BHPHBMRWJBXCHG-IZZDOVSWSA-N 0.000 description 1
- JCXHXYITGXZBNE-FMIVXFBMSA-N 5-(2,6-dichlorophenyl)-2-[(e)-2-[4-[3-(trifluoromethyl)phenyl]phenyl]ethenyl]-1h-imidazole Chemical compound FC(F)(F)C1=CC=CC(C=2C=CC(\C=C\C=3NC=C(N=3)C=3C(=CC=CC=3Cl)Cl)=CC=2)=C1 JCXHXYITGXZBNE-FMIVXFBMSA-N 0.000 description 1
- UJMNAXLCVJYZFM-JLHYYAGUSA-N 5-(2-chlorophenyl)-2-[(e)-2-[4-[3-(trifluoromethyl)phenyl]phenyl]ethenyl]-1h-imidazole Chemical compound FC(F)(F)C1=CC=CC(C=2C=CC(\C=C\C=3NC=C(N=3)C=3C(=CC=CC=3)Cl)=CC=2)=C1 UJMNAXLCVJYZFM-JLHYYAGUSA-N 0.000 description 1
- HMGPGTWELMVTIC-AWNIVKPZSA-N 5-(4-chlorophenyl)-2-[(e)-2-[4-[3-(trifluoromethyl)phenyl]phenyl]ethenyl]-1h-imidazole Chemical compound FC(F)(F)C1=CC=CC(C=2C=CC(\C=C\C=3NC=C(N=3)C=3C=CC(Cl)=CC=3)=CC=2)=C1 HMGPGTWELMVTIC-AWNIVKPZSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- SUNMCRLDSHRTQC-UHFFFAOYSA-N 5-[3-[4-[[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]methoxy]phenyl]phenoxy]-2-(trifluoromethyl)benzoic acid Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1COC(C=C1)=CC=C1C(C=1)=CC=CC=1OC1=CC=C(C(F)(F)F)C(C(O)=O)=C1 SUNMCRLDSHRTQC-UHFFFAOYSA-N 0.000 description 1
- XFFJERWJBDPKFF-UHFFFAOYSA-N 5-[3-[4-[[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]methyl]phenyl]phenoxy]-2-(trifluoromethyl)benzoic acid Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1CC(C=C1)=CC=C1C(C=1)=CC=CC=1OC1=CC=C(C(F)(F)F)C(C(O)=O)=C1 XFFJERWJBDPKFF-UHFFFAOYSA-N 0.000 description 1
- JMWYZPZRAFWNQC-UHFFFAOYSA-N 5-[4-[3-[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]propyl]phenoxy]-2-nitrobenzoic acid Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1CCCC(C=C1)=CC=C1OC1=CC=C([N+]([O-])=O)C(C(O)=O)=C1 JMWYZPZRAFWNQC-UHFFFAOYSA-N 0.000 description 1
- BQMLKMOWQWIDNZ-UHFFFAOYSA-N 5-[4-[4-(2,4-dichlorophenyl)-2-[[4-(3-methylsulfonylphenyl)phenyl]methyl]imidazol-1-yl]phenyl]-1,1-dioxo-1,2,5-thiadiazolidin-3-one Chemical compound CS(=O)(=O)C1=CC=CC(C=2C=CC(CC=3N(C=C(N=3)C=3C(=CC(Cl)=CC=3)Cl)C=3C=CC(=CC=3)N3S(NC(=O)C3)(=O)=O)=CC=2)=C1 BQMLKMOWQWIDNZ-UHFFFAOYSA-N 0.000 description 1
- DHTSFSDEOQWMHS-UHFFFAOYSA-N 5-[4-[4-[[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]methyl]phenyl]phenoxy]-2-nitrobenzoic acid Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1CC(C=C1)=CC=C1C(C=C1)=CC=C1OC1=CC=C([N+]([O-])=O)C(C(O)=O)=C1 DHTSFSDEOQWMHS-UHFFFAOYSA-N 0.000 description 1
- MMQLLKHKLIBXBS-UHFFFAOYSA-N 5-[4-[[4-(2,4-dichlorophenyl)-2-[2-[2-fluoro-4-(trifluoromethyl)phenyl]ethyl]imidazol-1-yl]methyl]phenyl]-1,1-dioxo-1,2,5-thiadiazolidin-3-one Chemical compound FC1=CC(C(F)(F)F)=CC=C1CCC1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CC1=CC=C(N2S(NC(=O)C2)(=O)=O)C=C1 MMQLLKHKLIBXBS-UHFFFAOYSA-N 0.000 description 1
- MTTOEVXELFMKGJ-UHFFFAOYSA-N 5-[4-[[4-(2,4-dichlorophenyl)-2-[2-[4-[3-(trifluoromethoxy)phenyl]phenyl]ethyl]imidazol-1-yl]methyl]phenyl]-1,1-dioxo-1,2,5-thiadiazolidin-3-one Chemical compound FC(F)(F)OC1=CC=CC(C=2C=CC(CCC=3N(C=C(N=3)C=3C(=CC(Cl)=CC=3)Cl)CC=3C=CC(=CC=3)N3S(NC(=O)C3)(=O)=O)=CC=2)=C1 MTTOEVXELFMKGJ-UHFFFAOYSA-N 0.000 description 1
- NRYHGWMVKHOUMT-LFIBNONCSA-N 5-[4-[[4-(2,6-dichlorophenyl)-2-[(e)-2-[4-[3-(trifluoromethyl)phenyl]phenyl]ethenyl]imidazol-1-yl]methyl]phenyl]-1,1-dioxo-1,2,5-thiadiazolidin-3-one Chemical compound FC(F)(F)C1=CC=CC(C=2C=CC(\C=C\C=3N(C=C(N=3)C=3C(=CC=CC=3Cl)Cl)CC=3C=CC(=CC=3)N3S(NC(=O)C3)(=O)=O)=CC=2)=C1 NRYHGWMVKHOUMT-LFIBNONCSA-N 0.000 description 1
- PLJZJIMAVPSXDU-CAOOACKPSA-N 5-[4-[[4-(4-chlorophenyl)-2-[(e)-2-[4-[3-(trifluoromethyl)phenyl]phenyl]ethenyl]imidazol-1-yl]methyl]phenyl]-1,1-dioxo-1,2,5-thiadiazolidin-3-one Chemical compound FC(F)(F)C1=CC=CC(C=2C=CC(\C=C\C=3N(C=C(N=3)C=3C=CC(Cl)=CC=3)CC=3C=CC(=CC=3)N3S(NC(=O)C3)(=O)=O)=CC=2)=C1 PLJZJIMAVPSXDU-CAOOACKPSA-N 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- CRAGDYRHPWTZJL-UHFFFAOYSA-N 6-hydroxy-1,2,3,4-tetrahydroisoquinolin-2-ium-3-carboxylate Chemical compound OC1=CC=C2CNC(C(=O)O)CC2=C1 CRAGDYRHPWTZJL-UHFFFAOYSA-N 0.000 description 1
- 102100028505 6-pyruvoyl tetrahydrobiopterin synthase Human genes 0.000 description 1
- 108010045523 6-pyruvoyltetrahydropterin synthase Proteins 0.000 description 1
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 208000021563 Alzheimer disease 1 Diseases 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- KHIMDWBWPULTDK-UHFFFAOYSA-N C(=O)(OC(C)(C)C)S(=O)(=O)NC(=O)N.NC1=CC=CC=C1 Chemical class C(=O)(OC(C)(C)C)S(=O)(=O)NC(=O)N.NC1=CC=CC=C1 KHIMDWBWPULTDK-UHFFFAOYSA-N 0.000 description 1
- IHBTTZFFCMHRNO-UHFFFAOYSA-N C(CCC)C1=CC=CC=C1S(=O)(=O)NC1=CC=C(C=C1)CCC=1N(C=C(N1)C1=C(C=C(C=C1)Cl)Cl)CC1=CC=C(C(=O)O)C=C1 Chemical compound C(CCC)C1=CC=CC=C1S(=O)(=O)NC1=CC=C(C=C1)CCC=1N(C=C(N1)C1=C(C=C(C=C1)Cl)Cl)CC1=CC=C(C(=O)O)C=C1 IHBTTZFFCMHRNO-UHFFFAOYSA-N 0.000 description 1
- KRUBOXKACFJWQP-UHFFFAOYSA-N COC=1C=C(C=CC1)C1=CC=C(C=C1)CC=1NC=CN1 Chemical compound COC=1C=C(C=CC1)C1=CC=C(C=C1)CC=1NC=CN1 KRUBOXKACFJWQP-UHFFFAOYSA-N 0.000 description 1
- 101100294111 Caenorhabditis elegans nhr-44 gene Proteins 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical group NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- PQUYQJUFTBPEEB-OVCLIPMQSA-N ClC1=C(C=CC(=C1)Cl)C=1N=C(N(C1)CC1=CC=C(C=C1)C(=O)OC)/C=C/C1=CC=C(C=C1)C=1N(C=CC1)C(=O)O Chemical compound ClC1=C(C=CC(=C1)Cl)C=1N=C(N(C1)CC1=CC=C(C=C1)C(=O)OC)/C=C/C1=CC=C(C=C1)C=1N(C=CC1)C(=O)O PQUYQJUFTBPEEB-OVCLIPMQSA-N 0.000 description 1
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- QWCKQJZIFLGMSD-GSVOUGTGSA-N D-alpha-aminobutyric acid Chemical compound CC[C@@H](N)C(O)=O QWCKQJZIFLGMSD-GSVOUGTGSA-N 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- HCYAFALTSJYZDH-UHFFFAOYSA-N Desimpramine Chemical compound C1CC2=CC=CC=C2N(CCCNC)C2=CC=CC=C21 HCYAFALTSJYZDH-UHFFFAOYSA-N 0.000 description 1
- 101100522280 Dictyostelium discoideum ptpA1-2 gene Proteins 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 101100457919 Drosophila melanogaster stg gene Proteins 0.000 description 1
- 102000010778 Dual Specificity Phosphatase 1 Human genes 0.000 description 1
- 108010038537 Dual Specificity Phosphatase 1 Proteins 0.000 description 1
- 102100028987 Dual specificity protein phosphatase 2 Human genes 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 108010008165 Etanercept Proteins 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- GISRWBROCYNDME-PELMWDNLSA-N F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C Chemical compound F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C GISRWBROCYNDME-PELMWDNLSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000030595 Glucokinase Human genes 0.000 description 1
- 108010021582 Glucokinase Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000282575 Gorilla Species 0.000 description 1
- 208000009329 Graft vs Host Disease Diseases 0.000 description 1
- 101000838335 Homo sapiens Dual specificity protein phosphatase 2 Proteins 0.000 description 1
- 101000624643 Homo sapiens M-phase inducer phosphatase 3 Proteins 0.000 description 1
- 101001080401 Homo sapiens Proteasome assembly chaperone 1 Proteins 0.000 description 1
- 101000580039 Homo sapiens Ras-specific guanine nucleotide-releasing factor 1 Proteins 0.000 description 1
- 101000606506 Homo sapiens Receptor-type tyrosine-protein phosphatase eta Proteins 0.000 description 1
- 101001094531 Homo sapiens Reticulon-4-interacting protein 1, mitochondrial Proteins 0.000 description 1
- 101000796022 Homo sapiens Thioredoxin-interacting protein Proteins 0.000 description 1
- 101001087422 Homo sapiens Tyrosine-protein phosphatase non-receptor type 13 Proteins 0.000 description 1
- 101001087426 Homo sapiens Tyrosine-protein phosphatase non-receptor type 14 Proteins 0.000 description 1
- 101001087388 Homo sapiens Tyrosine-protein phosphatase non-receptor type 21 Proteins 0.000 description 1
- 101001135565 Homo sapiens Tyrosine-protein phosphatase non-receptor type 3 Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- 101710176178 Kidney androgen-regulated protein Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- HXEACLLIILLPRG-YFKPBYRVSA-N L-pipecolic acid Chemical compound [O-]C(=O)[C@@H]1CCCC[NH2+]1 HXEACLLIILLPRG-YFKPBYRVSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 102100023330 M-phase inducer phosphatase 3 Human genes 0.000 description 1
- 241000282560 Macaca mulatta Species 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 description 1
- 101100521345 Mus musculus Prop1 gene Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- FEYNFHSRETUBEM-UHFFFAOYSA-N N-[3-(1,1-difluoroethyl)phenyl]-1-(4-methoxyphenyl)-3-methyl-5-oxo-4H-pyrazole-4-carboxamide Chemical compound COc1ccc(cc1)N1N=C(C)C(C(=O)Nc2cccc(c2)C(C)(F)F)C1=O FEYNFHSRETUBEM-UHFFFAOYSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 101710088428 Napsin-A Proteins 0.000 description 1
- 101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 108010015832 Non-Receptor Type 2 Protein Tyrosine Phosphatase Proteins 0.000 description 1
- 102000007399 Nuclear hormone receptor Human genes 0.000 description 1
- 108020005497 Nuclear hormone receptor Proteins 0.000 description 1
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
- 108010016076 Octreotide Proteins 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 229960005552 PAC-1 Drugs 0.000 description 1
- 101150006497 PTP-1 gene Proteins 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 241000282579 Pan Species 0.000 description 1
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 108700017836 Prophet of Pit-1 Proteins 0.000 description 1
- 101150056500 Ptpn6 gene Proteins 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 101000695843 Rattus norvegicus Receptor-type tyrosine-protein phosphatase V Proteins 0.000 description 1
- 101710138741 Receptor-type tyrosine-protein phosphatase F Proteins 0.000 description 1
- 102100034086 Receptor-type tyrosine-protein phosphatase O Human genes 0.000 description 1
- 101710138738 Receptor-type tyrosine-protein phosphatase O Proteins 0.000 description 1
- 102100039808 Receptor-type tyrosine-protein phosphatase eta Human genes 0.000 description 1
- 102100035121 Reticulon-4-interacting protein 1, mitochondrial Human genes 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 102000005157 Somatostatin Human genes 0.000 description 1
- 108010056088 Somatostatin Proteins 0.000 description 1
- 238000003477 Sonogashira cross-coupling reaction Methods 0.000 description 1
- 241000610375 Sparisoma viride Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229920002253 Tannate Polymers 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- 102100031344 Thioredoxin-interacting protein Human genes 0.000 description 1
- KLBQZWRITKRQQV-UHFFFAOYSA-N Thioridazine Chemical compound C12=CC(SC)=CC=C2SC2=CC=CC=C2N1CCC1CCCCN1C KLBQZWRITKRQQV-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- JLRGJRBPOGGCBT-UHFFFAOYSA-N Tolbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1 JLRGJRBPOGGCBT-UHFFFAOYSA-N 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- 244000250129 Trigonella foenum graecum Species 0.000 description 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 102100033014 Tyrosine-protein phosphatase non-receptor type 13 Human genes 0.000 description 1
- 102100033015 Tyrosine-protein phosphatase non-receptor type 14 Human genes 0.000 description 1
- 102100033141 Tyrosine-protein phosphatase non-receptor type 2 Human genes 0.000 description 1
- 102100033005 Tyrosine-protein phosphatase non-receptor type 21 Human genes 0.000 description 1
- 102100033131 Tyrosine-protein phosphatase non-receptor type 3 Human genes 0.000 description 1
- 102100021657 Tyrosine-protein phosphatase non-receptor type 6 Human genes 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- WERKSKAQRVDLDW-ANOHMWSOSA-N [(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO WERKSKAQRVDLDW-ANOHMWSOSA-N 0.000 description 1
- ZWGMJLNXIVRFRJ-UHFFFAOYSA-N [1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrol-2-yl]boronic acid Chemical compound CC(C)(C)OC(=O)N1C=CC=C1B(O)O ZWGMJLNXIVRFRJ-UHFFFAOYSA-N 0.000 description 1
- AIJCNTOYZPKURP-UHFFFAOYSA-N [2-(trifluoromethoxy)phenyl]boronic acid Chemical compound OB(O)C1=CC=CC=C1OC(F)(F)F AIJCNTOYZPKURP-UHFFFAOYSA-N 0.000 description 1
- JNSBEPKGFVENFS-UHFFFAOYSA-N [2-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=CC=C1C(F)(F)F JNSBEPKGFVENFS-UHFFFAOYSA-N 0.000 description 1
- KUHVVLFCTMTYGR-UHFFFAOYSA-N [2-fluoro-5-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC(C(F)(F)F)=CC=C1F KUHVVLFCTMTYGR-UHFFFAOYSA-N 0.000 description 1
- XXGDNBUDPANMAB-UHFFFAOYSA-N [3-methoxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]boronic acid Chemical compound COC1=CC=CC(B(O)O)=C1NC(=O)OC(C)(C)C XXGDNBUDPANMAB-UHFFFAOYSA-N 0.000 description 1
- PAWJDEHKEKNFAN-UHFFFAOYSA-N [3-methoxy-4-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]boronic acid Chemical compound COC1=CC(B(O)O)=CC=C1NC(=O)OC(C)(C)C PAWJDEHKEKNFAN-UHFFFAOYSA-N 0.000 description 1
- NDVJJEADFLTFCD-UHFFFAOYSA-N [4-(methanesulfonamido)phenyl]boronic acid Chemical compound CS(=O)(=O)NC1=CC=C(B(O)O)C=C1 NDVJJEADFLTFCD-UHFFFAOYSA-N 0.000 description 1
- UBVOLHQIEQVXGM-UHFFFAOYSA-N [4-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]boronic acid Chemical compound CC(C)(C)OC(=O)NC1=CC=C(B(O)O)C=C1 UBVOLHQIEQVXGM-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 150000000475 acetylene derivatives Chemical class 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 150000008043 acidic salts Chemical class 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- YKIOKAURTKXMSB-UHFFFAOYSA-N adams's catalyst Chemical compound O=[Pt]=O YKIOKAURTKXMSB-UHFFFAOYSA-N 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000003302 alkenyloxy group Chemical group 0.000 description 1
- 125000005137 alkenylsulfonyl group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 125000005133 alkynyloxy group Chemical group 0.000 description 1
- 125000005139 alkynylsulfonyl group Chemical group 0.000 description 1
- IYABWNGZIDDRAK-UHFFFAOYSA-N allene Chemical group C=C=C IYABWNGZIDDRAK-UHFFFAOYSA-N 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- ILOJFJBXXANEQW-UHFFFAOYSA-N aminooxy(phenyl)borinic acid Chemical compound NOB(O)C1=CC=CC=C1 ILOJFJBXXANEQW-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940045719 antineoplastic alkylating agent nitrosoureas Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000005251 aryl acyl group Chemical group 0.000 description 1
- 150000001501 aryl fluorides Chemical class 0.000 description 1
- 150000001503 aryl iodides Chemical class 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- METKIMKYRPQLGS-UHFFFAOYSA-N atenolol Chemical compound CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-UHFFFAOYSA-N 0.000 description 1
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical compound N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 1
- VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000001743 benzylic group Chemical group 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- WEDIIKBPDQQQJU-UHFFFAOYSA-N butane-1-sulfonyl chloride Chemical compound CCCCS(Cl)(=O)=O WEDIIKBPDQQQJU-UHFFFAOYSA-N 0.000 description 1
- LYTDAPQDKKIENM-UHFFFAOYSA-N butoxy(phenyl)borinic acid Chemical compound CCCCOB(O)C1=CC=CC=C1 LYTDAPQDKKIENM-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
- 229960000623 carbamazepine Drugs 0.000 description 1
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 229960004562 carboplatin Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 101150069072 cdc25 gene Proteins 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000004715 cellular signal transduction Effects 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- DGLFSNZWRYADFC-UHFFFAOYSA-N chembl2334586 Chemical compound C1CCC2=CN=C(N)N=C2C2=C1NC1=CC=C(C#CC(C)(O)C)C=C12 DGLFSNZWRYADFC-UHFFFAOYSA-N 0.000 description 1
- 125000002668 chloroacetyl group Chemical group ClCC(=O)* 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 229940090805 clavulanate Drugs 0.000 description 1
- HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000007819 coupling partner Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 229960000684 cytarabine Drugs 0.000 description 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
- 229960000975 daunorubicin Drugs 0.000 description 1
- 230000020335 dealkylation Effects 0.000 description 1
- 238000006900 dealkylation reaction Methods 0.000 description 1
- 229960003914 desipramine Drugs 0.000 description 1
- NIJJYAXOARWZEE-UHFFFAOYSA-N di-n-propyl-acetic acid Natural products CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- ACYGYJFTZSAZKR-UHFFFAOYSA-J dicalcium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Ca+2].[Ca+2].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O ACYGYJFTZSAZKR-UHFFFAOYSA-J 0.000 description 1
- VILAVOFMIJHSJA-UHFFFAOYSA-N dicarbon monoxide Chemical compound [C]=C=O VILAVOFMIJHSJA-UHFFFAOYSA-N 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 229960003530 donepezil Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229960004679 doxorubicin Drugs 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 229940009662 edetate Drugs 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 229950005627 embonate Drugs 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229950000206 estolate Drugs 0.000 description 1
- 229960000403 etanercept Drugs 0.000 description 1
- FRYHCSODNHYDPU-UHFFFAOYSA-N ethanesulfonyl chloride Chemical compound CCS(Cl)(=O)=O FRYHCSODNHYDPU-UHFFFAOYSA-N 0.000 description 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
- 125000005677 ethinylene group Chemical group [*:2]C#C[*:1] 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- LPXGSOQMMNSXBF-LHHJGKSTSA-N ethyl 4-[2-[(e)-2-(4-bromophenyl)ethenyl]-4-(2,4-difluorophenyl)imidazol-1-yl]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1N1C(\C=C\C=2C=CC(Br)=CC=2)=NC(C=2C(=CC(F)=CC=2)F)=C1 LPXGSOQMMNSXBF-LHHJGKSTSA-N 0.000 description 1
- WVLQRLADCWTHTO-UHFFFAOYSA-N ethyl 4-[2-[[6-(4-tert-butylphenoxy)isoquinoline-3-carbonyl]amino]-4-(2,4-dichlorophenyl)imidazol-1-yl]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1N1C(NC(=O)C=2N=CC3=CC=C(OC=4C=CC(=CC=4)C(C)(C)C)C=C3C=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 WVLQRLADCWTHTO-UHFFFAOYSA-N 0.000 description 1
- DTFVLIIWOTXQAR-UHFFFAOYSA-N ethyl 4-[4-(2,4-dichlorophenyl)-2-[1-(4-hydroxyphenyl)cyclopropyl]imidazol-1-yl]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1N1C(C2(CC2)C=2C=CC(O)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 DTFVLIIWOTXQAR-UHFFFAOYSA-N 0.000 description 1
- IVDZPYQMGFYZIN-UHFFFAOYSA-N ethyl 4-[4-(2,4-dichlorophenyl)-2-[1-(4-methoxyphenyl)cyclopropyl]imidazol-1-yl]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1N1C(C2(CC2)C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 IVDZPYQMGFYZIN-UHFFFAOYSA-N 0.000 description 1
- SOZRQDFUOUPCBV-UHFFFAOYSA-N ethyl 4-[4-(2,4-dichlorophenyl)-2-[1-[4-[3-(trifluoromethyl)phenoxy]phenyl]cyclopropyl]imidazol-1-yl]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1N1C(C2(CC2)C=2C=CC(OC=3C=C(C=CC=3)C(F)(F)F)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 SOZRQDFUOUPCBV-UHFFFAOYSA-N 0.000 description 1
- VRBLPSBDSGICGE-UHFFFAOYSA-N ethyl 4-[4-(2,4-dichlorophenyl)-2-[3-(4-iodophenyl)propyl]imidazol-1-yl]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1N1C(CCCC=2C=CC(I)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 VRBLPSBDSGICGE-UHFFFAOYSA-N 0.000 description 1
- MODMIXIAZRPQQN-UHFFFAOYSA-N ethyl 4-[4-(2,4-dichlorophenyl)-2-[[4-(3-methylsulfonylphenyl)phenyl]methyl]imidazol-1-yl]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1N1C(CC=2C=CC(=CC=2)C=2C=C(C=CC=2)S(C)(=O)=O)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 MODMIXIAZRPQQN-UHFFFAOYSA-N 0.000 description 1
- BWJDTJXZHNWHAX-UHFFFAOYSA-N ethyl 4-[4-(2,4-dichlorophenyl)-2-[[4-(4-ethoxyphenyl)phenyl]methyl]imidazol-1-yl]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1N1C(CC=2C=CC(=CC=2)C=2C=CC(OCC)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 BWJDTJXZHNWHAX-UHFFFAOYSA-N 0.000 description 1
- DCHRLENWRBGPIR-UHFFFAOYSA-N ethyl 4-[4-(2,4-dichlorophenyl)-2-[[4-[4-(4,4,4-trifluorobutoxy)phenyl]phenyl]methyl]imidazol-1-yl]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1N1C(CC=2C=CC(=CC=2)C=2C=CC(OCCCC(F)(F)F)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 DCHRLENWRBGPIR-UHFFFAOYSA-N 0.000 description 1
- ITMLWOKTRWPWPV-UHFFFAOYSA-N ethyl 4-[4-(2,4-dichlorophenyl)-2-[[4-[4-(4-methylsulfonylphenoxy)phenyl]phenyl]methyl]imidazol-1-yl]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1N1C(CC=2C=CC(=CC=2)C=2C=CC(OC=3C=CC(=CC=3)S(C)(=O)=O)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 ITMLWOKTRWPWPV-UHFFFAOYSA-N 0.000 description 1
- UDBOFVCYVKCPMH-GIJQJNRQSA-N ethyl 4-[4-(2,4-difluorophenyl)-2-[(e)-2-[4-(3-methylsulfonylphenyl)phenyl]ethenyl]imidazol-1-yl]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1N1C(\C=C\C=2C=CC(=CC=2)C=2C=C(C=CC=2)S(C)(=O)=O)=NC(C=2C(=CC(F)=CC=2)F)=C1 UDBOFVCYVKCPMH-GIJQJNRQSA-N 0.000 description 1
- REEMKMVBIMILRO-UHFFFAOYSA-N ethyl 4-[5-(2,4-dichlorophenyl)-2-[[4-[4-[4-(trifluoromethyl)phenoxy]phenyl]phenyl]methyl]-1h-imidazol-4-yl]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1C1=C(C=2C(=CC(Cl)=CC=2)Cl)NC(CC=2C=CC(=CC=2)C=2C=CC(OC=3C=CC(=CC=3)C(F)(F)F)=CC=2)=N1 REEMKMVBIMILRO-UHFFFAOYSA-N 0.000 description 1
- VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 1
- 229960005420 etoposide Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 1
- 229960004039 finasteride Drugs 0.000 description 1
- 125000005567 fluorenylene group Chemical group 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 229960002464 fluoxetine Drugs 0.000 description 1
- MKXKFYHWDHIYRV-UHFFFAOYSA-N flutamide Chemical compound CC(C)C(=O)NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 MKXKFYHWDHIYRV-UHFFFAOYSA-N 0.000 description 1
- 229960002074 flutamide Drugs 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 229940050411 fumarate Drugs 0.000 description 1
- 125000001543 furan-2,5-diyl group Chemical group O1C(=CC=C1*)* 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960004580 glibenclamide Drugs 0.000 description 1
- ZJJXGWJIGJFDTL-UHFFFAOYSA-N glipizide Chemical compound C1=NC(C)=CN=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZJJXGWJIGJFDTL-UHFFFAOYSA-N 0.000 description 1
- 229960001381 glipizide Drugs 0.000 description 1
- 229960001731 gluceptate Drugs 0.000 description 1
- KWMLJOLKUYYJFJ-VFUOTHLCSA-N glucoheptonic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C(O)=O KWMLJOLKUYYJFJ-VFUOTHLCSA-N 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229940049906 glutamate Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 1
- 229940074045 glyceryl distearate Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229940111120 gold preparations Drugs 0.000 description 1
- 208000024908 graft versus host disease Diseases 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 229960000789 guanidine hydrochloride Drugs 0.000 description 1
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
- 229960003878 haloperidol Drugs 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-UHFFFAOYSA-N hexane-1,2,3,4,5,6-hexol Chemical compound OCC(O)C(O)C(O)C(O)CO FBPFZTCFMRRESA-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- XGIHQYAWBCFNPY-AZOCGYLKSA-N hydrabamine Chemical compound C([C@@H]12)CC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC[C@@]1(C)CNCCNC[C@@]1(C)[C@@H]2CCC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC1 XGIHQYAWBCFNPY-AZOCGYLKSA-N 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- HQZMRJBVCVYVQA-UHFFFAOYSA-N hydron;methyl 2-(methylamino)acetate;chloride Chemical compound Cl.CNCC(=O)OC HQZMRJBVCVYVQA-UHFFFAOYSA-N 0.000 description 1
- COQRGFWWJBEXRC-UHFFFAOYSA-N hydron;methyl 2-aminoacetate;chloride Chemical compound Cl.COC(=O)CN COQRGFWWJBEXRC-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 150000005352 hydroxybiphenyls Chemical class 0.000 description 1
- XXSMGPRMXLTPCZ-UHFFFAOYSA-N hydroxychloroquine Chemical compound ClC1=CC=C2C(NC(C)CCCN(CCO)CC)=CC=NC2=C1 XXSMGPRMXLTPCZ-UHFFFAOYSA-N 0.000 description 1
- 229960004171 hydroxychloroquine Drugs 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 125000004129 indan-1-yl group Chemical group [H]C1=C([H])C([H])=C2C(=C1[H])C([H])([H])C([H])([H])C2([H])* 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000003701 inert diluent Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229960000598 infliximab Drugs 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 229940102213 injectable suspension Drugs 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 125000006631 isobutoxycarbonylamino group Chemical group 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 229940099584 lactobionate Drugs 0.000 description 1
- JYTUSYBCFIZPBE-AMTLMPIISA-N lactobionic acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O JYTUSYBCFIZPBE-AMTLMPIISA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 1
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- SGQCLTSYZNQSEI-UHFFFAOYSA-N methyl 2-(sulfonylamino)benzoate Chemical compound COC(C1=C(C=CC=C1)N=S(=O)=O)=O SGQCLTSYZNQSEI-UHFFFAOYSA-N 0.000 description 1
- JLCAMDSWNZBTEE-UHFFFAOYSA-N methyl 2-(trifluoromethyl)benzoate Chemical compound COC(=O)C1=CC=CC=C1C(F)(F)F JLCAMDSWNZBTEE-UHFFFAOYSA-N 0.000 description 1
- ANCDHWJDVUBRCT-LICLKQGHSA-N methyl 2-[2-[(e)-2-(4-methoxyphenyl)ethenyl]-4-(4-phenylphenyl)imidazol-1-yl]acetate Chemical compound COC(=O)CN1C=C(C=2C=CC(=CC=2)C=2C=CC=CC=2)N=C1\C=C\C1=CC=C(OC)C=C1 ANCDHWJDVUBRCT-LICLKQGHSA-N 0.000 description 1
- FNUVLQKSWOUBKS-UHFFFAOYSA-N methyl 2-[4-[4-(2,4-dichlorophenyl)-1-[[4-[3-(trifluoromethyl)phenyl]phenyl]methyl]imidazol-2-yl]phenoxy]acetate Chemical compound C1=CC(OCC(=O)OC)=CC=C1C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CC1=CC=C(C=2C=C(C=CC=2)C(F)(F)F)C=C1 FNUVLQKSWOUBKS-UHFFFAOYSA-N 0.000 description 1
- AFNKLOMOEKMEOJ-UHFFFAOYSA-N methyl 2-[4-[[4-(2,4-dichlorophenyl)-2-[[4-[3-(methanesulfonamido)phenyl]phenyl]methyl]imidazol-1-yl]methyl]anilino]acetate Chemical compound C1=CC(NCC(=O)OC)=CC=C1CN1C(CC=2C=CC(=CC=2)C=2C=C(NS(C)(=O)=O)C=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 AFNKLOMOEKMEOJ-UHFFFAOYSA-N 0.000 description 1
- XZTZVTLLPRUSAB-SFQUDFHCSA-N methyl 2-[4-[[4-(2,6-dichlorophenyl)-2-[(e)-2-[4-[3-(trifluoromethyl)phenyl]phenyl]ethenyl]imidazol-1-yl]methyl]anilino]acetate Chemical compound C1=CC(NCC(=O)OC)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC=CC=2Cl)Cl)=C1 XZTZVTLLPRUSAB-SFQUDFHCSA-N 0.000 description 1
- LELYUNLRMNKNTR-UHFFFAOYSA-N methyl 2-[[4-(2,4-dichlorophenyl)-2-[1-(4-methoxyphenyl)cyclopropyl]imidazol-1-yl]methyl]benzoate Chemical compound COC(C1=C(C=CC=C1)CN1C(=NC(=C1)C1=C(C=C(C=C1)Cl)Cl)C1(CC1)C1=CC=C(C=C1)OC)=O LELYUNLRMNKNTR-UHFFFAOYSA-N 0.000 description 1
- CARCWHNYBXYUAP-LICLKQGHSA-N methyl 2-[[4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-[3-(trifluoromethyl)phenyl]phenyl]ethenyl]imidazol-1-yl]methyl]phenyl]carbamoyl-methylamino]acetate Chemical compound C1=CC(NC(=O)N(C)CC(=O)OC)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 CARCWHNYBXYUAP-LICLKQGHSA-N 0.000 description 1
- JAGXFCRTUCBDRM-UHFFFAOYSA-N methyl 2-amino-4-[2-[(4-bromophenyl)methyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]benzoate Chemical compound C1=C(N)C(C(=O)OC)=CC=C1N1C(CC=2C=CC(Br)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 JAGXFCRTUCBDRM-UHFFFAOYSA-N 0.000 description 1
- QSUMZRFOCNQOJN-UHFFFAOYSA-N methyl 2-amino-4-[[2-[(4-bromophenyl)methyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]methylsulfonyl]benzoate Chemical compound C1=C(N)C(C(=O)OC)=CC=C1S(=O)(=O)CN1C(CC=2C=CC(Br)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 QSUMZRFOCNQOJN-UHFFFAOYSA-N 0.000 description 1
- ZJUSEPVIRQPKKC-UHFFFAOYSA-N methyl 2-amino-5-[4-[3-[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]propyl]phenoxy]benzoate Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1CCCC(C=C1)=CC=C1OC1=CC=C(N)C(C(=O)OC)=C1 ZJUSEPVIRQPKKC-UHFFFAOYSA-N 0.000 description 1
- ZZEACIKZMOLXPZ-UBKPWBPPSA-N methyl 2-amino-5-[4-[4-[(e)-2-[4-(2,4-difluorophenyl)-1-ethylimidazol-2-yl]ethenyl]phenyl]phenoxy]benzoate Chemical compound CCN1C=C(C=2C(=CC(F)=CC=2)F)N=C1\C=C\C(C=C1)=CC=C1C(C=C1)=CC=C1OC1=CC=C(N)C(C(=O)OC)=C1 ZZEACIKZMOLXPZ-UBKPWBPPSA-N 0.000 description 1
- PQUSVJVVRXWKDG-UHFFFAOYSA-N methyl 2-bromo-2-methylpropanoate Chemical compound COC(=O)C(C)(C)Br PQUSVJVVRXWKDG-UHFFFAOYSA-N 0.000 description 1
- QAFJIJWLEBLXHH-UHFFFAOYSA-N methyl 2-fluorobenzoate Chemical compound COC(=O)C1=CC=CC=C1F QAFJIJWLEBLXHH-UHFFFAOYSA-N 0.000 description 1
- YUHSMQQNPRLEEJ-UHFFFAOYSA-N methyl 3-(bromomethyl)benzoate Chemical compound COC(=O)C1=CC=CC(CBr)=C1 YUHSMQQNPRLEEJ-UHFFFAOYSA-N 0.000 description 1
- JNXMCBVBGUEQID-UHFFFAOYSA-N methyl 3-amino-4-[2-[(4-bromophenyl)methyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]-2-methylsulfonylbenzoate Chemical compound NC1=C(S(C)(=O)=O)C(C(=O)OC)=CC=C1N1C(CC=2C=CC(Br)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 JNXMCBVBGUEQID-UHFFFAOYSA-N 0.000 description 1
- BTQDOXCVNCBUIU-UHFFFAOYSA-N methyl 3-amino-4-[4-[4-[[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]methyl]phenyl]phenoxy]benzoate Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1CC(C=C1)=CC=C1C(C=C1)=CC=C1OC1=CC=C(C(=O)OC)C=C1N BTQDOXCVNCBUIU-UHFFFAOYSA-N 0.000 description 1
- QSRRZKPKHJHIRB-UHFFFAOYSA-N methyl 4-[(2,5-dichloro-4-methylthiophen-3-yl)sulfonylamino]-2-hydroxybenzoate Chemical compound C1=C(O)C(C(=O)OC)=CC=C1NS(=O)(=O)C1=C(Cl)SC(Cl)=C1C QSRRZKPKHJHIRB-UHFFFAOYSA-N 0.000 description 1
- RLYSYOXXBFYVEQ-UHFFFAOYSA-N methyl 4-[3-[4-[[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]methoxy]phenyl]phenoxy]butanoate Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1COC(C=C1)=CC=C1C1=CC=CC(OCCCC(=O)OC)=C1 RLYSYOXXBFYVEQ-UHFFFAOYSA-N 0.000 description 1
- VUWGHTRKLHLNSD-OVCLIPMQSA-N methyl 4-[4-[3-[(e)-2-[4-(2,4-dichlorophenyl)-1-(2-methoxy-2-oxoethyl)imidazol-2-yl]ethenyl]phenyl]phenoxy]butanoate Chemical compound C1=CC(OCCCC(=O)OC)=CC=C1C1=CC=CC(\C=C\C=2N(C=C(N=2)C=2C(=CC(Cl)=CC=2)Cl)CC(=O)OC)=C1 VUWGHTRKLHLNSD-OVCLIPMQSA-N 0.000 description 1
- UGCAKJYKJNVXEO-UBKPWBPPSA-N methyl 4-[4-[4-[(e)-2-[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]ethenyl]phenyl]phenoxy]-3-nitrobenzoate Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1\C=C\C(C=C1)=CC=C1C(C=C1)=CC=C1OC1=CC=C(C(=O)OC)C=C1[N+]([O-])=O UGCAKJYKJNVXEO-UBKPWBPPSA-N 0.000 description 1
- OOKVCICGCSFDQA-KGENOOAVSA-N methyl 4-[[2-[(e)-2-[4-[(4-butylphenyl)methylamino]phenyl]ethenyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(CCCC)=CC=C1CNC(C=C1)=CC=C1\C=C\C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1CC1=CC=C(C(=O)OC)C=C1 OOKVCICGCSFDQA-KGENOOAVSA-N 0.000 description 1
- BIGSSZXESOTIMP-AERZKKPOSA-N methyl 4-[[2-[(e)-2-[4-[4-(4-aminophenoxy)phenyl]phenyl]ethenyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=CC(OC=3C=CC(N)=CC=3)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 BIGSSZXESOTIMP-AERZKKPOSA-N 0.000 description 1
- SLVDIMWWVKRNKQ-UHFFFAOYSA-N methyl 4-[[2-[4-bromo-n-[(2-methylpropan-2-yl)oxycarbonyl]anilino]-4-(2,4-dichlorophenyl)imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(N(C(=O)OC(C)(C)C)C=2C=CC(Br)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 SLVDIMWWVKRNKQ-UHFFFAOYSA-N 0.000 description 1
- ZVTSGEBBLHWLED-UHFFFAOYSA-N methyl 4-[[2-[[6-(4-tert-butylphenoxy)isoquinoline-3-carbonyl]amino]-4-(2,4-dichlorophenyl)imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(NC(=O)C=2N=CC3=CC=C(OC=4C=CC(=CC=4)C(C)(C)C)C=C3C=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 ZVTSGEBBLHWLED-UHFFFAOYSA-N 0.000 description 1
- HZQXEKRDIBGTTJ-AWNIVKPZSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-(4-nitrophenyl)ethenyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)[N+]([O-])=O)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 HZQXEKRDIBGTTJ-AWNIVKPZSA-N 0.000 description 1
- CSCPMRAWAHKXMX-GIJQJNRQSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-[(4-methylphenyl)sulfonylamino]phenyl]ethenyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(\C=C\C=2C=CC(NS(=O)(=O)C=3C=CC(C)=CC=3)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 CSCPMRAWAHKXMX-GIJQJNRQSA-N 0.000 description 1
- SLIQMTGCCDLTPU-GIDUJCDVSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-[2-fluoro-5-(trifluoromethyl)phenyl]phenyl]ethenyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C(=CC=C(C=2)C(F)(F)F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 SLIQMTGCCDLTPU-GIDUJCDVSA-N 0.000 description 1
- YZHKDQFYEJDSKU-CXUHLZMHSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-[3-(trifluoromethyl)phenyl]phenyl]ethenyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 YZHKDQFYEJDSKU-CXUHLZMHSA-N 0.000 description 1
- NISHDXVJUPEAHC-CXUHLZMHSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-[3-(trifluoromethylsulfonylamino)phenyl]phenyl]ethenyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=C(NS(=O)(=O)C(F)(F)F)C=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 NISHDXVJUPEAHC-CXUHLZMHSA-N 0.000 description 1
- QVEZNCJLYJCUNL-AERZKKPOSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-[4-(4-nitrophenoxy)phenyl]phenyl]ethenyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=CC(OC=3C=CC(=CC=3)[N+]([O-])=O)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 QVEZNCJLYJCUNL-AERZKKPOSA-N 0.000 description 1
- BBAIVJGWQKWJHJ-CNHKJKLMSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-[4-(methanesulfonamido)phenyl]phenyl]ethenyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(\C=C\C=2C=CC(=CC=2)C=2C=CC(NS(C)(=O)=O)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 BBAIVJGWQKWJHJ-CNHKJKLMSA-N 0.000 description 1
- XTSJZYWQZZPFKF-CXUHLZMHSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-[[3-(trifluoromethyl)phenyl]sulfonylamino]phenyl]ethenyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(\C=C\C=2C=CC(NS(=O)(=O)C=3C=C(C=CC=3)C(F)(F)F)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 XTSJZYWQZZPFKF-CXUHLZMHSA-N 0.000 description 1
- KXGIEMQAODXKLI-UBKPWBPPSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[(e)-2-[4-[[4-(trifluoromethyl)phenyl]sulfonylamino]phenyl]ethenyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(\C=C\C=2C=CC(NS(=O)(=O)C=3C=CC(=CC=3)C(F)(F)F)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 KXGIEMQAODXKLI-UBKPWBPPSA-N 0.000 description 1
- BKOJINSLGOWTML-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[1-(4-methoxyphenyl)cyclopropyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(C2(CC2)C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 BKOJINSLGOWTML-UHFFFAOYSA-N 0.000 description 1
- AHGHPDGCMRJYOQ-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[3-[4-(3-methylsulfonylphenyl)phenyl]propyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(CCCC=2C=CC(=CC=2)C=2C=C(C=CC=2)S(C)(=O)=O)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 AHGHPDGCMRJYOQ-UHFFFAOYSA-N 0.000 description 1
- AJOXNCBETRAYJD-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[4-(3-methylsulfonylphenoxy)phenyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(C=2C=CC(OC=3C=C(C=CC=3)S(C)(=O)=O)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 AJOXNCBETRAYJD-UHFFFAOYSA-N 0.000 description 1
- ZHRCTCXOZKABNO-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[4-(3-methylsulfonylphenyl)phenyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(C=2C=CC(=CC=2)C=2C=C(C=CC=2)S(C)(=O)=O)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 ZHRCTCXOZKABNO-UHFFFAOYSA-N 0.000 description 1
- RIJNCXDCJBIELM-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[4-[3-(trifluoromethyl)phenyl]phenyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 RIJNCXDCJBIELM-UHFFFAOYSA-N 0.000 description 1
- NVCIHIIUTVGVOM-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[4-[3-methoxy-4-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]phenyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(C=2C=CC(=CC=2)C=2C=C(OC)C(NC(=O)OC(C)(C)C)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 NVCIHIIUTVGVOM-UHFFFAOYSA-N 0.000 description 1
- FNRRFFYYYMQJAB-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[4-[4-(methanesulfonamido)-3-methoxyphenyl]phenyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(C=2C=CC(=CC=2)C=2C=C(OC)C(NS(C)(=O)=O)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 FNRRFFYYYMQJAB-UHFFFAOYSA-N 0.000 description 1
- KNGNLJIZOMPIHL-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[[4-(3-methylsulfonylphenyl)phenyl]methyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(CC=2C=CC(=CC=2)C=2C=C(C=CC=2)S(C)(=O)=O)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 KNGNLJIZOMPIHL-UHFFFAOYSA-N 0.000 description 1
- ZDMYBHIPSNQUPD-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[[4-(4-methylsulfonylphenyl)phenyl]methyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(CC=2C=CC(=CC=2)C=2C=CC(=CC=2)S(C)(=O)=O)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 ZDMYBHIPSNQUPD-UHFFFAOYSA-N 0.000 description 1
- UPFFSHVBPIZRBC-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[[4-[3-(2,2,2-trifluoroethylsulfonylamino)phenyl]phenyl]methyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(CC=2C=CC(=CC=2)C=2C=C(NS(=O)(=O)CC(F)(F)F)C=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 UPFFSHVBPIZRBC-UHFFFAOYSA-N 0.000 description 1
- MWWIFCCFBWBNIT-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[[4-[3-(ethylsulfonylamino)phenyl]phenyl]methyl]imidazol-1-yl]methyl]benzoate Chemical compound CCS(=O)(=O)NC1=CC=CC(C=2C=CC(CC=3N(C=C(N=3)C=3C(=CC(Cl)=CC=3)Cl)CC=3C=CC(=CC=3)C(=O)OC)=CC=2)=C1 MWWIFCCFBWBNIT-UHFFFAOYSA-N 0.000 description 1
- PHHPWOZWGAYRCN-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[[4-[3-(methanesulfonamido)phenyl]phenyl]methyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(CC=2C=CC(=CC=2)C=2C=C(NS(C)(=O)=O)C=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 PHHPWOZWGAYRCN-UHFFFAOYSA-N 0.000 description 1
- HNCCGJDDXJSTQI-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[[4-[3-(methoxycarbonylamino)phenyl]phenyl]methyl]imidazol-1-yl]methyl]benzoate Chemical compound COC(=O)NC1=CC=CC(C=2C=CC(CC=3N(C=C(N=3)C=3C(=CC(Cl)=CC=3)Cl)CC=3C=CC(=CC=3)C(=O)OC)=CC=2)=C1 HNCCGJDDXJSTQI-UHFFFAOYSA-N 0.000 description 1
- UKZNXQBBZBYEFF-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[[4-[3-(propan-2-yloxycarbonylamino)phenyl]phenyl]methyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(CC=2C=CC(=CC=2)C=2C=C(NC(=O)OC(C)C)C=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 UKZNXQBBZBYEFF-UHFFFAOYSA-N 0.000 description 1
- GNMSIDSVLMFOEV-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[[4-[3-(trifluoromethylsulfonylamino)phenyl]phenyl]methyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(CC=2C=CC(=CC=2)C=2C=C(NS(=O)(=O)C(F)(F)F)C=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 GNMSIDSVLMFOEV-UHFFFAOYSA-N 0.000 description 1
- ONCFCMFSHLIPOE-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[[4-[3-methoxy-4-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]phenyl]methyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(CC=2C=CC(=CC=2)C=2C=C(OC)C(NC(=O)OC(C)(C)C)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 ONCFCMFSHLIPOE-UHFFFAOYSA-N 0.000 description 1
- AQGCIPZRSTYBSV-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[[4-[4-(methanesulfonamido)phenyl]phenyl]methyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(CC=2C=CC(=CC=2)C=2C=CC(NS(C)(=O)=O)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 AQGCIPZRSTYBSV-UHFFFAOYSA-N 0.000 description 1
- FEXQADVTIYXZFJ-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[[4-[4-(trifluoromethoxy)phenyl]phenyl]methyl]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(CC=2C=CC(=CC=2)C=2C=CC(OC(F)(F)F)=CC=2)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 FEXQADVTIYXZFJ-UHFFFAOYSA-N 0.000 description 1
- UZXYNGWNCWPYBC-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[n-[(2-methylpropan-2-yl)oxycarbonyl]-4-[3-(trifluoromethyl)phenyl]anilino]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(N(C(=O)OC(C)(C)C)C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 UZXYNGWNCWPYBC-UHFFFAOYSA-N 0.000 description 1
- RIFQXVRRMBZFLF-UHFFFAOYSA-N methyl 4-[[4-(2,4-dichlorophenyl)-2-[n-methyl-4-[3-(trifluoromethyl)phenyl]anilino]imidazol-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1C(N(C)C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=NC(C=2C(=CC(Cl)=CC=2)Cl)=C1 RIFQXVRRMBZFLF-UHFFFAOYSA-N 0.000 description 1
- YGDGZDGRCWHDOU-UHFFFAOYSA-N methyl 4-[[5-chloro-4-(2-hydroxyphenyl)thiophen-2-yl]sulfonylamino]-2-hydroxybenzoate Chemical compound C1=C(O)C(C(=O)OC)=CC=C1NS(=O)(=O)C1=CC(C=2C(=CC=CC=2)O)=C(Cl)S1 YGDGZDGRCWHDOU-UHFFFAOYSA-N 0.000 description 1
- YBAZOLISUXINHV-UHFFFAOYSA-N methyl 4-fluoro-2-nitrobenzoate Chemical compound COC(=O)C1=CC=C(F)C=C1[N+]([O-])=O YBAZOLISUXINHV-UHFFFAOYSA-N 0.000 description 1
- CNJJSTPBUHAEFH-UHFFFAOYSA-N methyl 4-fluoro-3-nitrobenzoate Chemical compound COC(=O)C1=CC=C(F)C([N+]([O-])=O)=C1 CNJJSTPBUHAEFH-UHFFFAOYSA-N 0.000 description 1
- UKSBPFGECWNXCC-UHFFFAOYSA-N methyl 5-[2-[[4-[4-(4-aminophenoxy)phenyl]phenyl]methyl]-4-(2,4-dichlorophenyl)imidazol-1-yl]-2-(trifluoromethyl)benzoate Chemical compound C1=C(C(F)(F)F)C(C(=O)OC)=CC(N2C(=NC(=C2)C=2C(=CC(Cl)=CC=2)Cl)CC=2C=CC(=CC=2)C=2C=CC(OC=3C=CC(N)=CC=3)=CC=2)=C1 UKSBPFGECWNXCC-UHFFFAOYSA-N 0.000 description 1
- TWOONNZENPVPLV-UHFFFAOYSA-N methyl 5-[4-(2,4-dichlorophenyl)-2-[[4-[4-(4-nitrophenoxy)phenyl]phenyl]methyl]imidazol-1-yl]-2-(trifluoromethyl)benzoate Chemical compound C1=C(C(F)(F)F)C(C(=O)OC)=CC(N2C(=NC(=C2)C=2C(=CC(Cl)=CC=2)Cl)CC=2C=CC(=CC=2)C=2C=CC(OC=3C=CC(=CC=3)[N+]([O-])=O)=CC=2)=C1 TWOONNZENPVPLV-UHFFFAOYSA-N 0.000 description 1
- YNUHUKFMJNQTDX-UHFFFAOYSA-N methyl 5-[4-(2,4-dichlorophenyl)-2-[[4-[4-[4-(2-methylpropylsulfonylamino)phenoxy]phenyl]phenyl]methyl]imidazol-1-yl]-2-(trifluoromethyl)benzoate Chemical compound C1=C(C(F)(F)F)C(C(=O)OC)=CC(N2C(=NC(=C2)C=2C(=CC(Cl)=CC=2)Cl)CC=2C=CC(=CC=2)C=2C=CC(OC=3C=CC(NS(=O)(=O)CC(C)C)=CC=3)=CC=2)=C1 YNUHUKFMJNQTDX-UHFFFAOYSA-N 0.000 description 1
- BQRFYYMQQKPDGK-UHFFFAOYSA-N methyl 5-[4-[3-[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]propyl]phenoxy]-2-nitrobenzoate Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1CCCC(C=C1)=CC=C1OC1=CC=C([N+]([O-])=O)C(C(=O)OC)=C1 BQRFYYMQQKPDGK-UHFFFAOYSA-N 0.000 description 1
- SYCRWDVQRHHKSY-UBKPWBPPSA-N methyl 5-[4-[4-[(e)-2-[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]ethenyl]phenyl]phenoxy]-2-(trifluoromethyl)benzoate Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1\C=C\C(C=C1)=CC=C1C(C=C1)=CC=C1OC1=CC=C(C(F)(F)F)C(C(=O)OC)=C1 SYCRWDVQRHHKSY-UBKPWBPPSA-N 0.000 description 1
- RWVOYTWWPRFBLB-CNHKJKLMSA-N methyl 5-[4-[4-[(e)-2-[4-(2,4-difluorophenyl)-1-ethylimidazol-2-yl]ethenyl]phenyl]phenoxy]-2-(methanesulfonamido)benzoate Chemical compound CCN1C=C(C=2C(=CC(F)=CC=2)F)N=C1\C=C\C(C=C1)=CC=C1C(C=C1)=CC=C1OC1=CC=C(NS(C)(=O)=O)C(C(=O)OC)=C1 RWVOYTWWPRFBLB-CNHKJKLMSA-N 0.000 description 1
- KWMLIAAIQHOFQX-UHFFFAOYSA-N methyl 6-[4-[4-[[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]methyl]phenyl]phenoxy]pyridine-3-carboxylate Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1CC(C=C1)=CC=C1C(C=C1)=CC=C1OC1=CC=C(C(=O)OC)C=N1 KWMLIAAIQHOFQX-UHFFFAOYSA-N 0.000 description 1
- RMEDXVIWDFLGES-UHFFFAOYSA-N methyl 6-chloropyridine-3-carboxylate Chemical compound COC(=O)C1=CC=C(Cl)N=C1 RMEDXVIWDFLGES-UHFFFAOYSA-N 0.000 description 1
- UFBYZIGTTYMVBM-UHFFFAOYSA-N methyl 6-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate Chemical compound OC1=CC=C2CNC(C(=O)OC)CC2=C1 UFBYZIGTTYMVBM-UHFFFAOYSA-N 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 1
- KQSSATDQUYCRGS-UHFFFAOYSA-N methyl glycinate Chemical compound COC(=O)CN KQSSATDQUYCRGS-UHFFFAOYSA-N 0.000 description 1
- LRMHVVPPGGOAJQ-UHFFFAOYSA-N methyl nitrate Chemical compound CO[N+]([O-])=O LRMHVVPPGGOAJQ-UHFFFAOYSA-N 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- SNVLJLYUUXKWOJ-UHFFFAOYSA-N methylidenecarbene Chemical compound C=[C] SNVLJLYUUXKWOJ-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- YNADRQHQKCKSCL-UHFFFAOYSA-N morpholine-2,4-diyl Chemical group C1C[O+]=CC[N-]1 YNADRQHQKCKSCL-UHFFFAOYSA-N 0.000 description 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-O morpholinium Chemical compound [H+].C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-O 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- FMASTMURQSHELY-UHFFFAOYSA-N n-(4-fluoro-2-methylphenyl)-3-methyl-n-[(2-methyl-1h-indol-4-yl)methyl]pyridine-4-carboxamide Chemical compound C1=CC=C2NC(C)=CC2=C1CN(C=1C(=CC(F)=CC=1)C)C(=O)C1=CC=NC=C1C FMASTMURQSHELY-UHFFFAOYSA-N 0.000 description 1
- VBBUFMFZDHLELS-UHFFFAOYSA-N n-(oxomethylidene)carbamoyl chloride Chemical compound ClC(=O)N=C=O VBBUFMFZDHLELS-UHFFFAOYSA-N 0.000 description 1
- BEKCXAJXAKIESF-UHFFFAOYSA-N n-[3-[4-[[1-[(4-aminophenyl)methyl]-4-(2,4-dichlorophenyl)imidazol-2-yl]methyl]phenyl]phenyl]methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=CC(C=2C=CC(CC=3N(C=C(N=3)C=3C(=CC(Cl)=CC=3)Cl)CC=3C=CC(N)=CC=3)=CC=2)=C1 BEKCXAJXAKIESF-UHFFFAOYSA-N 0.000 description 1
- BIESKFHDJJKTIV-UHFFFAOYSA-N n-[3-[4-[[4-(2,4-dichlorophenyl)-1-[(4-nitrophenyl)methyl]imidazol-2-yl]methyl]phenyl]phenyl]methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=CC(C=2C=CC(CC=3N(C=C(N=3)C=3C(=CC(Cl)=CC=3)Cl)CC=3C=CC(=CC=3)[N+]([O-])=O)=CC=2)=C1 BIESKFHDJJKTIV-UHFFFAOYSA-N 0.000 description 1
- HZCXOWFQTYOYCN-KPSZGOFPSA-N n-[4-[4-[4-[(e)-2-[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]ethenyl]phenyl]phenoxy]phenyl]-1,1,1-trifluoro-n-methylmethanesulfonamide Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1\C=C\C(C=C1)=CC=C1C(C=C1)=CC=C1OC1=CC=C(N(C)S(=O)(=O)C(F)(F)F)C=C1 HZCXOWFQTYOYCN-KPSZGOFPSA-N 0.000 description 1
- XJXOTRWABJELIX-BLLMUTORSA-N n-[4-[4-[4-[(e)-2-[4-(2,4-dichlorophenyl)-1-ethylimidazol-2-yl]ethenyl]phenyl]phenoxy]phenyl]-1,1,1-trifluoromethanesulfonamide Chemical compound CCN1C=C(C=2C(=CC(Cl)=CC=2)Cl)N=C1\C=C\C(C=C1)=CC=C1C(C=C1)=CC=C1OC1=CC=C(NS(=O)(=O)C(F)(F)F)C=C1 XJXOTRWABJELIX-BLLMUTORSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- NNKPHNTWNILINE-UHFFFAOYSA-N n-cyclopropyl-3-fluoro-4-methyl-5-[3-[[1-[2-[2-(methylamino)ethoxy]phenyl]cyclopropyl]amino]-2-oxopyrazin-1-yl]benzamide Chemical compound CNCCOC1=CC=CC=C1C1(NC=2C(N(C=3C(=C(F)C=C(C=3)C(=O)NC3CC3)C)C=CN=2)=O)CC1 NNKPHNTWNILINE-UHFFFAOYSA-N 0.000 description 1
- ICTGBOFCIDHVPA-UHFFFAOYSA-N n-methylsulfonylmethanesulfonamide Chemical compound CS(=O)(=O)NS(C)(=O)=O ICTGBOFCIDHVPA-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004957 naphthylene group Chemical group 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 150000002828 nitro derivatives Chemical class 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960001494 octreotide acetate Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 1
- 229940014662 pantothenate Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229960002296 paroxetine Drugs 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- LIGACIXOYTUXAW-UHFFFAOYSA-N phenacyl bromide Chemical compound BrCC(=O)C1=CC=CC=C1 LIGACIXOYTUXAW-UHFFFAOYSA-N 0.000 description 1
- WSDQIHATCCOMLH-UHFFFAOYSA-N phenyl n-(3,5-dichlorophenyl)carbamate Chemical compound ClC1=CC(Cl)=CC(NC(=O)OC=2C=CC=CC=2)=C1 WSDQIHATCCOMLH-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- ASUOLLHGALPRFK-UHFFFAOYSA-N phenylphosphonoylbenzene Chemical group C=1C=CC=CC=1P(=O)C1=CC=CC=C1 ASUOLLHGALPRFK-UHFFFAOYSA-N 0.000 description 1
- 150000008105 phosphatidylcholines Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 125000005544 phthalimido group Chemical group 0.000 description 1
- 229940075930 picrate Drugs 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- LZMJNVRJMFMYQS-UHFFFAOYSA-N poseltinib Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(OC=2C=C(NC(=O)C=C)C=CC=2)=C(OC=C2)C2=N1 LZMJNVRJMFMYQS-UHFFFAOYSA-N 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- QPMDWIOUHQWKHV-ODZAUARKSA-M potassium;(z)-4-hydroxy-4-oxobut-2-enoate Chemical compound [K+].OC(=O)\C=C/C([O-])=O QPMDWIOUHQWKHV-ODZAUARKSA-M 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000002810 primary assay Methods 0.000 description 1
- CPTBDICYNRMXFX-UHFFFAOYSA-N procarbazine Chemical compound CNNCC1=CC=C(C(=O)NC(C)C)C=C1 CPTBDICYNRMXFX-UHFFFAOYSA-N 0.000 description 1
- 229960000624 procarbazine Drugs 0.000 description 1
- IVRIRQXJSNCSPQ-UHFFFAOYSA-N propan-2-yl carbonochloridate Chemical compound CC(C)OC(Cl)=O IVRIRQXJSNCSPQ-UHFFFAOYSA-N 0.000 description 1
- KPBSJEBFALFJTO-UHFFFAOYSA-N propane-1-sulfonyl chloride Chemical compound CCCS(Cl)(=O)=O KPBSJEBFALFJTO-UHFFFAOYSA-N 0.000 description 1
- DRINJBFRTLBHNF-UHFFFAOYSA-N propane-2-sulfonyl chloride Chemical compound CC(C)S(Cl)(=O)=O DRINJBFRTLBHNF-UHFFFAOYSA-N 0.000 description 1
- 125000006628 propoxycarbonylamino group Chemical group 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 238000006268 reductive amination reaction Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 238000002805 secondary assay Methods 0.000 description 1
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 229910001467 sodium calcium phosphate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000012321 sodium triacetoxyborohydride Substances 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-N sodium;2-hydroxybenzoic acid Chemical compound [Na+].OC(=O)C1=CC=CC=C1O ABBQHOQBGMUPJH-UHFFFAOYSA-N 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 1
- 229960000553 somatostatin Drugs 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- NVBFHJWHLNUMCV-UHFFFAOYSA-N sulfamide Chemical compound NS(N)(=O)=O NVBFHJWHLNUMCV-UHFFFAOYSA-N 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical compound [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- 229960001940 sulfasalazine Drugs 0.000 description 1
- NCEXYHBECQHGNR-UHFFFAOYSA-N sulfasalazine Natural products C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 description 1
- 125000004646 sulfenyl group Chemical group S(*)* 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229960001685 tacrine Drugs 0.000 description 1
- YLJREFDVOIBQDA-UHFFFAOYSA-N tacrine Chemical compound C1=CC=C2C(N)=C(CCCC3)C3=NC2=C1 YLJREFDVOIBQDA-UHFFFAOYSA-N 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229960001603 tamoxifen Drugs 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 229950002757 teoclate Drugs 0.000 description 1
- YZUAOVCUGSBIPP-UHFFFAOYSA-N tert-butyl N-[1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl]carbamate Chemical compound C1=CC=CN2C(C(NC(=O)OC(C)(C)C)C)=NN=C21 YZUAOVCUGSBIPP-UHFFFAOYSA-N 0.000 description 1
- LFKDJXLFVYVEFG-UHFFFAOYSA-N tert-butyl carbamate Chemical group CC(C)(C)OC(N)=O LFKDJXLFVYVEFG-UHFFFAOYSA-N 0.000 description 1
- FQFILJKFZCVHNH-UHFFFAOYSA-N tert-butyl n-[3-[(5-bromo-2-chloropyrimidin-4-yl)amino]propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCNC1=NC(Cl)=NC=C1Br FQFILJKFZCVHNH-UHFFFAOYSA-N 0.000 description 1
- JMYNZGMPYGLNOM-UHFFFAOYSA-N tert-butyl n-[[4-[5-(2,4-dichlorophenyl)-1h-imidazol-2-yl]phenyl]methyl]carbamate Chemical compound C1=CC(CNC(=O)OC(C)(C)C)=CC=C1C1=NC(C=2C(=CC(Cl)=CC=2)Cl)=CN1 JMYNZGMPYGLNOM-UHFFFAOYSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 229960002784 thioridazine Drugs 0.000 description 1
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- OUDSBRTVNLOZBN-UHFFFAOYSA-N tolazamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)NN1CCCCCC1 OUDSBRTVNLOZBN-UHFFFAOYSA-N 0.000 description 1
- 229960002277 tolazamide Drugs 0.000 description 1
- 229960005371 tolbutamide Drugs 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- PHLBKPHSAVXXEF-UHFFFAOYSA-N trazodone Chemical compound ClC1=CC=CC(N2CCN(CCCN3C(N4C=CC=CC4=N3)=O)CC2)=C1 PHLBKPHSAVXXEF-UHFFFAOYSA-N 0.000 description 1
- 229960003991 trazodone Drugs 0.000 description 1
- 125000004665 trialkylsilyl group Chemical group 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 229940066528 trichloroacetate Drugs 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- KAKQVSNHTBLJCH-UHFFFAOYSA-N trifluoromethanesulfonimidic acid Chemical compound NS(=O)(=O)C(F)(F)F KAKQVSNHTBLJCH-UHFFFAOYSA-N 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
- 125000006493 trifluoromethyl benzyl group Chemical group 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- GXPHKUHSUJUWKP-UHFFFAOYSA-N troglitazone Chemical compound C1CC=2C(C)=C(O)C(C)=C(C)C=2OC1(C)COC(C=C1)=CC=C1CC1SC(=O)NC1=O GXPHKUHSUJUWKP-UHFFFAOYSA-N 0.000 description 1
- 229960001641 troglitazone Drugs 0.000 description 1
- GXPHKUHSUJUWKP-NTKDMRAZSA-N troglitazone Natural products C([C@@]1(OC=2C(C)=C(C(=C(C)C=2CC1)O)C)C)OC(C=C1)=CC=C1C[C@H]1SC(=O)NC1=O GXPHKUHSUJUWKP-NTKDMRAZSA-N 0.000 description 1
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 229940070710 valerate Drugs 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- MSRILKIQRXUYCT-UHFFFAOYSA-M valproate semisodium Chemical compound [Na+].CCCC(C(O)=O)CCC.CCCC(C([O-])=O)CCC MSRILKIQRXUYCT-UHFFFAOYSA-M 0.000 description 1
- 229960000604 valproic acid Drugs 0.000 description 1
- 229960003048 vinblastine Drugs 0.000 description 1
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 1
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 1
- 229960004528 vincristine Drugs 0.000 description 1
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Hospice & Palliative Care (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54397104P | 2004-02-12 | 2004-02-12 | |
| US60/543,971 | 2004-02-12 | ||
| PCT/US2005/004590 WO2005080346A1 (en) | 2004-02-12 | 2005-02-11 | Substituted azole derivatives, compositions, and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2005214349A1 AU2005214349A1 (en) | 2005-09-01 |
| AU2005214349B2 true AU2005214349B2 (en) | 2011-11-03 |
Family
ID=34885991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2005214349A Ceased AU2005214349B2 (en) | 2004-02-12 | 2005-02-11 | Substituted azole derivatives, compositions, and methods of use |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20050187277A1 (enExample) |
| EP (1) | EP1730118A1 (enExample) |
| JP (1) | JP4898458B2 (enExample) |
| CN (1) | CN1922151A (enExample) |
| AU (1) | AU2005214349B2 (enExample) |
| CA (1) | CA2551909C (enExample) |
| IL (1) | IL176571A0 (enExample) |
| NZ (1) | NZ548208A (enExample) |
| WO (1) | WO2005080346A1 (enExample) |
| ZA (1) | ZA200605526B (enExample) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007527912A (ja) * | 2004-03-08 | 2007-10-04 | ワイス | イオンチャンネルモジュレーター |
| EP1722787A4 (en) * | 2004-03-08 | 2007-09-26 | Wyeth Corp | ION CHANNEL MODULATORS |
| BRPI0511504A (pt) * | 2004-05-26 | 2008-01-22 | Eisai R&D Man Co Ltd | composto ou um sal farmaceuticamente aceitável do mesmo, e, agente preventivo ou terapêutico para uma doença resultante de beta-amilóides |
| MXPA06014909A (es) * | 2004-06-18 | 2007-02-28 | Chiron Corp | Derivados de n-(1-(1-bencil -4-fenil-1h -imidazol -2-il)-2, 2-dimetilpropil) benzamida y compuestos relacionados como inhibidores de proteina de huso de cinesina (ksp) para el tratamiento del cancer. |
| EP1808432B1 (en) | 2004-10-26 | 2010-02-24 | Eisai R&D Management Co., Ltd. | Amorphous form of cinnamide compound |
| CA2598365A1 (en) * | 2005-02-18 | 2006-11-16 | Innodia Inc. | Analogs of 4-hydroxyisoleucine and uses thereof |
| CN101252926A (zh) * | 2005-03-22 | 2008-08-27 | 因诺迪亚有限公司 | 用于预防和治疗肥胖症及相关综合征的化合物与组合物 |
| WO2007058304A1 (ja) * | 2005-11-18 | 2007-05-24 | Eisai R & D Management Co., Ltd. | シンナミド化合物の塩またはそれらの溶媒和物 |
| CA2628047A1 (en) * | 2005-11-18 | 2007-05-24 | Eisai R & D Management Co., Ltd. | Process for production of cinnamide derivative |
| JP5221144B2 (ja) * | 2005-11-24 | 2013-06-26 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | モルホリンタイプ・シンナミド化合物 |
| TWI370130B (en) | 2005-11-24 | 2012-08-11 | Eisai R&D Man Co Ltd | Two cyclic cinnamide compound |
| US7723369B2 (en) * | 2006-01-30 | 2010-05-25 | Transtech Pharma, Inc. | Substituted imidazole derivatives, compositions, and methods of use as PTPase inhibitors |
| TWI378091B (en) * | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
| CA2643796A1 (en) * | 2006-03-09 | 2007-09-13 | Eisai R & D Management Co., Ltd. | Polycyclic cinnamide derivatives |
| AR059898A1 (es) | 2006-03-15 | 2008-05-07 | Janssen Pharmaceutica Nv | Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2 |
| US20100048545A1 (en) * | 2006-03-22 | 2010-02-25 | Innodia Inc. | Compounds and Compositions for Use in the Prevention and Treatment of Disorders of Fat Metabolism and Obesity |
| US7737141B2 (en) * | 2006-07-28 | 2010-06-15 | Eisai R&D Management Co., Ltd. | Prodrug of cinnamide compound |
| CA2667003A1 (en) * | 2006-10-20 | 2008-05-02 | Merck & Co., Inc. | Substituted imidazoles as bombesin receptor subtype-3 modulators |
| BRPI0717976A2 (pt) * | 2006-10-20 | 2013-11-12 | Merck & Co Inc | Composto ou um sal farmaceuticamente aceitável do mesmo, composição, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo |
| AU2007309568A1 (en) * | 2006-10-20 | 2008-05-02 | Merck Sharp & Dohme Corp. | Substituted imidazoles as bombesin receptor subtype-3 modulators |
| JP5313161B2 (ja) * | 2006-12-11 | 2013-10-09 | メルク・シャープ・アンド・ドーム・コーポレーション | ボンベシンレセプターサブタイプ−３調節因子としての置換ジアゼピンスルホンアミド |
| KR20090097210A (ko) * | 2007-01-05 | 2009-09-15 | 노파르티스 아게 | 키네신 방추체 단백질 (ｅｇ－５) 억제제로서의 이미다졸 유도체 |
| CL2008000582A1 (es) * | 2007-02-28 | 2008-06-27 | Eisai R&D Man Co Ltd | Compuestos ciclicos derivados de oximorfolina condensados; farmacos que comprenden a dichos compuestos; y su uso para tratar enfermedad de alzheimer, demencia senil, sindrome de down o amiloidosis. |
| CN101679360A (zh) * | 2007-05-16 | 2010-03-24 | 卫材R&D管理有限公司 | 一步生产肉桂酰胺衍生物的方法 |
| KR20100055456A (ko) * | 2007-08-31 | 2010-05-26 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 다환식 화합물 |
| US7935815B2 (en) * | 2007-08-31 | 2011-05-03 | Eisai R&D Management Co., Ltd. | Imidazoyl pyridine compounds and salts thereof |
| EP2239265A1 (en) * | 2008-01-28 | 2010-10-13 | Eisai R&D Management Co., Ltd. | Crystalline cinnamide compounds or salts thereof |
| WO2010036613A1 (en) * | 2008-09-26 | 2010-04-01 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| MY158622A (en) * | 2008-10-06 | 2016-10-31 | Shikoku Chem | 2-benzyl-4-(2,4-dichlorophenyl)-5-methylimidazole compound |
| WO2010042652A2 (en) | 2008-10-08 | 2010-04-15 | Amira Pharmaceuticals, Inc. | Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors |
| EA020017B1 (ru) | 2009-04-30 | 2014-08-29 | Новартис Аг | Производные имидазола и их применение в качестве модуляторов циклинзависимых киназ |
| JP5368244B2 (ja) * | 2009-10-14 | 2013-12-18 | 四国化成工業株式会社 | ２−（２，４−ジクロロベンジル）−４−アリール−５−メチルイミダゾール化合物 |
| JP5368263B2 (ja) * | 2009-11-04 | 2013-12-18 | 四国化成工業株式会社 | ４−（２，４−ジクロロフェニル）−５−メチルイミダゾール化合物 |
| JP5368271B2 (ja) * | 2009-11-20 | 2013-12-18 | 四国化成工業株式会社 | ４−（４−ビフェニリル）−２−（２，４−ジクロロベンジル）イミダゾールおよび表面処理液 |
| JP5398076B2 (ja) * | 2009-12-10 | 2014-01-29 | 四国化成工業株式会社 | ２−（ブロモベンジル）−４−（ブロモフェニル）−５−メチルイミダゾール化合物 |
| JP5398075B2 (ja) * | 2010-01-13 | 2014-01-29 | 四国化成工業株式会社 | ４−（ジクロロフェニル）−２−（４−フルオロベンジル）−５−メチルイミダゾール化合物 |
| AU2011218830B2 (en) | 2010-02-25 | 2014-07-24 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| EP2590951B1 (en) | 2010-07-09 | 2015-01-07 | Pfizer Limited | Benzenesulfonamides useful as sodium channel inhibitors |
| US9102621B2 (en) | 2010-07-12 | 2015-08-11 | Pfizer Limited | Acyl sulfonamide compounds |
| JP2013536165A (ja) | 2010-07-12 | 2013-09-19 | ファイザー・リミテッド | 痛みの処置のためのｎａｖ１．７阻害薬としてのスルホンアミド誘導体 |
| US8772343B2 (en) | 2010-07-12 | 2014-07-08 | Pfizer Limited | Chemical compounds |
| CA2804716A1 (en) | 2010-07-12 | 2012-01-19 | Pfizer Limited | Chemical compounds |
| EP2593432B1 (en) | 2010-07-12 | 2014-10-22 | Pfizer Limited | N-sulfonylbenzamide derivatives useful as voltage gated sodium channel inhibitors |
| WO2012014109A1 (en) | 2010-07-30 | 2012-02-02 | Ranbaxy Laboratories Limited | Heterocyclic sulfonamides as inhibitors of transfer rna synthetase for use as antibacterial agents |
| US8691184B2 (en) * | 2011-01-25 | 2014-04-08 | The Regents Of The University Of Michigan | Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same |
| WO2012139010A1 (en) * | 2011-04-08 | 2012-10-11 | University Of Kansas | Grp94 inhibitors |
| JPWO2014123203A1 (ja) * | 2013-02-06 | 2017-02-02 | 京都薬品工業株式会社 | 糖尿病治療薬 |
| SI3013796T1 (sl) * | 2013-06-27 | 2020-07-31 | Lg Chem, Ltd. | Biaril derivati kot GPR120 agonisti |
| WO2015120610A1 (en) * | 2014-02-14 | 2015-08-20 | Eli Lilly And Company | Gpr142 agonist compound |
| WO2019036024A1 (en) | 2017-08-17 | 2019-02-21 | Bristol-Myers Squibb Company | 2- (1,1'-BIPHENYL) -1H-BENZO [D] IMIDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS AGONISTS OF APELIN AND APJ FOR THE TREATMENT OF CARDIOVASCULAR DISEASES |
| CN109825849B (zh) * | 2019-01-25 | 2021-02-19 | 华南理工大学 | 一种三氟甲基乙烯基类化合物的电化学制备方法 |
| EP4225435B1 (en) * | 2020-10-09 | 2024-12-11 | Bristol-Myers Squibb Company | Aminoimidazole fpr2 agonists |
| WO2023107705A1 (en) | 2021-12-10 | 2023-06-15 | Incyte Corporation | Bicyclic amines as cdk12 inhibitors |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994008982A1 (fr) * | 1992-10-13 | 1994-04-28 | Nippon Soda Co., Ltd. | Derives oxazole et thiazole |
| WO2000071120A1 (en) * | 1999-05-25 | 2000-11-30 | Smithkline Beecham Corporation | Antibacterial compounds |
| JP2002114768A (ja) * | 2000-10-11 | 2002-04-16 | Japan Tobacco Inc | ２−（２，５−ジハロゲン−３，４−ジヒドロキシフェニル）アゾール化合物及びそれを含有してなる医薬組成物 |
| WO2002032897A1 (en) * | 2000-10-20 | 2002-04-25 | Pfizer Products Inc. | Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| EP1227084A1 (en) * | 1999-10-28 | 2002-07-31 | Microcide Pharmaceuticals, Inc. | Drug discharge pump inhibitors |
| EP1253142A1 (en) * | 2000-01-24 | 2002-10-30 | Shionogi & Co., Ltd. | Compounds exhibiting thrombopoietin receptor agonism |
| WO2003048140A1 (en) * | 2001-12-03 | 2003-06-12 | Japan Tobacco Inc. | Azole compound and medicinal use thereof |
| JP2003231679A (ja) * | 2001-12-03 | 2003-08-19 | Japan Tobacco Inc | アゾール化合物及びその医薬用途 |
| WO2003075921A2 (en) * | 2002-03-05 | 2003-09-18 | Transtech Pharma, Inc. | Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| WO2003093263A1 (en) * | 2002-05-02 | 2003-11-13 | Neurogen Corporation | Substituted imidazole derivatives: gabaa receptor ligands |
| AU2004210711A1 (en) * | 2003-02-12 | 2004-08-26 | Transtech Pharma, Inc. | Substituted azole derivatives as therapeutic agents |
Family Cites Families (75)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4546113A (en) * | 1983-04-14 | 1985-10-08 | Pfizer Inc. | Antiprotozoal diamidines |
| CA2009925C (en) * | 1989-02-14 | 2002-10-01 | Koichi Kondo | Method for enhancement of chemiluminescence |
| DE69330713T2 (de) * | 1992-03-13 | 2002-07-04 | Merck Sharp & Dohme Ltd., Hoddesdon | Imidazol-, triazol- und tetrazolderivate |
| CA2171610A1 (en) * | 1993-09-14 | 1995-03-23 | Gideon A. Rodan | Cdna encoding a novel human protein tyrosine phosphatase |
| US5616601A (en) * | 1994-07-28 | 1997-04-01 | Gd Searle & Co | 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation |
| US5700816A (en) * | 1995-06-12 | 1997-12-23 | Isakson; Peter C. | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor |
| JPH11507670A (ja) * | 1995-06-12 | 1999-07-06 | ジー．ディー．サール アンド カンパニー | シクロオキシゲナーゼ−２インヒビターと５−リポキシゲナーゼインヒビターの組合せによる炎症と炎症関連疾患の治療 |
| US6388076B1 (en) * | 1995-06-19 | 2002-05-14 | Ontogen Corporation | Protein tyrosine phosphatase-inhibiting compounds |
| US5753687A (en) * | 1995-06-19 | 1998-05-19 | Ontogen Corporation | Modulators of proteins with phosphotryrosine recognition units |
| US6238902B1 (en) * | 1996-03-22 | 2001-05-29 | Genentech, Inc. | Protein tyrosine phosphatases |
| US5958957A (en) * | 1996-04-19 | 1999-09-28 | Novo Nordisk A/S | Modulators of molecules with phosphotyrosine recognition units |
| US5840721A (en) * | 1997-07-09 | 1998-11-24 | Ontogen Corporation | Imidazole derivatives as MDR modulators |
| GB9715816D0 (en) * | 1997-07-25 | 1997-10-01 | Black James Foundation | Histamine H receptor ligands |
| FR2767527B1 (fr) * | 1997-08-25 | 1999-11-12 | Pf Medicament | Derives de piperazines indoliques, utiles comme medicaments et procede de preparation |
| US6169087B1 (en) * | 1997-09-23 | 2001-01-02 | Novo Nordisk A/S | Modulators of protein tyrosine phosphatases (PTPases) |
| US5972986A (en) * | 1997-10-14 | 1999-10-26 | G.D. Searle & Co. | Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| US6159944A (en) * | 1998-02-27 | 2000-12-12 | Synchroneuron, Llc | Method for treating painful conditions of the anal region and compositions therefor |
| US6262044B1 (en) * | 1998-03-12 | 2001-07-17 | Novo Nordisk A/S | Modulators of protein tyrosine phosphatases (PTPASES) |
| US20020002199A1 (en) * | 1998-03-12 | 2002-01-03 | Lone Jeppesen | Modulators of protein tyrosine phosphatases (ptpases) |
| WO1999061410A1 (en) * | 1998-05-12 | 1999-12-02 | American Home Products Corporation | 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| US6699896B1 (en) * | 1998-05-12 | 2004-03-02 | Wyeth | Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| US20030194745A1 (en) * | 1998-06-26 | 2003-10-16 | Mcdowell Robert S. | Cysteine mutants and methods for detecting ligand binding to biological molecules |
| JP2004514402A (ja) * | 1998-07-24 | 2004-05-20 | メルク フロスト カナダ アンド カンパニー | プロテインチロシンホスファターゼ−１ｂ（ｐｔｐ−１ｂ）欠失マウスおよびその使用 |
| US6174874B1 (en) * | 1998-09-21 | 2001-01-16 | Merck Frosst Canada & Co. | Phosphonic acids derivatives as inhibitors of protein tyrosine phosphate 1B (PTP-1B) |
| US6534056B1 (en) * | 1998-12-11 | 2003-03-18 | Mcgill University | Therapeutic and diagnostic uses of protein tyrosine phosphatase TC-PTP |
| JP4221129B2 (ja) * | 1999-02-15 | 2009-02-12 | 富士フイルム株式会社 | 含窒素ヘテロ環化合物、有機発光素子材料、有機発光素子 |
| AU4738600A (en) * | 1999-05-14 | 2000-12-05 | Merck Frosst Canada & Co. | Phosphonic and carboxylic acid derivatives as inhibitors of protein tyrosine phosphatase-1b (ptp-1b) |
| DE60007697T2 (de) * | 1999-07-21 | 2004-12-09 | F. Hoffmann-La Roche Ag | Triazolderivate |
| JP2003508382A (ja) * | 1999-08-27 | 2003-03-04 | スージェン・インコーポレーテッド | リン酸模倣体およびホスファターゼ阻害剤を用いる治療方法 |
| US6410556B1 (en) * | 1999-09-10 | 2002-06-25 | Novo Nordisk A/S | Modulators of protein tyrosine phosphateses (PTPases) |
| US6777433B2 (en) * | 1999-12-22 | 2004-08-17 | Merck Frosst Canada & Co. | Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonates |
| WO2001046206A1 (en) * | 1999-12-22 | 2001-06-28 | Merck Frosst Canada & Co. | Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| US6486141B2 (en) * | 1999-12-22 | 2002-11-26 | Merck Frosst Canada & Co. | Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B) |
| JP2003518128A (ja) * | 1999-12-22 | 2003-06-03 | メルク フロスト カナダ アンド カンパニー | タンパク質チロシンホスファターゼ１ｂ（ｐｔｐ−１ｂ）のインヒビターとなる芳香族ホスホネート |
| WO2001046205A1 (en) * | 1999-12-22 | 2001-06-28 | Merck Frosst Canada & Co. | Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| JP2003520049A (ja) * | 2000-01-18 | 2003-07-02 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | ヒトタンパク質であるチロシンホスファターゼのポリヌクレオチド、ポリペプチド、および抗体 |
| EP1257824A2 (en) * | 2000-02-14 | 2002-11-20 | Ceptyr, Inc. | Improved assay for protein tyrosine phosphatases |
| AU4398801A (en) * | 2000-03-22 | 2001-10-03 | Banyu Pharmaceutical Co., Ltd. | Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors |
| US6627647B1 (en) * | 2000-03-23 | 2003-09-30 | Boehringer Ingelheim Pharmaceuticals, Inc. | Substituted 1-(4-aminophenyl)imidazoles and their use as anti-inflammatory agents |
| AU2001258784A1 (en) * | 2000-05-22 | 2001-12-03 | Takeda Chemical Industries Ltd. | Tyrosine phosphatase inhibitors |
| IL153804A0 (en) * | 2000-07-06 | 2003-07-31 | Array Biopharma Inc | Tyrosine derivatives as phosphatase inhibitors |
| US20020099073A1 (en) * | 2000-07-07 | 2002-07-25 | Andersen Henrik Sune | Modulators of protein tyrosine phosphatases (PTPases) |
| US6613903B2 (en) * | 2000-07-07 | 2003-09-02 | Novo Nordisk A/S | Modulators of protein tyrosine phosphatases (PTPases) |
| US20020035137A1 (en) * | 2000-08-29 | 2002-03-21 | Gang Liu | Amino (oxo) acetic acid protein tyrosine phosphatase inhibitors |
| US20020169157A1 (en) * | 2000-08-29 | 2002-11-14 | Gang Liu | Selective protein tyrosine phosphatatase inhibitors |
| US6627767B2 (en) * | 2000-08-29 | 2003-09-30 | Abbott Laboratories | Amino(oxo) acetic acid protein tyrosine phosphatase inhibitors |
| US6972340B2 (en) * | 2000-08-29 | 2005-12-06 | Abbott Laboratories | Selective protein tyrosine phosphatatase inhibitors |
| US6472545B2 (en) * | 2000-08-29 | 2002-10-29 | Abbott Laboratories | Protein tyrosine phosphatase inhibitors |
| GB0022079D0 (en) * | 2000-09-08 | 2000-10-25 | Inst Of Molecul & Cell Biology | Novel protein tyrosine phosphatase inhibitor |
| US20030108883A1 (en) * | 2001-02-13 | 2003-06-12 | Rondinone Cristina M. | Methods for identifying compounds that inhibit or reduce PTP1B expression |
| US20030120073A1 (en) * | 2001-04-25 | 2003-06-26 | Seto Christopher T. | Alpha-ketocarboxylic acid based inhibitors of phosphoryl tyrosine phosphatases |
| US7163932B2 (en) * | 2001-06-20 | 2007-01-16 | Merck Frosst Canada & Co. | Aryldifluoromethylphosphonic acids for treatment of diabetes |
| US20030064979A1 (en) * | 2001-06-29 | 2003-04-03 | Hansen Thomas Kruse | Method of inhibiting PTP 1B and /or T-cell PTP and/or other PTPases with an Asp residue at position 48 |
| US20030170660A1 (en) * | 2001-07-11 | 2003-09-11 | Sondergaard Helle Bach | P387L variant in protein tyrosine phosphatase-1B is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro |
| EP1435951B1 (en) * | 2001-10-12 | 2006-01-18 | Bayer Pharmaceuticals Corporation | Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity |
| ES2278064T3 (es) * | 2001-10-19 | 2007-08-01 | Transtech Pharma Inc. | Derivados de beta-carbolina como inhibidores de ptp. |
| JP2005508355A (ja) * | 2001-10-19 | 2005-03-31 | トランス テック ファーマ，インコーポレイテッド | 治療薬としてのビス−ヘテロアリールアルカン |
| US6642381B2 (en) * | 2001-12-27 | 2003-11-04 | Hoffman-La Roche Inc. | Pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds as protein tyrosine phosphatase inhibitors |
| US20030180827A1 (en) * | 2002-01-04 | 2003-09-25 | Aventis Pharma Deutschland Gmbh. | Highly sensitive and continuous protein tyrosine phosphatase test using 6,8-difluoro-4-methylumbelliferyl phosphate |
| US20030215899A1 (en) * | 2002-02-13 | 2003-11-20 | Ceptyr, Inc. | Reversible oxidation of protein tyrosine phosphatases |
| US6784205B2 (en) * | 2002-03-01 | 2004-08-31 | Sunesis Pharmaceuticals, Inc. | Compounds that modulate the activity of PTP-1B and TC-PTP |
| US7291635B2 (en) * | 2002-04-03 | 2007-11-06 | Novartis Ag | 5-substituted 1,1-dioxo-1,2,5,-thiadiazolidin-3-one derivatives |
| BR0309305A (pt) * | 2002-04-12 | 2005-02-15 | Pfizer | Compostos de imidazol como agentes antiinflamatórios e analgésicos |
| US20040009956A1 (en) * | 2002-04-29 | 2004-01-15 | Dehua Pei | Inhibition of protein tyrosine phosphatases and SH2 domains by a neutral phosphotyrosine mimetic |
| AU2003239897A1 (en) * | 2002-05-23 | 2003-12-12 | Ceptyr, Inc. | Modulation of ptp1b signal transduction by rna interference |
| DE60304718T2 (de) * | 2002-08-06 | 2007-04-26 | Astrazeneca Ab | Kondensierte pyridine und pyrimidine mit tie2 (tek) aktivität |
| US6849761B2 (en) * | 2002-09-05 | 2005-02-01 | Wyeth | Substituted naphthoic acid derivatives useful in the treatment of insulin resistance and hyperglycemia |
| WO2004062664A1 (en) * | 2002-12-30 | 2004-07-29 | Vertex Pharmaceuticals Incorporated | Sulfhydantoins as phosphate isosteres for use as phosphatase inhibitors in the treatment of cancer and autoimmune disorders |
| US7279576B2 (en) * | 2002-12-31 | 2007-10-09 | Deciphera Pharmaceuticals, Llc | Anti-cancer medicaments |
| US7144911B2 (en) * | 2002-12-31 | 2006-12-05 | Deciphera Pharmaceuticals Llc | Anti-inflammatory medicaments |
| US7135493B2 (en) * | 2003-01-13 | 2006-11-14 | Astellas Pharma Inc. | HDAC inhibitor |
| WO2004071448A2 (en) * | 2003-02-12 | 2004-08-26 | Transtech Pharma Inc. | Substituted azole derivatives as inhibitors of protein tyrosine phosphatases |
| US20040167188A1 (en) * | 2003-02-14 | 2004-08-26 | Zhili Xin | Protein-tyrosine phosphatase inhibitors and uses thereof |
| WO2005035551A2 (en) * | 2003-10-08 | 2005-04-21 | Incyte Corporation | Inhibitors of proteins that bind phosphorylated molecules |
| US7723369B2 (en) * | 2006-01-30 | 2010-05-25 | Transtech Pharma, Inc. | Substituted imidazole derivatives, compositions, and methods of use as PTPase inhibitors |
-
2005
- 2005-02-11 CA CA2551909A patent/CA2551909C/en not_active Expired - Fee Related
- 2005-02-11 EP EP05723026A patent/EP1730118A1/en not_active Withdrawn
- 2005-02-11 AU AU2005214349A patent/AU2005214349B2/en not_active Ceased
- 2005-02-11 WO PCT/US2005/004590 patent/WO2005080346A1/en not_active Ceased
- 2005-02-11 JP JP2006553310A patent/JP4898458B2/ja not_active Expired - Fee Related
- 2005-02-11 CN CNA2005800048601A patent/CN1922151A/zh active Pending
- 2005-02-11 US US11/056,498 patent/US20050187277A1/en not_active Abandoned
- 2005-02-11 ZA ZA200605526A patent/ZA200605526B/en unknown
- 2005-02-11 NZ NZ548208A patent/NZ548208A/en not_active IP Right Cessation
-
2006
- 2006-06-26 IL IL176571A patent/IL176571A0/en unknown
-
2010
- 2010-11-19 US US12/950,967 patent/US20110092553A1/en not_active Abandoned
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994008982A1 (fr) * | 1992-10-13 | 1994-04-28 | Nippon Soda Co., Ltd. | Derives oxazole et thiazole |
| WO2000071120A1 (en) * | 1999-05-25 | 2000-11-30 | Smithkline Beecham Corporation | Antibacterial compounds |
| EP1227084A1 (en) * | 1999-10-28 | 2002-07-31 | Microcide Pharmaceuticals, Inc. | Drug discharge pump inhibitors |
| EP1253142A1 (en) * | 2000-01-24 | 2002-10-30 | Shionogi & Co., Ltd. | Compounds exhibiting thrombopoietin receptor agonism |
| JP2002114768A (ja) * | 2000-10-11 | 2002-04-16 | Japan Tobacco Inc | ２−（２，５−ジハロゲン−３，４−ジヒドロキシフェニル）アゾール化合物及びそれを含有してなる医薬組成物 |
| WO2002032897A1 (en) * | 2000-10-20 | 2002-04-25 | Pfizer Products Inc. | Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| WO2003048140A1 (en) * | 2001-12-03 | 2003-06-12 | Japan Tobacco Inc. | Azole compound and medicinal use thereof |
| JP2003231679A (ja) * | 2001-12-03 | 2003-08-19 | Japan Tobacco Inc | アゾール化合物及びその医薬用途 |
| WO2003075921A2 (en) * | 2002-03-05 | 2003-09-18 | Transtech Pharma, Inc. | Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| WO2003093263A1 (en) * | 2002-05-02 | 2003-11-13 | Neurogen Corporation | Substituted imidazole derivatives: gabaa receptor ligands |
| AU2004210711A1 (en) * | 2003-02-12 | 2004-08-26 | Transtech Pharma, Inc. | Substituted azole derivatives as therapeutic agents |
Non-Patent Citations (11)
| Title |
|---|
| CAS Registry number 101341-14-4 * |
| CAS Registry number 143150-90-7 * |
| CAS Registry number 143182-51-8 * |
| CAS Registry number 96271-51-1 * |
| CAS Registry number 96772-99-5 * |
| CAS Registry number 96975-63-2 * |
| CAS Registry number 98016-87-6 * |
| Cocco, M. T. et al (1992) Il. Farm. 47:229-238 * |
| Laufer, S. A. et al (2002) J. Med. Chem. 45:4695-4705 * |
| Lipshutz, B. H. and Hungate, R. W. (1981) J. Org. Chem. 46:1410-1413 * |
| Meanwell, N. A. et al (1992) J. Med. Chem. 35:3483-3497 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2551909A1 (en) | 2005-09-01 |
| AU2005214349A1 (en) | 2005-09-01 |
| JP4898458B2 (ja) | 2012-03-14 |
| CN1922151A (zh) | 2007-02-28 |
| US20050187277A1 (en) | 2005-08-25 |
| WO2005080346A1 (en) | 2005-09-01 |
| ZA200605526B (en) | 2007-11-28 |
| IL176571A0 (en) | 2006-10-31 |
| NZ548208A (en) | 2010-09-30 |
| CA2551909C (en) | 2011-10-11 |
| EP1730118A1 (en) | 2006-12-13 |
| JP2007523903A (ja) | 2007-08-23 |
| US20110092553A1 (en) | 2011-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2005214349B2 (en) | Substituted azole derivatives, compositions, and methods of use | |
| AU2004210711B2 (en) | Substituted azole derivatives as therapeutic agents | |
| US20040186151A1 (en) | Substituted azole derivatives as therapeutic agents | |
| CN100575330C (zh) | 新化合物 | |
| US6933303B2 (en) | Heteroaryl-fused nitrogen heterocycles as therapeutic agents | |
| US7459472B2 (en) | Aryl and heteroaryl compounds, compositions, and methods of use | |
| AU2007211319B2 (en) | Substituted imidazole derivatives and their use as PTPase inhibitors | |
| US20060276518A1 (en) | Aryl and heteroaryl compounds and methods to modulate coagulation | |
| CA2525628C (en) | New benzimidazole derivatives | |
| US7115645B2 (en) | 1,2 diarylbenzimidazoles and their pharmaceutical use | |
| HRP940346A2 (en) | Imidazole 5-position substituted angiotensin ii antagonists | |
| US6875765B2 (en) | Arylsulfonamide ethers, and methods of use thereof | |
| US7582673B2 (en) | Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use | |
| EP2190811B1 (en) | Renin inhibitors | |
| KR20230116511A (ko) | 벤즈옥사지논 유도체 및 그를 포함하는 약제학적 조성물 | |
| KR20230132191A (ko) | Grk5 억제용 화합물, 이의 제조방법 및 이를 유효성분으로 포함하는 grk5 활성 관련 질환의 예방 또는 치료용 약학 조성물 | |
| US20210309616A1 (en) | Substituted quinazolines as matrix metalloproteinase-9 hemopexin domain inhibitors | |
| Chen et al. | Design and synthesis of new heterocyclic Bcr-Abl inhibitors | |
| HUP0002054A2 (hu) | N-4-(nitro-metil-szulfonil)-fenil-alkánamid és -benzolszulfonamid-származékok, alkalmazásuk, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények | |
| JP2002255799A (ja) | シクロブテン誘導体を含有する医薬組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TC | Change of applicant's name (sec. 104) |
Owner name: TRANSTECH PHARMA, INC. Free format text: FORMER NAME: TRANSTECH PHARMA INC. |
|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |